data_1pqr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1pqr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.23 -167.82 21.1 Favored Glycine 0 CA--C 1.56 2.872 0 N-CA-C 117.068 1.587 . . . . 0.0 117.068 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -53.94 -12.16 3.17 Favored 'Trans proline' 0 CA--C 1.563 1.958 1 N-CA-C 123.011 4.197 . . . . 0.0 123.011 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 . . . . . 0 N--CA 1.492 1.657 0 CA-C-N 119.611 1.096 . . . . 0.0 109.463 -169.59 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 . . . . . 0 N--CA 1.503 2.194 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.36 -92.0 0.14 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 169.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.25 -9.46 50.6 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 167.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.34 115.84 26.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.172 0.989 . . . . 0.0 111.435 -168.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.825 -174.3 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 1.208 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 20.7 t . . . . . 0 CA--C 1.558 1.285 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.66 -18.16 76.05 Favored Glycine 0 CA--C 1.569 3.46 0 O-C-N 121.868 -0.52 . . . . 0.0 114.242 167.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 m -74.94 172.63 11.93 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 126.458 1.903 . . . . 0.0 114.87 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -80.53 -76.9 0.21 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.183 169.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.0 m -95.55 142.11 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.713 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.51 85.04 0.95 Allowed Glycine 0 N--CA 1.483 1.828 0 CA-C-O 119.768 -0.462 . . . . 0.0 113.013 175.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 1.208 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER . . . . . 0 CA--C 1.566 1.578 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -169.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.5 p90 . . . . . 0 N--CA 1.495 1.823 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.0 t -83.7 -24.95 31.03 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -89.24 -28.87 19.64 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 124.333 1.053 . . . . 0.0 111.579 168.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 . . . . . 0 CA--C 1.573 1.832 0 CA-C-O 117.688 -1.149 . . . . 0.0 112.188 169.213 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 CA--C 1.56 1.362 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.901 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.84 -96.55 0.1 Allowed Glycine 0 CA--C 1.537 1.448 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 112.317 -0.313 . . . . 0.0 112.317 -179.962 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.38 -143.95 16.31 Favored Glycine 0 CA--C 1.558 2.763 0 CA-C-O 118.311 -1.272 . . . . 0.0 115.01 177.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -77.51 74.99 4.9 Favored 'Trans proline' 0 CA--C 1.566 2.091 0 C-N-CA 123.941 3.094 . . . . 0.0 114.099 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.547 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 63.5 m-85 . . . . . 0 CA--C 1.58 2.114 0 C-N-CA 125.218 1.407 . . . . 0.0 109.169 -171.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 . . . . . 0 N--CA 1.499 2.002 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.33 -84.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 120.504 1.502 . . . . 0.0 114.796 -169.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.02 -13.68 60.23 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 172.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 6' ' ' TYR . 1.7 t -74.2 118.42 17.15 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -168.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 . . . . . 0 CA--C 1.565 1.551 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -175.267 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.6 t . . . . . 0 CA--C 1.569 1.685 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.95 -33.98 87.19 Favored Glycine 0 CA--C 1.554 2.474 0 N-CA-C 116.564 1.386 . . . . 0.0 116.564 169.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.7 m -62.94 157.08 22.61 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -80.43 -71.21 0.47 Allowed 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.976 169.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.9 p -99.41 134.44 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.794 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.42 88.81 0.99 Allowed Glycine 0 N--CA 1.483 1.828 0 CA-C-O 119.757 -0.468 . . . . 0.0 112.663 175.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.423 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER . . . . . 0 CA--C 1.564 1.491 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -169.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.3 p90 . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.423 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 34.3 t -88.79 -24.14 22.69 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -89.58 -37.9 14.35 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 125.058 1.343 . . . . 0.0 111.88 169.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 . . . . . 0 CA--C 1.568 1.647 0 CA-C-O 116.891 -1.528 . . . . 0.0 111.457 169.513 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.8 m . . . . . 0 N--CA 1.485 1.298 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.36 -97.61 0.11 Allowed Glycine 0 CA--C 1.537 1.429 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.512 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.933 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 54.0 t . . . . . 0 CA--C 1.551 1.006 0 CA-C-O 116.602 -1.666 . . . . 0.0 108.285 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.8 -159.1 25.5 Favored Glycine 0 CA--C 1.561 2.958 0 CA-C-N 121.668 2.031 . . . . 0.0 115.187 -169.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -76.89 65.15 7.71 Favored 'Trans proline' 0 CA--C 1.568 2.184 0 C-N-CA 123.573 2.849 . . . . 0.0 117.258 -169.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 CA--C 1.568 1.644 0 N-CA-C 102.78 -3.044 . . . . 0.0 102.78 164.207 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 . . . . . 0 CA--C 1.564 1.485 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.56 -110.0 0.09 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 168.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.49 -44.55 28.48 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.801 0.728 . . . . 0.0 110.961 167.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 t 57.82 82.34 0.13 Allowed 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 126.715 2.006 . . . . 0.0 107.726 -172.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -169.363 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.0 t . . . . . 0 CA--C 1.573 1.861 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.3 -27.39 70.61 Favored Glycine 0 CA--C 1.564 3.098 0 O-C-N 120.558 -1.339 . . . . 0.0 116.352 168.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -54.02 137.89 38.61 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 169.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -80.94 -55.16 4.98 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.982 169.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 m -113.77 125.5 71.06 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.418 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.741 171.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.36 65.43 1.47 Allowed Glycine 0 CA--C 1.543 1.826 0 N-CA-C 115.421 0.928 . . . . 0.0 115.421 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.561 1.387 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 173.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.0 p90 . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.11 -25.75 20.57 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -176.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -102.41 -44.35 5.4 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.435 1.094 . . . . 0.0 111.841 169.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 . . . . . 0 CA--C 1.561 1.397 0 CA-C-O 116.32 -1.8 . . . . 0.0 108.46 169.422 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.2 t . . . . . 0 CA--C 1.557 1.23 0 CA-C-O 118.258 -0.877 . . . . 0.0 108.723 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.73 -99.66 0.15 Allowed Glycine 0 CA--C 1.537 1.468 0 CA-C-N 119.727 1.149 . . . . 0.0 111.731 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.448 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -172.715 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 64.3 m . . . . . 0 CA--C 1.554 1.123 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.76 -135.4 28.5 Favored Glycine 0 CA--C 1.555 2.548 0 CA-C-N 120.448 1.476 . . . . 0.0 115.2 174.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -64.34 -11.53 28.59 Favored 'Trans proline' 0 CA--C 1.567 2.127 0 C-N-CA 123.488 2.792 . . . . 0.0 118.504 170.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 . . . . . 0 CA--C 1.572 1.802 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 163.808 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.7 m120 . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.22 -92.03 0.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 104.67 -2.345 . . . . 0.0 104.67 168.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.54 63.56 1.6 Allowed 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 166.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.4 t -66.45 145.1 56.04 Favored 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 168.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 118.199 2.666 . . . . 0.0 118.199 -166.946 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.8 t . . . . . 0 CA--C 1.569 1.68 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.92 -6.79 60.73 Favored Glycine 0 CA--C 1.563 3.078 0 N-CA-C 118.137 2.015 . . . . 0.0 118.137 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.7 m -79.07 161.14 26.75 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.279 1.431 . . . . 0.0 114.632 -169.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -85.52 -72.95 0.46 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.797 169.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.1 p -101.71 133.51 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.498 0 CA-C-N 113.136 -1.847 . . . . 0.0 109.318 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.02 86.95 1.08 Allowed Glycine 0 N--CA 1.481 1.673 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.64 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.459 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 0.7 OUTLIER . . . . . 0 CA--C 1.56 1.351 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.3 p90 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.459 ' SG ' ' HG2' ' A' ' 20' ' ' ARG . 14.0 t -90.4 -22.06 21.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -89.69 -41.28 12.01 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.69 1.196 . . . . 0.0 111.884 169.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 . . . . . 0 CA--C 1.564 1.518 0 CA-C-O 116.696 -1.621 . . . . 0.0 110.809 169.661 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.0 t . . . . . 0 CA--C 1.559 1.302 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.35 -97.79 0.11 Allowed Glycine 0 N--CA 1.478 1.438 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.421 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.96 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.8 t . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.87 -142.67 47.97 Favored Glycine 0 CA--C 1.561 2.934 0 CA-C-O 118.721 -1.044 . . . . 0.0 115.102 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.44 -14.57 37.33 Favored 'Trans proline' 0 CA--C 1.569 2.262 0 C-N-CA 123.249 2.632 . . . . 0.0 118.114 169.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -178.627 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 . . . . . 0 CA--C 1.567 1.6 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.12 -44.32 9.34 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 118.489 2.774 . . . . 0.0 118.489 -169.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.79 71.98 0.76 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.775 0.83 . . . . 0.0 110.237 -169.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.06 93.19 8.93 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 124.004 1.859 . . . . 0.0 111.887 -169.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 . . . . . 0 CA--C 1.575 1.914 0 CA-C-N 111.265 -2.698 . . . . 0.0 106.122 -179.534 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 1.287 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 50.9 t . . . . . 0 CA--C 1.545 0.77 0 CA-C-O 122.153 0.978 . . . . 0.0 112.009 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.0 -0.28 90.22 Favored Glycine 1 CA--C 1.582 4.263 0 CA-C-N 115.066 -0.97 . . . . 0.0 113.509 166.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . 44.9 m -90.64 168.6 11.66 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 117.427 2.381 . . . . 0.0 117.427 -169.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -88.77 -63.36 1.31 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 112.911 -1.95 . . . . 0.0 109.46 168.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.8 p -110.55 133.93 54.43 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.28 169.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.88 82.62 1.59 Allowed Glycine 0 N--CA 1.487 2.065 0 C-N-CA 123.154 0.407 . . . . 0.0 113.37 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 1.287 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.57 1.713 0 CA-C-O 118.193 -0.908 . . . . 0.0 112.482 -169.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.6 p90 . . . . . 0 N--CA 1.498 1.96 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.515 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 12.2 t -85.1 -22.97 28.68 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -89.12 -31.49 17.97 Favored 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 124.7 1.2 . . . . 0.0 112.227 169.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 . . . . . 0 CA--C 1.567 1.597 0 CA-C-N 120.056 1.298 . . . . 0.0 113.164 169.321 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.7 p . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.45 97.77 0.11 Allowed Glycine 0 N--CA 1.478 1.461 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.946 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 117.334 -1.317 . . . . 0.0 108.319 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.58 -174.97 19.21 Favored Glycine 0 CA--C 1.556 2.648 0 CA-C-N 120.354 1.434 . . . . 0.0 116.522 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -46.87 -26.76 5.03 Favored 'Trans proline' 0 CA--C 1.559 1.725 1 N-CA-C 123.352 4.328 . . . . 0.0 123.352 -174.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 116.937 -1.506 . . . . 0.0 109.06 -169.287 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.7 p30 . . . . . 0 CA--C 1.562 1.411 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.75 -93.72 0.13 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 119.788 1.176 . . . . 0.0 110.62 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -107.41 54.19 0.67 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 118.863 0.756 . . . . 0.0 110.705 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 t -107.01 92.26 4.01 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 122.232 1.015 . . . . 0.0 109.575 -169.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 . . . . . 0 CA--C 1.564 1.49 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.188 -172.955 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 1.485 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 35.7 t . . . . . 0 CA--C 1.557 1.241 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.91 -29.82 49.98 Favored Glycine 0 CA--C 1.565 3.162 0 O-C-N 121.781 -0.574 . . . . 0.0 113.268 167.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 m -62.72 167.34 4.61 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 126.455 1.902 . . . . 0.0 115.859 173.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -79.8 -72.19 0.41 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.876 169.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.9 m -94.54 141.05 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 113.732 -1.577 . . . . 0.0 110.872 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.77 76.92 1.01 Allowed Glycine 0 CA--C 1.543 1.799 0 N-CA-C 114.426 0.531 . . . . 0.0 114.426 173.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 1.485 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.572 1.793 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.8 p90 . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.3 t -81.81 -32.16 31.4 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -89.78 -29.04 18.94 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 123.916 0.886 . . . . 0.0 113.204 169.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 . . . . . 0 CA--C 1.564 1.484 0 CA-C-O 116.418 -1.753 . . . . 0.0 110.235 169.702 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 CA--C 1.562 1.439 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.16 -96.96 0.1 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.618 0 CA-C-O 121.346 0.415 . . . . 0.0 112.367 179.329 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 117.695 -1.145 . . . . 0.0 108.697 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.27 -170.93 13.5 Favored Glycine 0 CA--C 1.557 2.713 0 N-CA-C 116.863 1.505 . . . . 0.0 116.863 172.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.86 63.58 8.4 Favored 'Trans proline' 0 CA--C 1.566 2.082 0 C-N-CA 123.501 2.801 . . . . 0.0 116.84 -169.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 CA--C 1.565 1.523 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 162.95 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 . . . . . 0 CA--C 1.559 1.307 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.71 -95.45 0.12 Allowed 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 118.97 0.804 . . . . 0.0 111.003 175.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.95 6.47 41.92 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.83 100.38 4.75 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 120.506 1.503 . . . . 0.0 112.832 -168.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 . . . . . 0 CA--C 1.569 1.706 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.948 -172.192 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.9 t . . . . . 0 CA--C 1.566 1.56 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.54 -7.04 88.04 Favored Glycine 0 CA--C 1.568 3.359 0 N-CA-C 115.728 1.051 . . . . 0.0 115.728 168.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.2 m -60.7 158.33 12.89 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -85.69 -50.36 7.24 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.208 -1.36 . . . . 0.0 113.525 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 p -137.16 126.89 37.68 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 170.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.08 83.86 1.75 Allowed Glycine 0 N--CA 1.483 1.823 0 CA-C-N 116.505 -0.316 . . . . 0.0 113.039 176.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.91 ' HB2' ' HB2' ' A' ' 25' ' ' ASP . 6.7 mpt_? . . . . . 0 CA--C 1.561 1.401 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.8 p90 . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.478 ' HB3' ' HG2' ' A' ' 20' ' ' ARG . 1.7 m -90.74 -8.09 50.73 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.91 ' HB2' ' HB2' ' A' ' 20' ' ' ARG . 13.2 t70 -132.45 -38.44 1.05 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.226 1.41 . . . . 0.0 112.019 175.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 . . . . . 0 CA--C 1.57 1.722 0 CA-C-O 116.549 -1.691 . . . . 0.0 110.423 169.899 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.1 p . . . . . 0 CA--C 1.559 1.296 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.38 -96.67 0.1 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.468 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.926 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.94 -166.3 37.06 Favored Glycine 0 CA--C 1.556 2.651 0 CA-C-N 120.35 1.432 . . . . 0.0 116.355 170.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.88 3.51 3.82 Favored 'Trans proline' 0 CA--C 1.57 2.3 0 C-N-CA 123.117 2.545 . . . . 0.0 118.535 172.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 . . . . . 0 CA--C 1.571 1.77 0 CA-C-O 115.164 -2.35 . . . . 0.0 112.795 -176.805 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.26 40.43 1.01 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.931 2.197 . . . . 0.0 116.931 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 31.33 64.37 0.2 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.2 t -50.78 152.96 1.88 Allowed 'General case' 0 CA--C 1.574 1.885 0 CA-C-N 113.251 -1.795 . . . . 0.0 110.833 169.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 60.3 m170 . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.234 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.423 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 3.1 t . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.45 3.04 87.78 Favored Glycine 0 CA--C 1.566 3.243 0 N-CA-C 116.309 1.284 . . . . 0.0 116.309 168.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.6 m -90.83 -167.22 1.76 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.281 1.432 . . . . 0.0 113.295 -172.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -116.54 -74.72 0.6 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 169.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 p -91.62 127.2 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.707 173.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.16 46.3 4.77 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 118.425 2.13 . . . . 0.0 118.425 170.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.401 ' HG2' ' HA ' ' A' ' 14' ' ' CYS 0.304 4.9 mpt_? . . . . . 0 CA--C 1.555 1.145 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.5 p90 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.8 m -90.98 -10.65 41.53 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -134.98 -37.68 0.8 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.9 1.28 . . . . 0.0 112.559 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 . . . . . 0 CA--C 1.57 1.733 0 CA-C-O 116.668 -1.634 . . . . 0.0 111.081 169.911 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 CA--C 1.562 1.428 0 N-CA-C 110.759 -0.089 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.58 97.9 0.11 Allowed Glycine 0 N--CA 1.479 1.529 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.414 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.89 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 61.6 m . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.81 -172.27 53.04 Favored Glycine 0 CA--C 1.558 2.768 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.022 -168.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.04 -16.75 28.78 Favored 'Trans proline' 0 CA--C 1.573 2.462 0 C-N-CA 122.672 2.248 . . . . 0.0 116.598 169.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 CA--C 1.575 1.941 0 CA-C-O 115.036 -2.411 . . . . 0.0 112.68 -171.061 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.0 m120 . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.26 -26.9 68.99 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.73 53.36 2.39 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 119.894 1.224 . . . . 0.0 113.119 169.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 1.8 t -80.6 121.72 26.18 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.224 0.61 . . . . 0.0 112.109 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 171.128 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.655 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 1.3 t . . . . . 0 CA--C 1.557 1.219 0 CA-C-O 122.742 1.258 . . . . 0.0 111.444 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.04 -4.03 14.84 Favored Glycine 0 CA--C 1.567 3.305 0 CA-C-N 114.427 -1.26 . . . . 0.0 114.027 167.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.723 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 80.0 m -90.6 -100.42 0.1 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.905 1.352 . . . . 0.0 111.18 -169.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.723 ' HB2' ' O ' ' A' ' 16' ' ' CYS . 48.5 tptt 164.6 -82.87 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -170.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.434 ' H ' ' HB3' ' A' ' 17' ' ' LYS . 13.4 p -92.03 118.15 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 113.375 -1.739 . . . . 0.0 108.61 174.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.97 93.9 0.67 Allowed Glycine 0 CA--C 1.541 1.657 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -172.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.655 ' HD2' ' HA ' ' A' ' 14' ' ' CYS . 29.8 ttp180 . . . . . 0 CA--C 1.568 1.659 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.374 -169.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.7 p90 . . . . . 0 N--CA 1.494 1.725 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.8 m -90.59 -19.25 23.93 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.78 -38.48 13.77 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.355 1.062 . . . . 0.0 111.743 169.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 . . . . . 0 CA--C 1.568 1.645 0 CA-C-N 119.601 1.092 . . . . 0.0 111.139 169.01 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 CA--C 1.561 1.388 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.74 -96.75 0.1 Allowed Glycine 0 N--CA 1.477 1.409 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 112.267 -0.333 . . . . 0.0 112.267 -179.913 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 116.806 -1.569 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.72 178.93 20.56 Favored Glycine 0 CA--C 1.555 2.592 0 CA-C-N 121.275 1.852 . . . . 0.0 115.556 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.2 85.68 1.74 Allowed 'Trans proline' 0 CA--C 1.562 1.895 0 C-N-CA 123.478 2.786 . . . . 0.0 113.286 -177.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 . . . . . 0 CA--C 1.564 1.499 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -176.507 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.28 -31.64 20.13 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 168.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 48.36 53.24 12.25 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -169.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.77 134.92 57.0 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.443 168.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -168.931 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.511 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 11.7 t . . . . . 0 CA--C 1.568 1.671 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.63 -29.81 62.98 Favored Glycine 0 CA--C 1.564 3.147 0 O-C-N 120.95 -1.094 . . . . 0.0 115.299 168.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.2 m -62.34 178.18 0.42 Allowed 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 116.866 2.172 . . . . 0.0 116.866 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -108.09 -71.75 0.75 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.941 168.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -95.84 136.13 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.61 169.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.11 82.81 1.04 Allowed Glycine 0 N--CA 1.486 1.972 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.511 ' HD2' ' HA ' ' A' ' 14' ' ' CYS . 17.2 ttp180 . . . . . 0 CA--C 1.566 1.584 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.362 -168.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.0 p90 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.2 m -90.41 -22.6 21.37 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -89.69 -35.31 15.87 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.19 0.996 . . . . 0.0 112.579 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 . . . . . 0 CA--C 1.571 1.763 0 CA-C-O 116.875 -1.536 . . . . 0.0 110.142 169.497 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 m . . . . . 0 CA--C 1.562 1.439 0 CA-C-O 119.665 -0.207 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.82 -96.6 0.1 Allowed Glycine 0 CA--C 1.538 1.469 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 CA-C-O 121.401 0.445 . . . . 0.0 112.148 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.561 1.366 0 CA-C-O 117.049 -1.453 . . . . 0.0 107.561 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.04 -168.07 40.59 Favored Glycine 0 CA--C 1.554 2.484 0 CA-C-N 121.764 2.075 . . . . 0.0 118.195 169.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.84 11.75 1.89 Allowed 'Trans proline' 0 CA--C 1.57 2.278 0 C-N-CA 123.482 2.788 . . . . 0.0 118.398 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 CA--C 1.568 1.649 0 CA-C-O 115.474 -2.203 . . . . 0.0 110.858 179.688 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.51 55.5 3.03 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -170.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 30.46 62.7 0.19 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 -169.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.0 t -70.8 118.02 13.06 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 168.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 . . . . . 0 N--CA 1.497 1.921 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -168.894 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 115.419 1.636 . . . . 0.0 115.419 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.8 -29.77 73.18 Favored Glycine 0 CA--C 1.564 3.137 0 CA-C-N 120.776 1.625 . . . . 0.0 115.563 168.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.2 m -62.81 137.9 58.39 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.882 1.273 . . . . 0.0 114.014 169.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -93.23 -2.57 55.0 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 169.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -150.15 115.4 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.345 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.02 86.16 0.6 Allowed Glycine 0 CA--C 1.543 1.79 0 CA-C-O 119.871 -0.405 . . . . 0.0 113.662 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.559 1.305 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -171.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.9 p90 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.9 m -90.6 -18.11 25.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -89.5 -28.58 19.56 Favored 'General case' 0 CA--C 1.565 1.552 0 C-N-CA 124.197 0.999 . . . . 0.0 112.608 169.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 . . . . . 0 CA--C 1.572 1.79 0 CA-C-O 117.695 -1.145 . . . . 0.0 112.92 169.157 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.8 t . . . . . 0 CA--C 1.564 1.5 0 CA-C-O 119.614 -0.231 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.71 -97.69 0.11 Allowed Glycine 0 N--CA 1.478 1.458 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.408 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.874 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.58 -174.61 15.83 Favored Glycine 0 CA--C 1.556 2.609 0 N-CA-C 116.41 1.324 . . . . 0.0 116.41 169.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.6 66.11 8.58 Favored 'Trans proline' 0 CA--C 1.566 2.118 0 C-N-CA 123.468 2.779 . . . . 0.0 117.341 -169.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 . . . . . 0 CA--C 1.568 1.668 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 163.002 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.7 m120 . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.73 -91.38 0.15 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 119.166 0.894 . . . . 0.0 110.256 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -107.74 46.0 0.97 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.836 0.743 . . . . 0.0 112.495 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 t -92.14 97.49 10.95 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 122.197 0.999 . . . . 0.0 109.094 -169.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 . . . . . 0 CA--C 1.568 1.653 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.392 -169.955 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.979 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 35.3 t . . . . . 0 CA--C 1.553 1.076 0 CA-C-O 122.242 1.02 . . . . 0.0 112.493 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.65 -34.51 56.64 Favored Glycine 0 CA--C 1.57 3.481 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.645 167.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -69.99 151.84 45.12 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 125.732 1.613 . . . . 0.0 114.504 169.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -98.39 3.54 48.48 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 168.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.0 p -150.12 118.4 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.16 80.39 0.82 Allowed Glycine 0 N--CA 1.487 2.065 0 CA-C-O 119.938 -0.368 . . . . 0.0 112.61 -175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.979 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER . . . . . 0 CA--C 1.566 1.581 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -169.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.3 p90 . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.5 t -82.0 -26.49 33.82 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -89.31 -28.48 19.83 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 124.36 1.064 . . . . 0.0 111.761 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 . . . . . 0 CA--C 1.572 1.789 0 CA-C-O 117.632 -1.175 . . . . 0.0 112.23 169.311 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 CA--C 1.565 1.535 0 CA-C-O 119.867 -0.111 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.24 97.79 0.11 Allowed Glycine 0 N--CA 1.478 1.478 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.66 0 CA-C-O 121.222 0.346 . . . . 0.0 112.366 -179.224 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 118.092 -0.956 . . . . 0.0 108.694 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.61 -170.44 13.3 Favored Glycine 0 CA--C 1.556 2.599 0 CA-C-N 119.351 0.978 . . . . 0.0 115.53 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.2 85.82 1.76 Allowed 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 123.634 2.889 . . . . 0.0 113.838 -174.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 . . . . . 0 CA--C 1.573 1.849 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.193 -176.997 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.7 m120 . . . . . 0 CA--C 1.566 1.586 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.84 -52.51 65.19 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.73 -30.87 66.09 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 169.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.88 104.42 4.75 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 122.017 0.913 . . . . 0.0 113.075 -168.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 . . . . . 0 CA--C 1.567 1.62 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.132 -176.637 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.518 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . 48.5 t . . . . . 0 CA--C 1.569 1.701 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.6 -21.72 77.79 Favored Glycine 0 CA--C 1.554 2.482 0 N-CA-C 118.44 2.136 . . . . 0.0 118.44 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.9 m -59.92 167.51 2.2 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -76.55 -70.75 0.43 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.304 169.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.86 84.64 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.406 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.353 175.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 163.98 74.4 0.03 OUTLIER Glycine 0 N--CA 1.481 1.642 0 CA-C-O 119.725 -0.486 . . . . 0.0 112.972 176.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.518 ' HG2' ' HA ' ' A' ' 14' ' ' CYS 0.305 2.6 mpt_? . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.7 p90 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.7 t -91.01 -26.74 19.05 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -93.42 -33.45 13.83 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 N--CA 1.49 1.564 0 CA-C-N 119.84 1.2 . . . . 0.0 113.357 171.107 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 CA--C 1.561 1.393 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.61 -96.49 0.1 Allowed Glycine 0 N--CA 1.479 1.547 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 CA-C-O 121.366 0.425 . . . . 0.0 112.195 179.957 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 99.7 m . . . . . 0 CA--C 1.552 1.033 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.87 -142.8 33.93 Favored Glycine 0 CA--C 1.557 2.668 0 CA-C-N 121.741 2.064 . . . . 0.0 116.011 169.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -46.33 -24.31 2.51 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 124.476 3.45 . . . . 0.0 120.319 169.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 CA--C 1.571 1.782 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 171.152 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.47 -88.73 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 168.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.75 62.83 1.64 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 166.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.8 t -68.06 137.59 55.14 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 168.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -169.374 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.6 t . . . . . 0 CA--C 1.565 1.547 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.2 -31.36 80.57 Favored Glycine 0 CA--C 1.566 3.241 0 CA-C-N 120.458 1.481 . . . . 0.0 114.531 167.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 m -47.08 140.15 5.26 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 169.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -99.6 -15.02 18.74 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.223 -1.353 . . . . 0.0 114.631 168.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 p -150.04 116.48 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 172.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.36 78.71 1.4 Allowed Glycine 0 N--CA 1.484 1.874 0 C-N-CA 122.778 0.228 . . . . 0.0 113.559 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . 0.324 2.8 mpt_? . . . . . 0 N--CA 1.483 1.207 0 C-N-CA 124.242 1.017 . . . . 0.0 113.18 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.0 p90 . . . . . 0 CA--C 1.563 1.463 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.9 m -90.49 -15.48 30.69 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.41 -36.54 15.41 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 124.277 1.031 . . . . 0.0 110.772 169.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 . . . . . 0 CA--C 1.572 1.808 0 CA-C-O 117.62 -1.181 . . . . 0.0 112.498 169.033 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 118.558 -0.734 . . . . 0.0 112.293 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -95.76 84.17 0.87 Allowed Glycine 0 N--CA 1.482 1.709 0 CA-C-N 118.846 0.748 . . . . 0.0 111.551 170.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.375 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -176.446 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 117.757 -1.116 . . . . 0.0 109.021 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 11' ' ' CYS . . . 114.93 -163.32 12.2 Favored Glycine 0 CA--C 1.558 2.751 0 CA-C-N 119.731 1.151 . . . . 0.0 115.276 -177.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.87 7.01 5.15 Favored 'Trans proline' 0 CA--C 1.569 2.257 0 N-CA-C 119.787 2.956 . . . . 0.0 119.787 -175.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 . . . . . 0 CA--C 1.574 1.869 0 CA-C-O 114.377 -2.725 . . . . 0.0 111.224 -164.592 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.8 m120 . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 115.632 1.715 . . . . 0.0 115.632 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.28 -83.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -169.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.63 -14.47 60.77 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 171.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 4' ' ' GLY . 1.3 t -75.46 110.39 9.79 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -168.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 . . . . . 0 CA--C 1.564 1.512 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.078 -179.98 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.6 t . . . . . 0 CA--C 1.566 1.578 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.36 -30.89 57.89 Favored Glycine 0 CA--C 1.559 2.825 0 O-C-N 120.745 -1.222 . . . . 0.0 115.22 168.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.8 m -68.7 160.86 29.47 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -84.56 -72.55 0.47 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.295 169.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.45 134.67 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 CA-C-N 113.458 -1.701 . . . . 0.0 109.587 169.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.51 79.36 1.33 Allowed Glycine 0 N--CA 1.482 1.763 0 C-N-CA 123.037 0.351 . . . . 0.0 113.562 177.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.677 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.571 1.768 0 C-N-CA 123.669 0.788 . . . . 0.0 112.455 -174.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.3 p90 . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.677 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 18.3 t -84.02 -24.38 30.54 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -89.37 -37.36 14.91 Favored 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 124.58 1.152 . . . . 0.0 111.332 168.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 . . . . . 0 CA--C 1.568 1.648 0 CA-C-N 119.606 1.093 . . . . 0.0 112.771 169.444 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 118.663 -0.684 . . . . 0.0 112.69 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -95.25 98.26 2.24 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-N 118.977 0.808 . . . . 0.0 111.989 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.331 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -179.782 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 78.4 m . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.16 -132.79 0.43 Allowed Glycine 0 CA--C 1.557 2.692 0 N-CA-C 117.792 1.877 . . . . 0.0 117.792 -169.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -34.98 -38.27 0.16 Allowed 'Trans proline' 0 CA--C 1.557 1.634 1 C-N-CA 125.502 4.135 . . . . 0.0 121.468 175.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 . . . . . 0 CA--C 1.566 1.579 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 169.195 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 p30 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.5 -47.63 32.01 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.08 65.28 0.82 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 118.784 0.72 . . . . 0.0 111.596 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.5 t -79.43 110.29 14.6 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.111 0.481 . . . . 0.0 109.798 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.373 -1.299 . . . . 0.0 108.796 -169.943 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.2 t . . . . . 0 CA--C 1.569 1.711 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.06 -33.7 6.21 Favored Glycine 0 CA--C 1.566 3.274 0 O-C-N 121.456 -0.778 . . . . 0.0 111.233 168.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 m -45.93 131.92 9.41 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 126.485 1.914 . . . . 0.0 115.027 168.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -93.12 -14.6 27.02 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 169.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 m -145.41 115.03 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.99 84.46 0.72 Allowed Glycine 0 CA--C 1.543 1.783 0 O-C-N 122.186 -0.321 . . . . 0.0 113.48 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . 0.318 1.3 mpt_? . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -176.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.2 p90 . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 116.374 1.99 . . . . 0.0 116.374 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.7 t -90.24 -20.87 22.48 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -89.55 -35.06 16.13 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.15 0.98 . . . . 0.0 112.44 169.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 . . . . . 0 N--CA 1.487 1.4 0 CA-C-N 119.683 1.128 . . . . 0.0 112.304 169.245 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.67 -97.82 0.11 Allowed Glycine 0 N--CA 1.477 1.43 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.398 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.91 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.84 178.51 31.95 Favored Glycine 0 CA--C 1.554 2.495 0 N-CA-C 115.928 1.131 . . . . 0.0 115.928 -175.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.07 -14.41 35.06 Favored 'Trans proline' 0 CA--C 1.563 1.95 0 N-CA-C 119.791 2.958 . . . . 0.0 119.791 -173.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 CA--C 1.566 1.589 0 CA-C-O 117.288 -1.339 . . . . 0.0 108.443 -177.606 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 . . . . . 0 CA--C 1.562 1.412 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.89 -81.07 0.32 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.564 1.075 . . . . 0.0 111.019 172.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.62 -9.73 59.48 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 173.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.5 t -74.03 117.35 15.72 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 119.341 0.973 . . . . 0.0 112.165 -168.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 . . . . . 0 CA--C 1.566 1.589 0 C-N-CA 123.935 0.894 . . . . 0.0 109.835 -173.357 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 1.058 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 49.8 t . . . . . 0 CA--C 1.552 1.047 0 CA-C-O 121.781 0.8 . . . . 0.0 112.188 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.35 -2.54 87.72 Favored Glycine 0 CA--C 1.576 3.856 0 N-CA-C 114.771 0.668 . . . . 0.0 114.771 167.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.9 m -90.11 172.2 8.99 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.59 1.956 . . . . 0.0 115.772 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -87.44 -67.69 0.8 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.055 168.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 p -106.57 133.41 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 CA-C-N 113.869 -1.514 . . . . 0.0 108.874 169.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.87 88.05 1.97 Allowed Glycine 0 N--CA 1.484 1.857 0 C-N-CA 123.167 0.413 . . . . 0.0 113.238 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 1.058 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.562 1.404 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -173.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.5 p90 . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.447 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 30.8 t -78.8 -27.21 44.39 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -174.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -89.37 -32.25 17.39 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.046 0.938 . . . . 0.0 112.358 169.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.565 1.537 0 CA-C-N 119.541 1.064 . . . . 0.0 110.454 169.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.96 -96.74 0.1 Allowed Glycine 0 N--CA 1.478 1.476 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 -179.909 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 99.3 m . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.86 -128.1 0.42 Allowed Glycine 0 CA--C 1.553 2.423 0 CA-C-O 117.846 -1.53 . . . . 0.0 116.622 -169.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -38.1 -30.75 0.17 Allowed 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 125.144 3.896 . . . . 0.0 121.474 172.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 CA--C 1.568 1.652 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 170.069 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 119.077 -0.487 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.05 -49.13 60.2 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 172.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.73 64.27 0.77 Allowed 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 118.496 0.589 . . . . 0.0 110.886 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.0 t -83.22 106.6 15.13 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.312 0.645 . . . . 0.0 109.61 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 116.989 -1.481 . . . . 0.0 108.276 -169.965 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.537 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.356 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.23 13.32 67.91 Favored Glycine 0 CA--C 1.577 3.945 0 O-C-N 120.454 -1.404 . . . . 0.0 113.563 166.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -91.54 163.79 14.02 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.16 2.184 . . . . 0.0 115.158 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -91.2 -62.67 1.39 Allowed 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 113.042 -1.89 . . . . 0.0 109.206 167.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.23 139.58 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.233 169.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.66 84.41 1.4 Allowed Glycine 0 N--CA 1.486 1.977 0 C-N-CA 123.188 0.423 . . . . 0.0 113.065 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.563 1.466 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -169.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.9 p90 . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.2 m -90.23 -19.41 24.18 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.48 2.029 . . . . 0.0 116.48 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.34 -35.53 16.04 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 124.677 1.191 . . . . 0.0 112.305 169.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 . . . . . 0 CA--C 1.569 1.711 0 CA-C-O 117.253 -1.356 . . . . 0.0 111.201 169.338 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.9 m . . . . . 0 CA--C 1.561 1.387 0 CA-C-O 119.682 -0.199 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.72 -97.29 0.11 Allowed Glycine 0 N--CA 1.479 1.552 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.399 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.926 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.434 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.6 t -124.15 -121.34 0.27 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.1 t -150.77 -86.86 0.07 Allowed 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.23 -167.82 21.1 Favored Glycine 0 CA--C 1.56 2.872 0 N-CA-C 117.068 1.587 . . . . 0.0 117.068 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -53.94 -12.16 3.17 Favored 'Trans proline' 0 CA--C 1.563 1.958 1 N-CA-C 123.011 4.197 . . . . 0.0 123.011 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -89.19 131.6 35.24 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 119.611 1.096 . . . . 0.0 109.463 -169.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -143.11 39.09 1.45 Allowed 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -155.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.36 -92.0 0.14 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 169.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.25 -9.46 50.6 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 167.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.34 115.84 26.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.172 0.989 . . . . 0.0 111.435 -168.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -134.94 145.97 48.68 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.825 -174.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 1.208 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 20.7 t -116.87 56.07 0.81 Allowed 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 168.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.66 -18.16 76.05 Favored Glycine 0 CA--C 1.569 3.46 0 O-C-N 121.868 -0.52 . . . . 0.0 114.242 167.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 m -74.94 172.63 11.93 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 126.458 1.903 . . . . 0.0 114.87 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -80.53 -76.9 0.21 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.183 169.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.0 m -95.55 142.11 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.713 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.51 85.04 0.95 Allowed Glycine 0 N--CA 1.483 1.828 0 CA-C-O 119.768 -0.462 . . . . 0.0 113.013 175.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 1.208 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -163.58 160.08 22.58 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -169.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -63.65 -33.24 75.18 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 175.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.0 t -83.7 -24.95 31.03 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -89.24 -28.87 19.64 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 124.333 1.053 . . . . 0.0 111.579 168.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -66.48 151.51 47.07 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-O 117.688 -1.149 . . . . 0.0 112.188 169.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -78.26 -66.09 0.9 Allowed 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.901 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.84 -96.55 0.1 Allowed Glycine 0 CA--C 1.537 1.448 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.39 -98.26 1.26 Allowed Glycine 0 N--CA 1.48 1.599 0 N-CA-C 112.317 -0.313 . . . . 0.0 112.317 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.485 0 O-C-N 120.516 -1.579 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.326 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 39.3 t -119.32 -123.04 0.29 Allowed 'General case' 0 CA--C 1.562 1.404 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.6 t -150.75 -79.81 0.12 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 169.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.38 -143.95 16.31 Favored Glycine 0 CA--C 1.558 2.763 0 CA-C-O 118.311 -1.272 . . . . 0.0 115.01 177.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -77.51 74.99 4.9 Favored 'Trans proline' 0 CA--C 1.566 2.091 0 C-N-CA 123.941 3.094 . . . . 0.0 114.099 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.547 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 63.5 m-85 -150.11 161.13 42.98 Favored 'General case' 0 CA--C 1.58 2.114 0 C-N-CA 125.218 1.407 . . . . 0.0 109.169 -171.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -133.51 -52.15 0.87 Allowed 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -155.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.33 -84.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 120.504 1.502 . . . . 0.0 114.796 -169.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.02 -13.68 60.23 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 172.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 6' ' ' TYR . 1.7 t -74.2 118.42 17.15 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -168.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -149.32 132.53 16.41 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.6 t -85.68 16.45 3.95 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 168.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.95 -33.98 87.19 Favored Glycine 0 CA--C 1.554 2.474 0 N-CA-C 116.564 1.386 . . . . 0.0 116.564 169.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.7 m -62.94 157.08 22.61 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -80.43 -71.21 0.47 Allowed 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.976 169.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.9 p -99.41 134.44 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.794 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.42 88.81 0.99 Allowed Glycine 0 N--CA 1.483 1.828 0 CA-C-O 119.757 -0.468 . . . . 0.0 112.663 175.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.895 ' HB2' HD22 ' A' ' 21' ' ' HYP . 0.1 OUTLIER -160.87 173.73 14.91 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -169.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HYP . . . . . 0.895 HD22 ' HB2' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -71.88 -31.51 66.52 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.423 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 34.3 t -88.79 -24.14 22.69 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -89.58 -37.9 14.35 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 125.058 1.343 . . . . 0.0 111.88 169.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -67.42 139.18 57.11 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-O 116.891 -1.528 . . . . 0.0 111.457 169.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.8 m -79.45 -64.57 1.16 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.228 -171.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.36 -97.61 0.11 Allowed Glycine 0 CA--C 1.537 1.429 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.65 -99.33 0.12 Allowed Glycine 0 N--CA 1.479 1.512 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.462 0 O-C-N 120.455 -1.615 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.364 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.7 t -71.99 -50.8 25.69 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 54.0 t -133.29 -85.91 0.44 Allowed 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 116.602 -1.666 . . . . 0.0 108.285 169.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.8 -159.1 25.5 Favored Glycine 0 CA--C 1.561 2.958 0 CA-C-N 121.668 2.031 . . . . 0.0 115.187 -169.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -76.89 65.15 7.71 Favored 'Trans proline' 0 CA--C 1.568 2.184 0 C-N-CA 123.573 2.849 . . . . 0.0 117.258 -169.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -140.61 91.12 2.4 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 102.78 -3.044 . . . . 0.0 102.78 164.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -101.19 -76.07 0.57 Allowed 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 151.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.56 -110.0 0.09 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 168.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.49 -44.55 28.48 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.801 0.728 . . . . 0.0 110.961 167.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 t 57.82 82.34 0.13 Allowed 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 126.715 2.006 . . . . 0.0 107.726 -172.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -106.19 153.84 21.55 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -169.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.0 t -78.79 18.02 0.65 Allowed 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 162.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.3 -27.39 70.61 Favored Glycine 0 CA--C 1.564 3.098 0 O-C-N 120.558 -1.339 . . . . 0.0 116.352 168.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -54.02 137.89 38.61 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 169.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -80.94 -55.16 4.98 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.982 169.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 m -113.77 125.5 71.06 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.418 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.741 171.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.36 65.43 1.47 Allowed Glycine 0 CA--C 1.543 1.826 0 N-CA-C 115.421 0.928 . . . . 0.0 115.421 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.908 ' HB3' HD22 ' A' ' 21' ' ' HYP . 0.7 OUTLIER -94.44 -173.27 3.0 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 173.136 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HYP . . . . . 0.908 HD22 ' HB3' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HYP . . . . . 1.292 ' O ' ' HB3' ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -87.54 -35.74 17.99 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 170.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.11 -25.75 20.57 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -176.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -102.41 -44.35 5.4 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.435 1.094 . . . . 0.0 111.841 169.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 1.292 ' HB3' ' O ' ' A' ' 22' ' ' HYP . 78.1 ttt180 -74.16 119.42 18.35 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-O 116.32 -1.8 . . . . 0.0 108.46 169.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.2 t -150.68 -83.55 0.09 Allowed 'General case' 0 CA--C 1.557 1.23 0 CA-C-O 118.258 -0.877 . . . . 0.0 108.723 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.73 -99.66 0.15 Allowed Glycine 0 CA--C 1.537 1.468 0 CA-C-N 119.727 1.149 . . . . 0.0 111.731 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.22 98.3 0.17 Allowed Glycine 0 N--CA 1.478 1.448 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -172.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.405 0 O-C-N 120.35 -1.677 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.406 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -99.19 -98.61 0.23 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 116.654 -1.641 . . . . 0.0 108.312 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 64.3 m -139.88 -108.61 0.16 Allowed 'General case' 0 CA--C 1.554 1.123 0 CA-C-N 121.939 2.154 . . . . 0.0 107.638 -174.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.76 -135.4 28.5 Favored Glycine 0 CA--C 1.555 2.548 0 CA-C-N 120.448 1.476 . . . . 0.0 115.2 174.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -64.34 -11.53 28.59 Favored 'Trans proline' 0 CA--C 1.567 2.127 0 C-N-CA 123.488 2.792 . . . . 0.0 118.504 170.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -123.86 81.49 1.92 Allowed 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 163.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -85.99 -82.48 0.19 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 160.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.22 -92.03 0.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 104.67 -2.345 . . . . 0.0 104.67 168.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.54 63.56 1.6 Allowed 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 166.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.4 t -66.45 145.1 56.04 Favored 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 168.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -88.84 158.8 17.99 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 118.199 2.666 . . . . 0.0 118.199 -166.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.8 t -75.01 6.11 4.48 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 162.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.92 -6.79 60.73 Favored Glycine 0 CA--C 1.563 3.078 0 N-CA-C 118.137 2.015 . . . . 0.0 118.137 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.7 m -79.07 161.14 26.75 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.279 1.431 . . . . 0.0 114.632 -169.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -85.52 -72.95 0.46 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.797 169.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.1 p -101.71 133.51 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.498 0 CA-C-N 113.136 -1.847 . . . . 0.0 109.318 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.02 86.95 1.08 Allowed Glycine 0 N--CA 1.481 1.673 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.64 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.459 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 0.7 OUTLIER -125.5 169.7 12.15 Favored 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -177.101 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HYP . . . . . 0.425 ' O ' ' HB3' ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -76.82 -33.53 57.96 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.459 ' SG ' ' HG2' ' A' ' 20' ' ' ARG . 14.0 t -90.4 -22.06 21.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -89.69 -41.28 12.01 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.69 1.196 . . . . 0.0 111.884 169.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.425 ' HB3' ' O ' ' A' ' 22' ' ' HYP . 78.3 ttt180 -70.8 132.34 45.17 Favored 'General case' 0 CA--C 1.564 1.518 0 CA-C-O 116.696 -1.621 . . . . 0.0 110.809 169.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.0 t -78.58 -65.43 0.99 Allowed 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.35 -97.79 0.11 Allowed Glycine 0 N--CA 1.478 1.438 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.03 -99.18 0.12 Allowed Glycine 0 CA--C 1.537 1.421 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.458 0 O-C-N 120.503 -1.587 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.446 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 40.9 t -87.14 -107.99 0.06 Allowed 'General case' 0 CA--C 1.562 1.42 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' A' ' 7' ' ' HYP . 16.8 t -150.74 -76.87 0.14 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 171.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.87 -142.67 47.97 Favored Glycine 0 CA--C 1.561 2.934 0 CA-C-O 118.721 -1.044 . . . . 0.0 115.102 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.44 -14.57 37.33 Favored 'Trans proline' 0 CA--C 1.569 2.262 0 C-N-CA 123.249 2.632 . . . . 0.0 118.114 169.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -131.98 95.52 3.71 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HYP . . . . . 0.595 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -141.4 -111.1 0.14 Allowed 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 172.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.12 -44.32 9.34 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 118.489 2.774 . . . . 0.0 118.489 -169.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.79 71.98 0.76 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.775 0.83 . . . . 0.0 110.237 -169.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.06 93.19 8.93 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 124.004 1.859 . . . . 0.0 111.887 -169.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -150.2 156.04 40.87 Favored 'General case' 0 CA--C 1.575 1.914 0 CA-C-N 111.265 -2.698 . . . . 0.0 106.122 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 1.287 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 50.9 t -116.63 74.2 0.9 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.153 0.978 . . . . 0.0 112.009 161.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.0 -0.28 90.22 Favored Glycine 1 CA--C 1.582 4.263 0 CA-C-N 115.066 -0.97 . . . . 0.0 113.509 166.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . 44.9 m -90.64 168.6 11.66 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 117.427 2.381 . . . . 0.0 117.427 -169.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -88.77 -63.36 1.31 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 112.911 -1.95 . . . . 0.0 109.46 168.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.8 p -110.55 133.93 54.43 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.28 169.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.88 82.62 1.59 Allowed Glycine 0 N--CA 1.487 2.065 0 C-N-CA 123.154 0.407 . . . . 0.0 113.37 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 1.287 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -166.91 152.43 7.8 Favored 'General case' 0 CA--C 1.57 1.713 0 CA-C-O 118.193 -0.908 . . . . 0.0 112.482 -169.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -62.13 -28.72 69.84 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.515 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 12.2 t -85.1 -22.97 28.68 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -89.12 -31.49 17.97 Favored 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 124.7 1.2 . . . . 0.0 112.227 169.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -69.12 170.84 9.26 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 120.056 1.298 . . . . 0.0 113.164 169.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.7 p -76.47 -58.56 3.21 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.45 97.77 0.11 Allowed Glycine 0 N--CA 1.478 1.461 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 178.82 99.24 0.12 Allowed Glycine 0 CA--C 1.537 1.413 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.469 0 O-C-N 120.497 -1.59 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.394 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.7 t -124.39 -121.36 0.27 Allowed 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.8 t -150.82 -80.83 0.11 Allowed 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 117.334 -1.317 . . . . 0.0 108.319 172.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.58 -174.97 19.21 Favored Glycine 0 CA--C 1.556 2.648 0 CA-C-N 120.354 1.434 . . . . 0.0 116.522 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -46.87 -26.76 5.03 Favored 'Trans proline' 0 CA--C 1.559 1.725 1 N-CA-C 123.352 4.328 . . . . 0.0 123.352 -174.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -91.93 113.91 26.3 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 116.937 -1.506 . . . . 0.0 109.06 -169.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -152.99 -83.95 0.08 Allowed 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 170.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.75 -93.72 0.13 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 119.788 1.176 . . . . 0.0 110.62 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -107.41 54.19 0.67 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 118.863 0.756 . . . . 0.0 110.705 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 t -107.01 92.26 4.01 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 122.232 1.015 . . . . 0.0 109.575 -169.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -122.81 149.92 43.52 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.188 -172.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 1.485 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 35.7 t -114.56 54.86 0.76 Allowed 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 165.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.91 -29.82 49.98 Favored Glycine 0 CA--C 1.565 3.162 0 O-C-N 121.781 -0.574 . . . . 0.0 113.268 167.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 m -62.72 167.34 4.61 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 126.455 1.902 . . . . 0.0 115.859 173.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -79.8 -72.19 0.41 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.876 169.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.9 m -94.54 141.05 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 113.732 -1.577 . . . . 0.0 110.872 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.77 76.92 1.01 Allowed Glycine 0 CA--C 1.543 1.799 0 N-CA-C 114.426 0.531 . . . . 0.0 114.426 173.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 1.485 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -153.82 166.1 33.97 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HYP . . . . . 0.635 HD22 ' HB2' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -69.82 -29.56 66.86 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.3 t -81.81 -32.16 31.4 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -89.78 -29.04 18.94 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 123.916 0.886 . . . . 0.0 113.204 169.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -69.05 122.14 18.11 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 116.418 -1.753 . . . . 0.0 110.235 169.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 89.3 p -75.01 -57.95 3.58 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -176.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.16 -96.96 0.1 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.0 -101.5 2.67 Favored Glycine 0 N--CA 1.48 1.618 0 CA-C-O 121.346 0.415 . . . . 0.0 112.367 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.459 0 O-C-N 120.556 -1.556 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.381 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 41.3 t -98.59 -110.39 0.17 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 38.2 t -150.45 -75.26 0.15 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.825 1.193 . . . . 0.0 108.697 170.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.27 -170.93 13.5 Favored Glycine 0 CA--C 1.557 2.713 0 N-CA-C 116.863 1.505 . . . . 0.0 116.863 172.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.86 63.58 8.4 Favored 'Trans proline' 0 CA--C 1.566 2.082 0 C-N-CA 123.501 2.801 . . . . 0.0 116.84 -169.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -138.04 84.41 2.04 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 162.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -140.54 -82.14 0.25 Allowed 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 166.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.71 -95.45 0.12 Allowed 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 118.97 0.804 . . . . 0.0 111.003 175.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.95 6.47 41.92 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.83 100.38 4.75 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 120.506 1.503 . . . . 0.0 112.832 -168.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -150.3 152.69 34.89 Favored 'General case' 0 CA--C 1.569 1.706 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.948 -172.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.9 t -92.13 30.14 1.5 Allowed 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 171.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.54 -7.04 88.04 Favored Glycine 0 CA--C 1.568 3.359 0 N-CA-C 115.728 1.051 . . . . 0.0 115.728 168.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.2 m -60.7 158.33 12.89 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -85.69 -50.36 7.24 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.208 -1.36 . . . . 0.0 113.525 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 p -137.16 126.89 37.68 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 170.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.08 83.86 1.75 Allowed Glycine 0 N--CA 1.483 1.823 0 CA-C-N 116.505 -0.316 . . . . 0.0 113.039 176.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.91 ' HB2' ' HB2' ' A' ' 25' ' ' ASP . 6.7 mpt_? -116.17 168.54 10.02 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -175.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HYP . . . . . 1.112 ' O ' ' HB3' ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -79.06 -39.65 33.3 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 169.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.478 ' HB3' ' HG2' ' A' ' 20' ' ' ARG . 1.7 m -90.74 -8.09 50.73 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.91 ' HB2' ' HB2' ' A' ' 20' ' ' ARG . 13.2 t70 -132.45 -38.44 1.05 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.226 1.41 . . . . 0.0 112.019 175.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 1.112 ' HB3' ' O ' ' A' ' 22' ' ' HYP . 24.2 tpt180 -70.14 128.92 37.94 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-O 116.549 -1.691 . . . . 0.0 110.423 169.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.1 p -84.6 -61.71 1.73 Allowed 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.38 -96.67 0.1 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.01 -99.32 0.12 Allowed Glycine 0 N--CA 1.478 1.468 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.431 0 O-C-N 120.531 -1.57 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.393 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 5.7 t -81.54 -87.04 0.09 Allowed 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 117.835 -1.078 . . . . 0.0 112.146 -177.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.07 -95.86 0.11 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -169.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.94 -166.3 37.06 Favored Glycine 0 CA--C 1.556 2.651 0 CA-C-N 120.35 1.432 . . . . 0.0 116.355 170.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.88 3.51 3.82 Favored 'Trans proline' 0 CA--C 1.57 2.3 0 C-N-CA 123.117 2.545 . . . . 0.0 118.535 172.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -89.86 -46.55 8.48 Favored 'General case' 0 CA--C 1.571 1.77 0 CA-C-O 115.164 -2.35 . . . . 0.0 112.795 -176.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -66.03 -57.9 6.7 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -169.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.26 40.43 1.01 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.931 2.197 . . . . 0.0 116.931 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 31.33 64.37 0.2 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.2 t -50.78 152.96 1.88 Allowed 'General case' 0 CA--C 1.574 1.885 0 CA-C-N 113.251 -1.795 . . . . 0.0 110.833 169.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 60.3 m170 -88.32 140.07 29.85 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.423 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 3.1 t -97.76 38.58 1.28 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 171.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.45 3.04 87.78 Favored Glycine 0 CA--C 1.566 3.243 0 N-CA-C 116.309 1.284 . . . . 0.0 116.309 168.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.6 m -90.83 -167.22 1.76 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.281 1.432 . . . . 0.0 113.295 -172.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -116.54 -74.72 0.6 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 169.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 p -91.62 127.2 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.707 173.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.16 46.3 4.77 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 118.425 2.13 . . . . 0.0 118.425 170.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.74 ' HB3' HD23 ' A' ' 21' ' ' HYP 0.304 4.9 mpt_? -85.14 -176.09 6.02 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.73 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HYP . . . . . 0.74 HD23 ' HB3' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HYP . . . . . 1.078 ' O ' ' HB3' ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -83.1 -39.84 20.61 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 173.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.8 m -90.98 -10.65 41.53 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -134.98 -37.68 0.8 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.9 1.28 . . . . 0.0 112.559 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 1.078 ' HB3' ' O ' ' A' ' 22' ' ' HYP . 23.6 tpt180 -68.61 132.85 47.6 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-O 116.668 -1.634 . . . . 0.0 111.081 169.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.6 p -96.26 87.29 4.45 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.759 -174.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.58 97.9 0.11 Allowed Glycine 0 N--CA 1.479 1.529 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.09 99.3 0.12 Allowed Glycine 0 N--CA 1.477 1.414 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.435 0 O-C-N 120.472 -1.605 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.389 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 23.1 t -160.57 94.45 1.06 Allowed 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 61.6 m -134.9 61.47 1.67 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 168.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.81 -172.27 53.04 Favored Glycine 0 CA--C 1.558 2.768 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.022 -168.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.04 -16.75 28.78 Favored 'Trans proline' 0 CA--C 1.573 2.462 0 C-N-CA 122.672 2.248 . . . . 0.0 116.598 169.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.446 ' H ' HD22 ' A' ' 7' ' ' HYP . 83.7 m-85 -150.38 -46.21 0.12 Allowed 'General case' 0 CA--C 1.575 1.941 0 CA-C-O 115.036 -2.411 . . . . 0.0 112.68 -171.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HYP . . . . . 0.446 HD22 ' H ' ' A' ' 6' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -139.61 -53.46 0.54 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.858 1.263 . . . . 0.0 109.355 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.26 -26.9 68.99 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.73 53.36 2.39 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 119.894 1.224 . . . . 0.0 113.119 169.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 1.8 t -80.6 121.72 26.18 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.224 0.61 . . . . 0.0 112.109 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -128.77 123.13 32.14 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 171.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.655 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 1.3 t -108.8 64.89 0.61 Allowed 'General case' 0 CA--C 1.557 1.219 0 CA-C-O 122.742 1.258 . . . . 0.0 111.444 172.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.04 -4.03 14.84 Favored Glycine 0 CA--C 1.567 3.305 0 CA-C-N 114.427 -1.26 . . . . 0.0 114.027 167.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.723 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 80.0 m -90.6 -100.42 0.1 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.905 1.352 . . . . 0.0 111.18 -169.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.723 ' HB2' ' O ' ' A' ' 16' ' ' CYS . 48.5 tptt 164.6 -82.87 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -170.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.434 ' H ' ' HB3' ' A' ' 17' ' ' LYS . 13.4 p -92.03 118.15 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 113.375 -1.739 . . . . 0.0 108.61 174.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.97 93.9 0.67 Allowed Glycine 0 CA--C 1.541 1.657 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -172.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.708 ' HG3' HD23 ' A' ' 21' ' ' HYP . 29.8 ttp180 -166.71 150.52 7.08 Favored 'General case' 0 CA--C 1.568 1.659 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.374 -169.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HYP . . . . . 0.708 HD23 ' HG3' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -70.61 -35.67 73.09 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.8 m -90.59 -19.25 23.93 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.78 -38.48 13.77 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.355 1.062 . . . . 0.0 111.743 169.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -68.95 152.76 44.86 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 119.601 1.092 . . . . 0.0 111.139 169.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.3 t -78.66 -65.67 0.96 Allowed 'General case' 0 CA--C 1.561 1.388 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.98 -175.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.74 -96.75 0.1 Allowed Glycine 0 N--CA 1.477 1.409 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.53 -98.16 1.28 Allowed Glycine 0 N--CA 1.48 1.628 0 N-CA-C 112.267 -0.333 . . . . 0.0 112.267 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.474 0 O-C-N 120.461 -1.611 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.338 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 38.7 t -134.08 -88.99 0.38 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.213 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 m -137.28 -71.44 0.44 Allowed 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 116.806 -1.569 . . . . 0.0 109.265 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.72 178.93 20.56 Favored Glycine 0 CA--C 1.555 2.592 0 CA-C-N 121.275 1.852 . . . . 0.0 115.556 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.2 85.68 1.74 Allowed 'Trans proline' 0 CA--C 1.562 1.895 0 C-N-CA 123.478 2.786 . . . . 0.0 113.286 -177.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -132.37 112.1 11.89 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -141.83 -72.6 0.33 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 156.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.28 -31.64 20.13 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 168.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 48.36 53.24 12.25 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -169.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.77 134.92 57.0 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.443 168.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -89.4 165.19 14.51 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -168.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.511 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 11.7 t -87.85 30.31 0.85 Allowed 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 162.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.63 -29.81 62.98 Favored Glycine 0 CA--C 1.564 3.147 0 O-C-N 120.95 -1.094 . . . . 0.0 115.299 168.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.2 m -62.34 178.18 0.42 Allowed 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 116.866 2.172 . . . . 0.0 116.866 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -108.09 -71.75 0.75 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.941 168.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -95.84 136.13 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.61 169.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.11 82.81 1.04 Allowed Glycine 0 N--CA 1.486 1.972 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.511 ' HD2' ' HA ' ' A' ' 14' ' ' CYS . 17.2 ttp180 -160.95 153.41 20.52 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.362 -168.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HYP . . . . . 0.438 HD23 ' HG3' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HYP . . . . . 0.474 ' O ' ' CB ' ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -73.98 -37.35 64.49 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.2 m -90.41 -22.6 21.37 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -89.69 -35.31 15.87 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.19 0.996 . . . . 0.0 112.579 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.474 ' CB ' ' O ' ' A' ' 22' ' ' HYP . 22.8 tpp180 -68.37 132.45 47.07 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-O 116.875 -1.536 . . . . 0.0 110.142 169.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 m -86.73 99.49 11.81 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.587 -171.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.82 -96.6 0.1 Allowed Glycine 0 CA--C 1.538 1.469 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.17 101.11 2.66 Favored Glycine 0 N--CA 1.48 1.614 0 CA-C-O 121.401 0.445 . . . . 0.0 112.148 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.448 0 O-C-N 120.496 -1.591 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.438 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 47.9 t -87.57 -62.11 1.57 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -176.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.66 -80.88 0.6 Allowed 'General case' 0 CA--C 1.561 1.366 0 CA-C-O 117.049 -1.453 . . . . 0.0 107.561 -169.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.04 -168.07 40.59 Favored Glycine 0 CA--C 1.554 2.484 0 CA-C-N 121.764 2.075 . . . . 0.0 118.195 169.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.84 11.75 1.89 Allowed 'Trans proline' 0 CA--C 1.57 2.278 0 C-N-CA 123.482 2.788 . . . . 0.0 118.398 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -89.69 -54.6 3.99 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-O 115.474 -2.203 . . . . 0.0 110.858 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -75.34 -65.63 0.87 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -159.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.51 55.5 3.03 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -170.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 30.46 62.7 0.19 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 -169.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.0 t -70.8 118.02 13.06 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 168.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -93.76 162.93 13.73 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -168.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.2 t -74.41 -3.66 31.86 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 115.419 1.636 . . . . 0.0 115.419 161.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.8 -29.77 73.18 Favored Glycine 0 CA--C 1.564 3.137 0 CA-C-N 120.776 1.625 . . . . 0.0 115.563 168.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.2 m -62.81 137.9 58.39 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.882 1.273 . . . . 0.0 114.014 169.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -93.23 -2.57 55.0 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 169.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -150.15 115.4 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.345 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.02 86.16 0.6 Allowed Glycine 0 CA--C 1.543 1.79 0 CA-C-O 119.871 -0.405 . . . . 0.0 113.662 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.844 ' HB2' HD23 ' A' ' 21' ' ' HYP . 0.0 OUTLIER -157.23 174.0 16.12 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -171.508 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' HYP . . . . . 0.844 HD23 ' HB2' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -69.15 -38.61 78.88 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.9 m -90.6 -18.11 25.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -89.5 -28.58 19.56 Favored 'General case' 0 CA--C 1.565 1.552 0 C-N-CA 124.197 0.999 . . . . 0.0 112.608 169.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -63.4 152.54 37.87 Favored 'General case' 0 CA--C 1.572 1.79 0 CA-C-O 117.695 -1.145 . . . . 0.0 112.92 169.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.8 t -86.49 98.34 10.99 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.537 -176.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.71 -97.69 0.11 Allowed Glycine 0 N--CA 1.478 1.458 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.04 -99.35 0.12 Allowed Glycine 0 N--CA 1.477 1.408 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.436 0 O-C-N 120.479 -1.601 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.417 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 28.3 t -91.37 -81.49 0.32 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 118.733 -0.651 . . . . 0.0 109.431 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.5 t -149.21 -73.82 0.18 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 169.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.58 -174.61 15.83 Favored Glycine 0 CA--C 1.556 2.609 0 N-CA-C 116.41 1.324 . . . . 0.0 116.41 169.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.6 66.11 8.58 Favored 'Trans proline' 0 CA--C 1.566 2.118 0 C-N-CA 123.468 2.779 . . . . 0.0 117.341 -169.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -143.03 86.63 1.93 Allowed 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 163.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -139.14 -85.7 0.24 Allowed 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.73 -91.38 0.15 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 119.166 0.894 . . . . 0.0 110.256 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -107.74 46.0 0.97 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.836 0.743 . . . . 0.0 112.495 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 t -92.14 97.49 10.95 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 122.197 0.999 . . . . 0.0 109.094 -169.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -149.97 153.29 36.33 Favored 'General case' 0 CA--C 1.568 1.653 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.392 -169.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.979 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 35.3 t -108.13 59.15 0.61 Allowed 'General case' 0 CA--C 1.553 1.076 0 CA-C-O 122.242 1.02 . . . . 0.0 112.493 165.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.65 -34.51 56.64 Favored Glycine 0 CA--C 1.57 3.481 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.645 167.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -69.99 151.84 45.12 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 125.732 1.613 . . . . 0.0 114.504 169.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -98.39 3.54 48.48 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 168.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.0 p -150.12 118.4 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.16 80.39 0.82 Allowed Glycine 0 N--CA 1.487 2.065 0 CA-C-O 119.938 -0.368 . . . . 0.0 112.61 -175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.979 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -162.94 168.18 21.52 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -169.462 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' HYP . . . . . 0.579 HD22 ' HB2' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -64.69 -31.97 73.43 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 175.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.5 t -82.0 -26.49 33.82 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -89.31 -28.48 19.83 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 124.36 1.064 . . . . 0.0 111.761 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -66.63 149.64 50.19 Favored 'General case' 0 CA--C 1.572 1.789 0 CA-C-O 117.632 -1.175 . . . . 0.0 112.23 169.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.9 p -85.93 93.98 9.08 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 123.317 0.647 . . . . 0.0 111.163 -176.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.24 97.79 0.11 Allowed Glycine 0 N--CA 1.478 1.478 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.17 -97.87 1.35 Allowed Glycine 0 N--CA 1.481 1.66 0 CA-C-O 121.222 0.346 . . . . 0.0 112.366 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.406 0 O-C-N 120.434 -1.627 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.364 0 N-CA-C 111.389 -0.685 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 41.1 t -108.22 -118.01 0.27 Allowed 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 45.2 t -150.68 -75.02 0.15 Allowed 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 118.092 -0.956 . . . . 0.0 108.694 169.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.61 -170.44 13.3 Favored Glycine 0 CA--C 1.556 2.599 0 CA-C-N 119.351 0.978 . . . . 0.0 115.53 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.2 85.82 1.76 Allowed 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 123.634 2.889 . . . . 0.0 113.838 -174.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -144.02 151.28 39.49 Favored 'General case' 0 CA--C 1.573 1.849 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.193 -176.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -153.47 160.4 42.54 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 172.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.84 -52.51 65.19 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.73 -30.87 66.09 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 169.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.88 104.42 4.75 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 122.017 0.913 . . . . 0.0 113.075 -168.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -143.64 146.88 33.59 Favored 'General case' 0 CA--C 1.567 1.62 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.132 -176.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.518 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . 48.5 t -82.67 13.72 3.6 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 167.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.6 -21.72 77.79 Favored Glycine 0 CA--C 1.554 2.482 0 N-CA-C 118.44 2.136 . . . . 0.0 118.44 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.9 m -59.92 167.51 2.2 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -76.55 -70.75 0.43 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.304 169.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.86 84.64 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.406 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.353 175.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 163.98 74.4 0.03 OUTLIER Glycine 0 N--CA 1.481 1.642 0 CA-C-O 119.725 -0.486 . . . . 0.0 112.972 176.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.682 ' HB3' HD23 ' A' ' 21' ' ' HYP 0.305 2.6 mpt_? -130.68 179.79 5.74 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.173 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' HYP . . . . . 0.682 HD23 ' HB3' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -77.48 -36.63 52.55 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.7 t -91.01 -26.74 19.05 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -93.42 -33.45 13.83 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 1.044 ' HB3' HD22 ' A' ' 27' ' ' HYP . 99.3 mtt180 -76.31 -162.55 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 119.84 1.2 . . . . 0.0 113.357 171.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HYP . . . . . 1.044 HD22 ' HB3' ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.1 m -91.17 95.82 10.26 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 123.125 0.57 . . . . 0.0 110.382 -172.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.61 -96.49 0.1 Allowed Glycine 0 N--CA 1.479 1.547 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.03 101.02 2.65 Favored Glycine 0 N--CA 1.48 1.625 0 CA-C-O 121.366 0.425 . . . . 0.0 112.195 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.461 0 O-C-N 120.52 -1.576 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.179 0 CA-C-O 118.753 -1.026 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.2 t -90.78 -71.36 0.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 123.589 3.694 . . . . 0.0 111.807 5.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 99.7 m -137.37 -89.73 0.25 Allowed 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.87 -142.8 33.93 Favored Glycine 0 CA--C 1.557 2.668 0 CA-C-N 121.741 2.064 . . . . 0.0 116.011 169.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -46.33 -24.31 2.51 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 124.476 3.45 . . . . 0.0 120.319 169.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -119.89 83.53 2.06 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 171.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -86.32 -82.94 0.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 157.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.47 -88.73 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 168.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.75 62.83 1.64 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 166.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.8 t -68.06 137.59 55.14 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 168.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -98.09 166.89 11.21 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -169.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.6 t -75.65 11.09 1.43 Allowed 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 161.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.2 -31.36 80.57 Favored Glycine 0 CA--C 1.566 3.241 0 CA-C-N 120.458 1.481 . . . . 0.0 114.531 167.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 m -47.08 140.15 5.26 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 169.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -99.6 -15.02 18.74 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.223 -1.353 . . . . 0.0 114.631 168.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 p -150.04 116.48 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 172.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.36 78.71 1.4 Allowed Glycine 0 N--CA 1.484 1.874 0 C-N-CA 122.778 0.228 . . . . 0.0 113.559 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . 0.324 2.8 mpt_? -122.66 177.73 5.32 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.242 1.017 . . . . 0.0 113.18 -175.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -90.05 -37.69 14.1 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.9 m -90.49 -15.48 30.69 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.41 -36.54 15.41 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 124.277 1.031 . . . . 0.0 110.772 169.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -65.48 155.16 36.45 Favored 'General case' 0 CA--C 1.572 1.808 0 CA-C-O 117.62 -1.181 . . . . 0.0 112.498 169.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.8 m -80.68 -65.98 0.94 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 118.558 -0.734 . . . . 0.0 112.293 -171.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -95.76 84.17 0.87 Allowed Glycine 0 N--CA 1.482 1.709 0 CA-C-N 118.846 0.748 . . . . 0.0 111.551 170.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.32 -95.05 0.12 Allowed Glycine 0 CA--C 1.536 1.375 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -176.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.419 0 O-C-N 120.467 -1.607 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.303 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 18.0 t -115.01 -121.09 0.3 Allowed 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 47.4 t -150.83 -77.59 0.13 Allowed 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 117.757 -1.116 . . . . 0.0 109.021 171.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 11' ' ' CYS . . . 114.93 -163.32 12.2 Favored Glycine 0 CA--C 1.558 2.751 0 CA-C-N 119.731 1.151 . . . . 0.0 115.276 -177.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.87 7.01 5.15 Favored 'Trans proline' 0 CA--C 1.569 2.257 0 N-CA-C 119.787 2.956 . . . . 0.0 119.787 -175.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -93.53 -75.55 0.5 Allowed 'General case' 0 CA--C 1.574 1.869 0 CA-C-O 114.377 -2.725 . . . . 0.0 111.224 -164.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -113.46 -52.47 2.76 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.632 1.715 . . . . 0.0 115.632 -155.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.28 -83.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -169.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.63 -14.47 60.77 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 171.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 4' ' ' GLY . 1.3 t -75.46 110.39 9.79 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -168.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -135.06 139.93 45.15 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.078 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.6 t -92.7 28.25 2.1 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 170.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.36 -30.89 57.89 Favored Glycine 0 CA--C 1.559 2.825 0 O-C-N 120.745 -1.222 . . . . 0.0 115.22 168.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.8 m -68.7 160.86 29.47 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -84.56 -72.55 0.47 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.295 169.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.45 134.67 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 CA-C-N 113.458 -1.701 . . . . 0.0 109.587 169.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.51 79.36 1.33 Allowed Glycine 0 N--CA 1.482 1.763 0 C-N-CA 123.037 0.351 . . . . 0.0 113.562 177.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.677 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -151.27 155.48 38.85 Favored 'General case' 0 CA--C 1.571 1.768 0 C-N-CA 123.669 0.788 . . . . 0.0 112.455 -174.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -71.08 -31.29 67.64 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 170.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.677 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 18.3 t -84.02 -24.38 30.54 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -89.37 -37.36 14.91 Favored 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 124.58 1.152 . . . . 0.0 111.332 168.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -69.28 164.85 21.87 Favored 'General case' 0 CA--C 1.568 1.648 0 CA-C-N 119.606 1.093 . . . . 0.0 112.771 169.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.3 m -82.5 -66.08 0.93 Allowed 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.69 -171.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -95.25 98.26 2.24 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-N 118.977 0.808 . . . . 0.0 111.989 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 178.96 99.38 0.12 Allowed Glycine 0 CA--C 1.535 1.331 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.464 0 O-C-N 120.458 -1.613 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.471 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.8 t -159.67 104.62 1.59 Allowed 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 100.721 -3.807 . . . . 0.0 100.721 167.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 78.4 m -92.53 80.25 4.86 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -173.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.16 -132.79 0.43 Allowed Glycine 0 CA--C 1.557 2.692 0 N-CA-C 117.792 1.877 . . . . 0.0 117.792 -169.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -34.98 -38.27 0.16 Allowed 'Trans proline' 0 CA--C 1.557 1.634 1 C-N-CA 125.502 4.135 . . . . 0.0 121.468 175.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -115.5 97.59 6.24 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 169.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -172.31 -52.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.889 1.275 . . . . 0.0 109.413 -172.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.5 -47.63 32.01 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.08 65.28 0.82 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 118.784 0.72 . . . . 0.0 111.596 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.5 t -79.43 110.29 14.6 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.111 0.481 . . . . 0.0 109.798 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -144.14 133.3 22.96 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 117.373 -1.299 . . . . 0.0 108.796 -169.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.2 t -89.9 35.08 0.84 Allowed 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 167.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.06 -33.7 6.21 Favored Glycine 0 CA--C 1.566 3.274 0 O-C-N 121.456 -0.778 . . . . 0.0 111.233 168.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 m -45.93 131.92 9.41 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 126.485 1.914 . . . . 0.0 115.027 168.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -93.12 -14.6 27.02 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 169.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 m -145.41 115.03 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.99 84.46 0.72 Allowed Glycine 0 CA--C 1.543 1.783 0 O-C-N 122.186 -0.321 . . . . 0.0 113.48 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 1.035 ' HB3' HD22 ' A' ' 21' ' ' HYP 0.318 1.3 mpt_? -125.65 -170.59 2.21 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -176.739 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' HYP . . . . . 1.035 HD22 ' HB3' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -75.06 -34.32 61.81 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 116.374 1.99 . . . . 0.0 116.374 174.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.7 t -90.24 -20.87 22.48 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -89.55 -35.06 16.13 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.15 0.98 . . . . 0.0 112.44 169.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 1.017 ' HB3' HD23 ' A' ' 27' ' ' HYP . 99.8 mtt180 -77.53 -160.91 0.2 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 119.683 1.128 . . . . 0.0 112.304 169.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HYP . . . . . 1.017 HD23 ' HB3' ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.3 t -81.93 -65.46 1.01 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -173.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.67 -97.82 0.11 Allowed Glycine 0 N--CA 1.477 1.43 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.04 -99.2 0.12 Allowed Glycine 0 CA--C 1.536 1.398 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.464 0 O-C-N 120.474 -1.603 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.415 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.9 t -113.31 -116.77 0.32 Allowed 'General case' 0 CA--C 1.559 1.294 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.5 t -150.64 -90.25 0.06 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.84 178.51 31.95 Favored Glycine 0 CA--C 1.554 2.495 0 N-CA-C 115.928 1.131 . . . . 0.0 115.928 -175.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.469 ' HA ' ' HD1' ' A' ' 13' ' ' HYP . 58.6 Cg_endo -70.07 -14.41 35.06 Favored 'Trans proline' 0 CA--C 1.563 1.95 0 N-CA-C 119.791 2.958 . . . . 0.0 119.791 -173.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -90.99 116.28 28.66 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-O 117.288 -1.339 . . . . 0.0 108.443 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -135.64 -104.8 0.22 Allowed 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 169.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.89 -81.07 0.32 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.564 1.075 . . . . 0.0 111.019 172.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.62 -9.73 59.48 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 173.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.5 t -74.03 117.35 15.72 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 119.341 0.973 . . . . 0.0 112.165 -168.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -144.88 151.07 38.15 Favored 'General case' 0 CA--C 1.566 1.589 0 C-N-CA 123.935 0.894 . . . . 0.0 109.835 -173.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HYP . . . . . 0.469 ' HD1' ' HA ' ' A' ' 5' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 1.058 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 49.8 t -114.76 64.45 0.67 Allowed 'General case' 0 CA--C 1.552 1.047 0 CA-C-O 121.781 0.8 . . . . 0.0 112.188 165.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.35 -2.54 87.72 Favored Glycine 0 CA--C 1.576 3.856 0 N-CA-C 114.771 0.668 . . . . 0.0 114.771 167.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.9 m -90.11 172.2 8.99 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.59 1.956 . . . . 0.0 115.772 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -87.44 -67.69 0.8 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.055 168.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 p -106.57 133.41 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 CA-C-N 113.869 -1.514 . . . . 0.0 108.874 169.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.87 88.05 1.97 Allowed Glycine 0 N--CA 1.484 1.857 0 C-N-CA 123.167 0.413 . . . . 0.0 113.238 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 1.058 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -160.82 160.48 31.19 Favored 'General case' 0 CA--C 1.562 1.404 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -173.435 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' HYP . . . . . 0.649 ' HA ' HH21 ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -63.54 -33.06 74.76 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.447 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 30.8 t -78.8 -27.21 44.39 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -174.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -89.37 -32.25 17.39 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.046 0.938 . . . . 0.0 112.358 169.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 1.093 ' HB3' ' CD ' ' A' ' 27' ' ' HYP . 0.7 OUTLIER -86.37 -150.2 0.15 Allowed 'General case' 0 CA--C 1.565 1.537 0 CA-C-N 119.541 1.064 . . . . 0.0 110.454 169.499 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HYP . . . . . 1.093 ' CD ' ' HB3' ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.2 t -75.99 -63.25 1.35 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.96 -96.74 0.1 Allowed Glycine 0 N--CA 1.478 1.476 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.5 -98.3 1.27 Allowed Glycine 0 N--CA 1.481 1.67 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.44 0 O-C-N 120.521 -1.576 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.424 0 CA-C-O 119.968 -0.351 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 45.8 t -115.26 65.8 0.69 Allowed 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 123.624 0.77 . . . . 0.0 109.909 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 99.3 m -91.85 72.72 5.7 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 169.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.86 -128.1 0.42 Allowed Glycine 0 CA--C 1.553 2.423 0 CA-C-O 117.846 -1.53 . . . . 0.0 116.622 -169.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -38.1 -30.75 0.17 Allowed 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 125.144 3.896 . . . . 0.0 121.474 172.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -116.85 89.59 3.15 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 170.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -170.52 -53.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.565 1.146 . . . . 0.0 109.736 -168.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.05 -49.13 60.2 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 172.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.73 64.27 0.77 Allowed 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 118.496 0.589 . . . . 0.0 110.886 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.0 t -83.22 106.6 15.13 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.312 0.645 . . . . 0.0 109.61 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -141.58 128.55 20.69 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 116.989 -1.481 . . . . 0.0 108.276 -169.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.537 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -117.67 56.01 0.85 Allowed 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 124.612 1.165 . . . . 0.0 112.451 174.363 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.23 13.32 67.91 Favored Glycine 0 CA--C 1.577 3.945 0 O-C-N 120.454 -1.404 . . . . 0.0 113.563 166.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -91.54 163.79 14.02 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.16 2.184 . . . . 0.0 115.158 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -91.2 -62.67 1.39 Allowed 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 113.042 -1.89 . . . . 0.0 109.206 167.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.23 139.58 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.233 169.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.66 84.41 1.4 Allowed Glycine 0 N--CA 1.486 1.977 0 C-N-CA 123.188 0.423 . . . . 0.0 113.065 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.409 ' HB2' HD23 ' A' ' 21' ' ' HYP . 0.0 OUTLIER -160.18 161.27 33.56 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -169.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' HYP . . . . . 0.409 HD23 ' HB2' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -72.11 -33.66 68.0 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 173.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.2 m -90.23 -19.41 24.18 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.48 2.029 . . . . 0.0 116.48 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.34 -35.53 16.04 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 124.677 1.191 . . . . 0.0 112.305 169.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -70.95 145.26 50.2 Favored 'General case' 0 CA--C 1.569 1.711 0 CA-C-O 117.253 -1.356 . . . . 0.0 111.201 169.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.9 m -88.0 99.31 12.06 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.563 -171.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.72 -97.29 0.11 Allowed Glycine 0 N--CA 1.479 1.552 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.82 99.29 0.12 Allowed Glycine 0 N--CA 1.477 1.399 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.46 0 O-C-N 120.535 -1.567 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.23 -167.82 21.1 Favored Glycine 0 CA--C 1.56 2.872 0 N-CA-C 117.068 1.587 . . . . 0.0 117.068 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -53.94 -12.16 3.17 Favored 'Trans proline' 0 CA--C 1.563 1.958 1 N-CA-C 123.011 4.197 . . . . 0.0 123.011 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 . . . . . 0 N--CA 1.492 1.657 0 CA-C-N 119.611 1.096 . . . . 0.0 109.463 -169.59 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 . . . . . 0 N--CA 1.503 2.194 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.36 -92.0 0.14 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 169.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.25 -9.46 50.6 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 167.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.34 115.84 26.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.172 0.989 . . . . 0.0 111.435 -168.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.825 -174.3 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 1.196 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 20.7 t . . . . . 0 CA--C 1.558 1.285 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.66 -18.16 76.05 Favored Glycine 0 CA--C 1.569 3.46 0 O-C-N 121.868 -0.52 . . . . 0.0 114.242 167.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 m -74.94 172.63 11.93 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 126.458 1.903 . . . . 0.0 114.87 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -80.53 -76.9 0.21 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.183 169.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.0 m -95.55 142.11 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.713 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.51 85.04 0.95 Allowed Glycine 0 N--CA 1.483 1.828 0 CA-C-O 119.768 -0.462 . . . . 0.0 113.013 175.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 1.196 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER . . . . . 0 CA--C 1.566 1.578 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -169.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.5 p90 . . . . . 0 N--CA 1.495 1.823 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.0 t -83.7 -24.95 31.03 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -89.24 -28.87 19.64 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 124.333 1.053 . . . . 0.0 111.579 168.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 . . . . . 0 CA--C 1.573 1.832 0 CA-C-O 117.688 -1.149 . . . . 0.0 112.188 169.213 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 CA--C 1.56 1.362 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.901 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.84 -96.55 0.1 Allowed Glycine 0 CA--C 1.537 1.448 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 112.317 -0.313 . . . . 0.0 112.317 -179.962 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.38 -143.95 16.31 Favored Glycine 0 CA--C 1.558 2.763 0 CA-C-O 118.311 -1.272 . . . . 0.0 115.01 177.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -77.51 74.99 4.9 Favored 'Trans proline' 0 CA--C 1.566 2.091 0 C-N-CA 123.941 3.094 . . . . 0.0 114.099 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.531 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 63.5 m-85 . . . . . 0 CA--C 1.58 2.114 0 C-N-CA 125.218 1.407 . . . . 0.0 109.169 -171.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 . . . . . 0 N--CA 1.499 2.002 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.33 -84.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 120.504 1.502 . . . . 0.0 114.796 -169.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.02 -13.68 60.23 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 172.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 6' ' ' TYR . 1.7 t -74.2 118.42 17.15 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -168.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 . . . . . 0 CA--C 1.565 1.551 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -175.267 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.6 t . . . . . 0 CA--C 1.569 1.685 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.95 -33.98 87.19 Favored Glycine 0 CA--C 1.554 2.474 0 N-CA-C 116.564 1.386 . . . . 0.0 116.564 169.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.7 m -62.94 157.08 22.61 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -80.43 -71.21 0.47 Allowed 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.976 169.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.9 p -99.41 134.44 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.794 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.42 88.81 0.99 Allowed Glycine 0 N--CA 1.483 1.828 0 CA-C-O 119.757 -0.468 . . . . 0.0 112.663 175.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.43 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER . . . . . 0 CA--C 1.564 1.491 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -169.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.3 p90 . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.43 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 34.3 t -88.79 -24.14 22.69 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -89.58 -37.9 14.35 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 125.058 1.343 . . . . 0.0 111.88 169.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 . . . . . 0 CA--C 1.568 1.647 0 CA-C-O 116.891 -1.528 . . . . 0.0 111.457 169.513 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.8 m . . . . . 0 N--CA 1.485 1.298 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.36 -97.61 0.11 Allowed Glycine 0 CA--C 1.537 1.429 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.512 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.933 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 54.0 t . . . . . 0 CA--C 1.551 1.006 0 CA-C-O 116.602 -1.666 . . . . 0.0 108.285 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.8 -159.1 25.5 Favored Glycine 0 CA--C 1.561 2.958 0 CA-C-N 121.668 2.031 . . . . 0.0 115.187 -169.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -76.89 65.15 7.71 Favored 'Trans proline' 0 CA--C 1.568 2.184 0 C-N-CA 123.573 2.849 . . . . 0.0 117.258 -169.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 CA--C 1.568 1.644 0 N-CA-C 102.78 -3.044 . . . . 0.0 102.78 164.207 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 . . . . . 0 CA--C 1.564 1.485 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.56 -110.0 0.09 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 168.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.49 -44.55 28.48 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.801 0.728 . . . . 0.0 110.961 167.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 t 57.82 82.34 0.13 Allowed 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 126.715 2.006 . . . . 0.0 107.726 -172.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -169.363 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.0 t . . . . . 0 CA--C 1.573 1.861 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.3 -27.39 70.61 Favored Glycine 0 CA--C 1.564 3.098 0 O-C-N 120.558 -1.339 . . . . 0.0 116.352 168.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -54.02 137.89 38.61 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 169.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -80.94 -55.16 4.98 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.982 169.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 m -113.77 125.5 71.06 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.418 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.741 171.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.36 65.43 1.47 Allowed Glycine 0 CA--C 1.543 1.826 0 N-CA-C 115.421 0.928 . . . . 0.0 115.421 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.561 1.387 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 173.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.0 p90 . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.11 -25.75 20.57 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -176.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -102.41 -44.35 5.4 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.435 1.094 . . . . 0.0 111.841 169.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 . . . . . 0 CA--C 1.561 1.397 0 CA-C-O 116.32 -1.8 . . . . 0.0 108.46 169.422 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.2 t . . . . . 0 CA--C 1.557 1.23 0 CA-C-O 118.258 -0.877 . . . . 0.0 108.723 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.73 -99.66 0.15 Allowed Glycine 0 CA--C 1.537 1.468 0 CA-C-N 119.727 1.149 . . . . 0.0 111.731 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.448 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -172.715 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 64.3 m . . . . . 0 CA--C 1.554 1.123 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.76 -135.4 28.5 Favored Glycine 0 CA--C 1.555 2.548 0 CA-C-N 120.448 1.476 . . . . 0.0 115.2 174.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -64.34 -11.53 28.59 Favored 'Trans proline' 0 CA--C 1.567 2.127 0 C-N-CA 123.488 2.792 . . . . 0.0 118.504 170.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 . . . . . 0 CA--C 1.572 1.802 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 163.808 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.7 m120 . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.22 -92.03 0.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 104.67 -2.345 . . . . 0.0 104.67 168.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.54 63.56 1.6 Allowed 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 166.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.4 t -66.45 145.1 56.04 Favored 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 168.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 118.199 2.666 . . . . 0.0 118.199 -166.946 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.8 t . . . . . 0 CA--C 1.569 1.68 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.92 -6.79 60.73 Favored Glycine 0 CA--C 1.563 3.078 0 N-CA-C 118.137 2.015 . . . . 0.0 118.137 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.7 m -79.07 161.14 26.75 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.279 1.431 . . . . 0.0 114.632 -169.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -85.52 -72.95 0.46 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.797 169.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.1 p -101.71 133.51 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.498 0 CA-C-N 113.136 -1.847 . . . . 0.0 109.318 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.02 86.95 1.08 Allowed Glycine 0 N--CA 1.481 1.673 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.64 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.443 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 0.7 OUTLIER . . . . . 0 CA--C 1.56 1.351 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.3 p90 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.443 ' SG ' ' HG2' ' A' ' 20' ' ' ARG . 14.0 t -90.4 -22.06 21.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -89.69 -41.28 12.01 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.69 1.196 . . . . 0.0 111.884 169.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 . . . . . 0 CA--C 1.564 1.518 0 CA-C-O 116.696 -1.621 . . . . 0.0 110.809 169.661 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.0 t . . . . . 0 CA--C 1.559 1.302 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.35 -97.79 0.11 Allowed Glycine 0 N--CA 1.478 1.438 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.421 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.96 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.8 t . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.87 -142.67 47.97 Favored Glycine 0 CA--C 1.561 2.934 0 CA-C-O 118.721 -1.044 . . . . 0.0 115.102 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.44 -14.57 37.33 Favored 'Trans proline' 0 CA--C 1.569 2.262 0 C-N-CA 123.249 2.632 . . . . 0.0 118.114 169.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -178.627 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 . . . . . 0 CA--C 1.567 1.6 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.12 -44.32 9.34 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 118.489 2.774 . . . . 0.0 118.489 -169.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.79 71.98 0.76 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.775 0.83 . . . . 0.0 110.237 -169.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.06 93.19 8.93 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 124.004 1.859 . . . . 0.0 111.887 -169.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 . . . . . 0 CA--C 1.575 1.914 0 CA-C-N 111.265 -2.698 . . . . 0.0 106.122 -179.534 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 1.244 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 50.9 t . . . . . 0 CA--C 1.545 0.77 0 CA-C-O 122.153 0.978 . . . . 0.0 112.009 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.0 -0.28 90.22 Favored Glycine 1 CA--C 1.582 4.263 0 CA-C-N 115.066 -0.97 . . . . 0.0 113.509 166.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . 44.9 m -90.64 168.6 11.66 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 117.427 2.381 . . . . 0.0 117.427 -169.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -88.77 -63.36 1.31 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 112.911 -1.95 . . . . 0.0 109.46 168.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.8 p -110.55 133.93 54.43 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.28 169.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.88 82.62 1.59 Allowed Glycine 0 N--CA 1.487 2.065 0 C-N-CA 123.154 0.407 . . . . 0.0 113.37 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 1.244 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.57 1.713 0 CA-C-O 118.193 -0.908 . . . . 0.0 112.482 -169.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.6 p90 . . . . . 0 N--CA 1.498 1.96 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.445 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 12.2 t -85.1 -22.97 28.68 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -89.12 -31.49 17.97 Favored 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 124.7 1.2 . . . . 0.0 112.227 169.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 . . . . . 0 CA--C 1.567 1.597 0 CA-C-N 120.056 1.298 . . . . 0.0 113.164 169.321 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.7 p . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.45 97.77 0.11 Allowed Glycine 0 N--CA 1.478 1.461 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.946 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 117.334 -1.317 . . . . 0.0 108.319 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.58 -174.97 19.21 Favored Glycine 0 CA--C 1.556 2.648 0 CA-C-N 120.354 1.434 . . . . 0.0 116.522 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -46.87 -26.76 5.03 Favored 'Trans proline' 0 CA--C 1.559 1.725 1 N-CA-C 123.352 4.328 . . . . 0.0 123.352 -174.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 116.937 -1.506 . . . . 0.0 109.06 -169.287 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.7 p30 . . . . . 0 CA--C 1.562 1.411 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.75 -93.72 0.13 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 119.788 1.176 . . . . 0.0 110.62 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -107.41 54.19 0.67 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 118.863 0.756 . . . . 0.0 110.705 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 t -107.01 92.26 4.01 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 122.232 1.015 . . . . 0.0 109.575 -169.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 . . . . . 0 CA--C 1.564 1.49 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.188 -172.955 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 1.537 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 35.7 t . . . . . 0 CA--C 1.557 1.241 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.91 -29.82 49.98 Favored Glycine 0 CA--C 1.565 3.162 0 O-C-N 121.781 -0.574 . . . . 0.0 113.268 167.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 m -62.72 167.34 4.61 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 126.455 1.902 . . . . 0.0 115.859 173.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -79.8 -72.19 0.41 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.876 169.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.9 m -94.54 141.05 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 113.732 -1.577 . . . . 0.0 110.872 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.77 76.92 1.01 Allowed Glycine 0 CA--C 1.543 1.799 0 N-CA-C 114.426 0.531 . . . . 0.0 114.426 173.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 1.537 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.572 1.793 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.8 p90 . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.3 t -81.81 -32.16 31.4 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -89.78 -29.04 18.94 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 123.916 0.886 . . . . 0.0 113.204 169.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 . . . . . 0 CA--C 1.564 1.484 0 CA-C-O 116.418 -1.753 . . . . 0.0 110.235 169.702 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 CA--C 1.562 1.439 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.16 -96.96 0.1 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.618 0 CA-C-O 121.346 0.415 . . . . 0.0 112.367 179.329 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 117.695 -1.145 . . . . 0.0 108.697 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.27 -170.93 13.5 Favored Glycine 0 CA--C 1.557 2.713 0 N-CA-C 116.863 1.505 . . . . 0.0 116.863 172.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.86 63.58 8.4 Favored 'Trans proline' 0 CA--C 1.566 2.082 0 C-N-CA 123.501 2.801 . . . . 0.0 116.84 -169.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 CA--C 1.565 1.523 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 162.95 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 . . . . . 0 CA--C 1.559 1.307 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.71 -95.45 0.12 Allowed 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 118.97 0.804 . . . . 0.0 111.003 175.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.95 6.47 41.92 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.83 100.38 4.75 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 120.506 1.503 . . . . 0.0 112.832 -168.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 . . . . . 0 CA--C 1.569 1.706 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.948 -172.192 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.9 t . . . . . 0 CA--C 1.566 1.56 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.54 -7.04 88.04 Favored Glycine 0 CA--C 1.568 3.359 0 N-CA-C 115.728 1.051 . . . . 0.0 115.728 168.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.2 m -60.7 158.33 12.89 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -85.69 -50.36 7.24 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.208 -1.36 . . . . 0.0 113.525 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 p -137.16 126.89 37.68 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 170.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.08 83.86 1.75 Allowed Glycine 0 N--CA 1.483 1.823 0 CA-C-N 116.505 -0.316 . . . . 0.0 113.039 176.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.924 ' HB2' ' HB2' ' A' ' 25' ' ' ASP . 6.7 mpt_? . . . . . 0 CA--C 1.561 1.401 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.8 p90 . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.497 ' HB3' ' HG2' ' A' ' 20' ' ' ARG . 1.7 m -90.74 -8.09 50.73 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.924 ' HB2' ' HB2' ' A' ' 20' ' ' ARG . 13.2 t70 -132.45 -38.44 1.05 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.226 1.41 . . . . 0.0 112.019 175.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 . . . . . 0 CA--C 1.57 1.722 0 CA-C-O 116.549 -1.691 . . . . 0.0 110.423 169.899 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.1 p . . . . . 0 CA--C 1.559 1.296 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.38 -96.67 0.1 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.468 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.926 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.94 -166.3 37.06 Favored Glycine 0 CA--C 1.556 2.651 0 CA-C-N 120.35 1.432 . . . . 0.0 116.355 170.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.88 3.51 3.82 Favored 'Trans proline' 0 CA--C 1.57 2.3 0 C-N-CA 123.117 2.545 . . . . 0.0 118.535 172.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 . . . . . 0 CA--C 1.571 1.77 0 CA-C-O 115.164 -2.35 . . . . 0.0 112.795 -176.805 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.26 40.43 1.01 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.931 2.197 . . . . 0.0 116.931 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 31.33 64.37 0.2 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.2 t -50.78 152.96 1.88 Allowed 'General case' 0 CA--C 1.574 1.885 0 CA-C-N 113.251 -1.795 . . . . 0.0 110.833 169.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 60.3 m170 . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.234 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.423 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 3.1 t . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.45 3.04 87.78 Favored Glycine 0 CA--C 1.566 3.243 0 N-CA-C 116.309 1.284 . . . . 0.0 116.309 168.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.6 m -90.83 -167.22 1.76 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.281 1.432 . . . . 0.0 113.295 -172.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -116.54 -74.72 0.6 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 169.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 p -91.62 127.2 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.707 173.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.16 46.3 4.77 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 118.425 2.13 . . . . 0.0 118.425 170.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.456 ' HB2' ' HB2' ' A' ' 25' ' ' ASP 0.304 4.9 mpt_? . . . . . 0 CA--C 1.555 1.145 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.5 p90 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.8 m -90.98 -10.65 41.53 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 20' ' ' ARG . 17.2 t70 -134.98 -37.68 0.8 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.9 1.28 . . . . 0.0 112.559 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 . . . . . 0 CA--C 1.57 1.733 0 CA-C-O 116.668 -1.634 . . . . 0.0 111.081 169.911 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 CA--C 1.562 1.428 0 N-CA-C 110.759 -0.089 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.58 97.9 0.11 Allowed Glycine 0 N--CA 1.479 1.529 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.414 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.89 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 61.6 m . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.81 -172.27 53.04 Favored Glycine 0 CA--C 1.558 2.768 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.022 -168.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.04 -16.75 28.78 Favored 'Trans proline' 0 CA--C 1.573 2.462 0 C-N-CA 122.672 2.248 . . . . 0.0 116.598 169.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 CA--C 1.575 1.941 0 CA-C-O 115.036 -2.411 . . . . 0.0 112.68 -171.061 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.0 m120 . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.26 -26.9 68.99 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.73 53.36 2.39 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 119.894 1.224 . . . . 0.0 113.119 169.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 1.8 t -80.6 121.72 26.18 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.224 0.61 . . . . 0.0 112.109 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 171.128 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.65 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 1.3 t . . . . . 0 CA--C 1.557 1.219 0 CA-C-O 122.742 1.258 . . . . 0.0 111.444 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.04 -4.03 14.84 Favored Glycine 0 CA--C 1.567 3.305 0 CA-C-N 114.427 -1.26 . . . . 0.0 114.027 167.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.709 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 80.0 m -90.6 -100.42 0.1 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.905 1.352 . . . . 0.0 111.18 -169.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.709 ' HB2' ' O ' ' A' ' 16' ' ' CYS . 48.5 tptt 164.6 -82.87 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -170.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.448 ' H ' ' HB3' ' A' ' 17' ' ' LYS . 13.4 p -92.03 118.15 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 113.375 -1.739 . . . . 0.0 108.61 174.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.97 93.9 0.67 Allowed Glycine 0 CA--C 1.541 1.657 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -172.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.65 ' HD2' ' HA ' ' A' ' 14' ' ' CYS . 29.8 ttp180 . . . . . 0 CA--C 1.568 1.659 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.374 -169.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.7 p90 . . . . . 0 N--CA 1.494 1.725 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.8 m -90.59 -19.25 23.93 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.78 -38.48 13.77 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.355 1.062 . . . . 0.0 111.743 169.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 . . . . . 0 CA--C 1.568 1.645 0 CA-C-N 119.601 1.092 . . . . 0.0 111.139 169.01 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 CA--C 1.561 1.388 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.74 -96.75 0.1 Allowed Glycine 0 N--CA 1.477 1.409 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 112.267 -0.333 . . . . 0.0 112.267 -179.913 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 116.806 -1.569 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.72 178.93 20.56 Favored Glycine 0 CA--C 1.555 2.592 0 CA-C-N 121.275 1.852 . . . . 0.0 115.556 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.2 85.68 1.74 Allowed 'Trans proline' 0 CA--C 1.562 1.895 0 C-N-CA 123.478 2.786 . . . . 0.0 113.286 -177.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 . . . . . 0 CA--C 1.564 1.499 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -176.507 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.28 -31.64 20.13 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 168.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 48.36 53.24 12.25 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -169.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.77 134.92 57.0 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.443 168.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -168.931 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.513 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 11.7 t . . . . . 0 CA--C 1.568 1.671 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.63 -29.81 62.98 Favored Glycine 0 CA--C 1.564 3.147 0 O-C-N 120.95 -1.094 . . . . 0.0 115.299 168.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.2 m -62.34 178.18 0.42 Allowed 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 116.866 2.172 . . . . 0.0 116.866 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -108.09 -71.75 0.75 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.941 168.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -95.84 136.13 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.61 169.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.11 82.81 1.04 Allowed Glycine 0 N--CA 1.486 1.972 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.513 ' HD2' ' HA ' ' A' ' 14' ' ' CYS . 17.2 ttp180 . . . . . 0 CA--C 1.566 1.584 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.362 -168.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.0 p90 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.2 m -90.41 -22.6 21.37 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -89.69 -35.31 15.87 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.19 0.996 . . . . 0.0 112.579 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 . . . . . 0 CA--C 1.571 1.763 0 CA-C-O 116.875 -1.536 . . . . 0.0 110.142 169.497 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 m . . . . . 0 CA--C 1.562 1.439 0 CA-C-O 119.665 -0.207 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.82 -96.6 0.1 Allowed Glycine 0 CA--C 1.538 1.469 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 CA-C-O 121.401 0.445 . . . . 0.0 112.148 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.561 1.366 0 CA-C-O 117.049 -1.453 . . . . 0.0 107.561 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.04 -168.07 40.59 Favored Glycine 0 CA--C 1.554 2.484 0 CA-C-N 121.764 2.075 . . . . 0.0 118.195 169.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.84 11.75 1.89 Allowed 'Trans proline' 0 CA--C 1.57 2.278 0 C-N-CA 123.482 2.788 . . . . 0.0 118.398 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 CA--C 1.568 1.649 0 CA-C-O 115.474 -2.203 . . . . 0.0 110.858 179.688 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.51 55.5 3.03 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -170.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 30.46 62.7 0.19 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 -169.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.0 t -70.8 118.02 13.06 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 168.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 . . . . . 0 N--CA 1.497 1.921 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -168.894 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 115.419 1.636 . . . . 0.0 115.419 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.8 -29.77 73.18 Favored Glycine 0 CA--C 1.564 3.137 0 CA-C-N 120.776 1.625 . . . . 0.0 115.563 168.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.2 m -62.81 137.9 58.39 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.882 1.273 . . . . 0.0 114.014 169.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -93.23 -2.57 55.0 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 169.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -150.15 115.4 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.345 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.02 86.16 0.6 Allowed Glycine 0 CA--C 1.543 1.79 0 CA-C-O 119.871 -0.405 . . . . 0.0 113.662 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.559 1.305 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -171.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.9 p90 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.9 m -90.6 -18.11 25.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -89.5 -28.58 19.56 Favored 'General case' 0 CA--C 1.565 1.552 0 C-N-CA 124.197 0.999 . . . . 0.0 112.608 169.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 . . . . . 0 CA--C 1.572 1.79 0 CA-C-O 117.695 -1.145 . . . . 0.0 112.92 169.157 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.8 t . . . . . 0 CA--C 1.564 1.5 0 CA-C-O 119.614 -0.231 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.71 -97.69 0.11 Allowed Glycine 0 N--CA 1.478 1.458 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.408 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.874 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.58 -174.61 15.83 Favored Glycine 0 CA--C 1.556 2.609 0 N-CA-C 116.41 1.324 . . . . 0.0 116.41 169.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.6 66.11 8.58 Favored 'Trans proline' 0 CA--C 1.566 2.118 0 C-N-CA 123.468 2.779 . . . . 0.0 117.341 -169.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 . . . . . 0 CA--C 1.568 1.668 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 163.002 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.7 m120 . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.73 -91.38 0.15 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 119.166 0.894 . . . . 0.0 110.256 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -107.74 46.0 0.97 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.836 0.743 . . . . 0.0 112.495 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 t -92.14 97.49 10.95 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 122.197 0.999 . . . . 0.0 109.094 -169.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 . . . . . 0 CA--C 1.568 1.653 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.392 -169.955 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 1.007 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 35.3 t . . . . . 0 CA--C 1.553 1.076 0 CA-C-O 122.242 1.02 . . . . 0.0 112.493 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.65 -34.51 56.64 Favored Glycine 0 CA--C 1.57 3.481 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.645 167.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -69.99 151.84 45.12 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 125.732 1.613 . . . . 0.0 114.504 169.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -98.39 3.54 48.48 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 168.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.0 p -150.12 118.4 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.16 80.39 0.82 Allowed Glycine 0 N--CA 1.487 2.065 0 CA-C-O 119.938 -0.368 . . . . 0.0 112.61 -175.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 1.007 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER . . . . . 0 CA--C 1.566 1.581 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -169.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.3 p90 . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.5 t -82.0 -26.49 33.82 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -89.31 -28.48 19.83 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 124.36 1.064 . . . . 0.0 111.761 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 . . . . . 0 CA--C 1.572 1.789 0 CA-C-O 117.632 -1.175 . . . . 0.0 112.23 169.311 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 CA--C 1.565 1.535 0 CA-C-O 119.867 -0.111 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.24 97.79 0.11 Allowed Glycine 0 N--CA 1.478 1.478 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.66 0 CA-C-O 121.222 0.346 . . . . 0.0 112.366 -179.224 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 118.092 -0.956 . . . . 0.0 108.694 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.61 -170.44 13.3 Favored Glycine 0 CA--C 1.556 2.599 0 CA-C-N 119.351 0.978 . . . . 0.0 115.53 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.2 85.82 1.76 Allowed 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 123.634 2.889 . . . . 0.0 113.838 -174.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 . . . . . 0 CA--C 1.573 1.849 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.193 -176.997 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.7 m120 . . . . . 0 CA--C 1.566 1.586 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.84 -52.51 65.19 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.73 -30.87 66.09 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 169.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.88 104.42 4.75 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 122.017 0.913 . . . . 0.0 113.075 -168.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 . . . . . 0 CA--C 1.567 1.62 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.132 -176.637 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.533 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . 48.5 t . . . . . 0 CA--C 1.569 1.701 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.6 -21.72 77.79 Favored Glycine 0 CA--C 1.554 2.482 0 N-CA-C 118.44 2.136 . . . . 0.0 118.44 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.9 m -59.92 167.51 2.2 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -76.55 -70.75 0.43 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.304 169.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.86 84.64 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.406 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.353 175.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 163.98 74.4 0.03 OUTLIER Glycine 0 N--CA 1.481 1.642 0 CA-C-O 119.725 -0.486 . . . . 0.0 112.972 176.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.533 ' HG2' ' HA ' ' A' ' 14' ' ' CYS 0.305 2.6 mpt_? . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.7 p90 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.7 t -91.01 -26.74 19.05 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -93.42 -33.45 13.83 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 N--CA 1.49 1.564 0 CA-C-N 119.84 1.2 . . . . 0.0 113.357 171.107 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 CA--C 1.561 1.393 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.61 -96.49 0.1 Allowed Glycine 0 N--CA 1.479 1.547 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 CA-C-O 121.366 0.425 . . . . 0.0 112.195 179.957 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 99.7 m . . . . . 0 CA--C 1.552 1.033 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.87 -142.8 33.93 Favored Glycine 0 CA--C 1.557 2.668 0 CA-C-N 121.741 2.064 . . . . 0.0 116.011 169.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -46.33 -24.31 2.51 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 124.476 3.45 . . . . 0.0 120.319 169.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 CA--C 1.571 1.782 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 171.152 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.47 -88.73 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 168.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.75 62.83 1.64 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 166.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.8 t -68.06 137.59 55.14 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 168.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -169.374 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.6 t . . . . . 0 CA--C 1.565 1.547 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.2 -31.36 80.57 Favored Glycine 0 CA--C 1.566 3.241 0 CA-C-N 120.458 1.481 . . . . 0.0 114.531 167.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 m -47.08 140.15 5.26 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 169.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -99.6 -15.02 18.74 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.223 -1.353 . . . . 0.0 114.631 168.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 p -150.04 116.48 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 172.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.36 78.71 1.4 Allowed Glycine 0 N--CA 1.484 1.874 0 C-N-CA 122.778 0.228 . . . . 0.0 113.559 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.452 ' HG2' ' HB3' ' A' ' 24' ' ' CYS 0.324 2.8 mpt_? . . . . . 0 N--CA 1.483 1.207 0 C-N-CA 124.242 1.017 . . . . 0.0 113.18 -175.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.0 p90 . . . . . 0 CA--C 1.563 1.463 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.452 ' HB3' ' HG2' ' A' ' 20' ' ' ARG . 4.9 m -90.49 -15.48 30.69 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.41 -36.54 15.41 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 124.277 1.031 . . . . 0.0 110.772 169.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 . . . . . 0 CA--C 1.572 1.808 0 CA-C-O 117.62 -1.181 . . . . 0.0 112.498 169.033 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 118.558 -0.734 . . . . 0.0 112.293 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -95.76 84.17 0.87 Allowed Glycine 0 N--CA 1.482 1.709 0 CA-C-N 118.846 0.748 . . . . 0.0 111.551 170.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.375 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -176.446 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 117.757 -1.116 . . . . 0.0 109.021 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 11' ' ' CYS . . . 114.93 -163.32 12.2 Favored Glycine 0 CA--C 1.558 2.751 0 CA-C-N 119.731 1.151 . . . . 0.0 115.276 -177.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.87 7.01 5.15 Favored 'Trans proline' 0 CA--C 1.569 2.257 0 N-CA-C 119.787 2.956 . . . . 0.0 119.787 -175.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 . . . . . 0 CA--C 1.574 1.869 0 CA-C-O 114.377 -2.725 . . . . 0.0 111.224 -164.592 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.8 m120 . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 115.632 1.715 . . . . 0.0 115.632 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.28 -83.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -169.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.63 -14.47 60.77 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 171.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 4' ' ' GLY . 1.3 t -75.46 110.39 9.79 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -168.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 . . . . . 0 CA--C 1.564 1.512 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.078 -179.98 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.6 t . . . . . 0 CA--C 1.566 1.578 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.36 -30.89 57.89 Favored Glycine 0 CA--C 1.559 2.825 0 O-C-N 120.745 -1.222 . . . . 0.0 115.22 168.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.8 m -68.7 160.86 29.47 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -84.56 -72.55 0.47 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.295 169.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.45 134.67 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 CA-C-N 113.458 -1.701 . . . . 0.0 109.587 169.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.51 79.36 1.33 Allowed Glycine 0 N--CA 1.482 1.763 0 C-N-CA 123.037 0.351 . . . . 0.0 113.562 177.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.707 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.571 1.768 0 C-N-CA 123.669 0.788 . . . . 0.0 112.455 -174.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.3 p90 . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.707 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 18.3 t -84.02 -24.38 30.54 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -89.37 -37.36 14.91 Favored 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 124.58 1.152 . . . . 0.0 111.332 168.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 . . . . . 0 CA--C 1.568 1.648 0 CA-C-N 119.606 1.093 . . . . 0.0 112.771 169.444 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 118.663 -0.684 . . . . 0.0 112.69 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -95.25 98.26 2.24 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-N 118.977 0.808 . . . . 0.0 111.989 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.331 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -179.782 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 78.4 m . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.16 -132.79 0.43 Allowed Glycine 0 CA--C 1.557 2.692 0 N-CA-C 117.792 1.877 . . . . 0.0 117.792 -169.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -34.98 -38.27 0.16 Allowed 'Trans proline' 0 CA--C 1.557 1.634 1 C-N-CA 125.502 4.135 . . . . 0.0 121.468 175.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 . . . . . 0 CA--C 1.566 1.579 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 169.195 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 p30 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.5 -47.63 32.01 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.08 65.28 0.82 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 118.784 0.72 . . . . 0.0 111.596 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.5 t -79.43 110.29 14.6 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.111 0.481 . . . . 0.0 109.798 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.373 -1.299 . . . . 0.0 108.796 -169.943 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.2 t . . . . . 0 CA--C 1.569 1.711 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.06 -33.7 6.21 Favored Glycine 0 CA--C 1.566 3.274 0 O-C-N 121.456 -0.778 . . . . 0.0 111.233 168.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 m -45.93 131.92 9.41 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 126.485 1.914 . . . . 0.0 115.027 168.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -93.12 -14.6 27.02 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 169.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 m -145.41 115.03 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.99 84.46 0.72 Allowed Glycine 0 CA--C 1.543 1.783 0 O-C-N 122.186 -0.321 . . . . 0.0 113.48 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . 0.318 1.3 mpt_? . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -176.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.2 p90 . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 116.374 1.99 . . . . 0.0 116.374 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.7 t -90.24 -20.87 22.48 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -89.55 -35.06 16.13 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.15 0.98 . . . . 0.0 112.44 169.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 . . . . . 0 N--CA 1.487 1.4 0 CA-C-N 119.683 1.128 . . . . 0.0 112.304 169.245 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.67 -97.82 0.11 Allowed Glycine 0 N--CA 1.477 1.43 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.398 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.91 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.84 178.51 31.95 Favored Glycine 0 CA--C 1.554 2.495 0 N-CA-C 115.928 1.131 . . . . 0.0 115.928 -175.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.07 -14.41 35.06 Favored 'Trans proline' 0 CA--C 1.563 1.95 0 N-CA-C 119.791 2.958 . . . . 0.0 119.791 -173.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 CA--C 1.566 1.589 0 CA-C-O 117.288 -1.339 . . . . 0.0 108.443 -177.606 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 . . . . . 0 CA--C 1.562 1.412 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.89 -81.07 0.32 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.564 1.075 . . . . 0.0 111.019 172.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.62 -9.73 59.48 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 173.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.5 t -74.03 117.35 15.72 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 119.341 0.973 . . . . 0.0 112.165 -168.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 . . . . . 0 CA--C 1.566 1.589 0 C-N-CA 123.935 0.894 . . . . 0.0 109.835 -173.357 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.977 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 49.8 t . . . . . 0 CA--C 1.552 1.047 0 CA-C-O 121.781 0.8 . . . . 0.0 112.188 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.35 -2.54 87.72 Favored Glycine 0 CA--C 1.576 3.856 0 N-CA-C 114.771 0.668 . . . . 0.0 114.771 167.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.9 m -90.11 172.2 8.99 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.59 1.956 . . . . 0.0 115.772 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -87.44 -67.69 0.8 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.055 168.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 p -106.57 133.41 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 CA-C-N 113.869 -1.514 . . . . 0.0 108.874 169.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.87 88.05 1.97 Allowed Glycine 0 N--CA 1.484 1.857 0 C-N-CA 123.167 0.413 . . . . 0.0 113.238 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.977 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.562 1.404 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -173.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.5 p90 . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.462 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 30.8 t -78.8 -27.21 44.39 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -174.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -89.37 -32.25 17.39 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.046 0.938 . . . . 0.0 112.358 169.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.565 1.537 0 CA-C-N 119.541 1.064 . . . . 0.0 110.454 169.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.96 -96.74 0.1 Allowed Glycine 0 N--CA 1.478 1.476 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 -179.909 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 99.3 m . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.86 -128.1 0.42 Allowed Glycine 0 CA--C 1.553 2.423 0 CA-C-O 117.846 -1.53 . . . . 0.0 116.622 -169.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -38.1 -30.75 0.17 Allowed 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 125.144 3.896 . . . . 0.0 121.474 172.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 CA--C 1.568 1.652 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 170.069 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 119.077 -0.487 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.05 -49.13 60.2 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 172.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.73 64.27 0.77 Allowed 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 118.496 0.589 . . . . 0.0 110.886 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.0 t -83.22 106.6 15.13 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.312 0.645 . . . . 0.0 109.61 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 116.989 -1.481 . . . . 0.0 108.276 -169.965 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.537 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.356 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.23 13.32 67.91 Favored Glycine 0 CA--C 1.577 3.945 0 O-C-N 120.454 -1.404 . . . . 0.0 113.563 166.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -91.54 163.79 14.02 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.16 2.184 . . . . 0.0 115.158 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -91.2 -62.67 1.39 Allowed 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 113.042 -1.89 . . . . 0.0 109.206 167.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.23 139.58 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.233 169.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.66 84.41 1.4 Allowed Glycine 0 N--CA 1.486 1.977 0 C-N-CA 123.188 0.423 . . . . 0.0 113.065 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.563 1.466 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -169.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.9 p90 . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.2 m -90.23 -19.41 24.18 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.48 2.029 . . . . 0.0 116.48 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.34 -35.53 16.04 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 124.677 1.191 . . . . 0.0 112.305 169.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 . . . . . 0 CA--C 1.569 1.711 0 CA-C-O 117.253 -1.356 . . . . 0.0 111.201 169.338 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.9 m . . . . . 0 CA--C 1.561 1.387 0 CA-C-O 119.682 -0.199 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.72 -97.29 0.11 Allowed Glycine 0 N--CA 1.479 1.552 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.399 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.926 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.434 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.6 t -124.15 -121.34 0.27 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.1 t -150.77 -86.86 0.07 Allowed 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.23 -167.82 21.1 Favored Glycine 0 CA--C 1.56 2.872 0 N-CA-C 117.068 1.587 . . . . 0.0 117.068 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -53.94 -12.16 3.17 Favored 'Trans proline' 0 CA--C 1.563 1.958 1 N-CA-C 123.011 4.197 . . . . 0.0 123.011 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -89.19 131.6 35.24 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 119.611 1.096 . . . . 0.0 109.463 -169.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -143.11 39.09 1.45 Allowed 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -155.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.36 -92.0 0.14 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 169.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.25 -9.46 50.6 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 167.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.34 115.84 26.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.172 0.989 . . . . 0.0 111.435 -168.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -134.94 145.97 48.68 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.825 -174.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 1.196 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 20.7 t -116.87 56.07 0.81 Allowed 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 168.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.66 -18.16 76.05 Favored Glycine 0 CA--C 1.569 3.46 0 O-C-N 121.868 -0.52 . . . . 0.0 114.242 167.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 m -74.94 172.63 11.93 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 126.458 1.903 . . . . 0.0 114.87 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -80.53 -76.9 0.21 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.183 169.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.0 m -95.55 142.11 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.713 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.51 85.04 0.95 Allowed Glycine 0 N--CA 1.483 1.828 0 CA-C-O 119.768 -0.462 . . . . 0.0 113.013 175.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 1.196 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -163.58 160.08 22.58 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -169.634 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -63.65 -33.24 75.18 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 175.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.0 t -83.7 -24.95 31.03 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -89.24 -28.87 19.64 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 124.333 1.053 . . . . 0.0 111.579 168.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -66.48 151.51 47.07 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-O 117.688 -1.149 . . . . 0.0 112.188 169.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -78.26 -66.09 0.9 Allowed 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.901 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.84 -96.55 0.1 Allowed Glycine 0 CA--C 1.537 1.448 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.39 -98.26 1.26 Allowed Glycine 0 N--CA 1.48 1.599 0 N-CA-C 112.317 -0.313 . . . . 0.0 112.317 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.485 0 O-C-N 120.516 -1.579 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.326 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 39.3 t -119.32 -123.04 0.29 Allowed 'General case' 0 CA--C 1.562 1.404 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.6 t -150.75 -79.81 0.12 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 169.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.38 -143.95 16.31 Favored Glycine 0 CA--C 1.558 2.763 0 CA-C-O 118.311 -1.272 . . . . 0.0 115.01 177.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -77.51 74.99 4.9 Favored 'Trans proline' 0 CA--C 1.566 2.091 0 C-N-CA 123.941 3.094 . . . . 0.0 114.099 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.531 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 63.5 m-85 -150.11 161.13 42.98 Favored 'General case' 0 CA--C 1.58 2.114 0 C-N-CA 125.218 1.407 . . . . 0.0 109.169 -171.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -133.51 -52.15 0.87 Allowed 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -155.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.33 -84.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 120.504 1.502 . . . . 0.0 114.796 -169.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.02 -13.68 60.23 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 172.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 6' ' ' TYR . 1.7 t -74.2 118.42 17.15 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -168.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -149.32 132.53 16.41 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.6 t -85.68 16.45 3.95 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 168.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.95 -33.98 87.19 Favored Glycine 0 CA--C 1.554 2.474 0 N-CA-C 116.564 1.386 . . . . 0.0 116.564 169.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.7 m -62.94 157.08 22.61 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -80.43 -71.21 0.47 Allowed 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.976 169.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.9 p -99.41 134.44 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.794 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.42 88.81 0.99 Allowed Glycine 0 N--CA 1.483 1.828 0 CA-C-O 119.757 -0.468 . . . . 0.0 112.663 175.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.846 ' HB2' HD22 ' A' ' 21' ' ' HYP . 0.1 OUTLIER -160.87 173.73 14.91 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -169.78 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HYP . . . . . 0.846 HD22 ' HB2' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -71.88 -31.51 66.52 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.43 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 34.3 t -88.79 -24.14 22.69 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -89.58 -37.9 14.35 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 125.058 1.343 . . . . 0.0 111.88 169.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -67.42 139.18 57.11 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-O 116.891 -1.528 . . . . 0.0 111.457 169.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.8 m -79.45 -64.57 1.16 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.228 -171.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.36 -97.61 0.11 Allowed Glycine 0 CA--C 1.537 1.429 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.65 -99.33 0.12 Allowed Glycine 0 N--CA 1.479 1.512 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.462 0 O-C-N 120.455 -1.615 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.364 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.7 t -71.99 -50.8 25.69 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 54.0 t -133.29 -85.91 0.44 Allowed 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 116.602 -1.666 . . . . 0.0 108.285 169.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.8 -159.1 25.5 Favored Glycine 0 CA--C 1.561 2.958 0 CA-C-N 121.668 2.031 . . . . 0.0 115.187 -169.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -76.89 65.15 7.71 Favored 'Trans proline' 0 CA--C 1.568 2.184 0 C-N-CA 123.573 2.849 . . . . 0.0 117.258 -169.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -140.61 91.12 2.4 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 102.78 -3.044 . . . . 0.0 102.78 164.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -101.19 -76.07 0.57 Allowed 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 151.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.56 -110.0 0.09 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 168.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.49 -44.55 28.48 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.801 0.728 . . . . 0.0 110.961 167.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 t 57.82 82.34 0.13 Allowed 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 126.715 2.006 . . . . 0.0 107.726 -172.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -106.19 153.84 21.55 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -169.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.0 t -78.79 18.02 0.65 Allowed 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 162.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.3 -27.39 70.61 Favored Glycine 0 CA--C 1.564 3.098 0 O-C-N 120.558 -1.339 . . . . 0.0 116.352 168.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -54.02 137.89 38.61 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 169.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -80.94 -55.16 4.98 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.982 169.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 m -113.77 125.5 71.06 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.418 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.741 171.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.36 65.43 1.47 Allowed Glycine 0 CA--C 1.543 1.826 0 N-CA-C 115.421 0.928 . . . . 0.0 115.421 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.89 ' HB3' HD22 ' A' ' 21' ' ' HYP . 0.7 OUTLIER -94.44 -173.27 3.0 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 173.136 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HYP . . . . . 0.89 HD22 ' HB3' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HYP . . . . . 1.276 ' O ' ' HB3' ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -87.54 -35.74 17.99 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 170.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.11 -25.75 20.57 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -176.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -102.41 -44.35 5.4 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.435 1.094 . . . . 0.0 111.841 169.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 1.276 ' HB3' ' O ' ' A' ' 22' ' ' HYP . 78.1 ttt180 -74.16 119.42 18.35 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-O 116.32 -1.8 . . . . 0.0 108.46 169.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.2 t -150.68 -83.55 0.09 Allowed 'General case' 0 CA--C 1.557 1.23 0 CA-C-O 118.258 -0.877 . . . . 0.0 108.723 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.73 -99.66 0.15 Allowed Glycine 0 CA--C 1.537 1.468 0 CA-C-N 119.727 1.149 . . . . 0.0 111.731 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.22 98.3 0.17 Allowed Glycine 0 N--CA 1.478 1.448 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -172.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.405 0 O-C-N 120.35 -1.677 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.406 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -99.19 -98.61 0.23 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 116.654 -1.641 . . . . 0.0 108.312 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 64.3 m -139.88 -108.61 0.16 Allowed 'General case' 0 CA--C 1.554 1.123 0 CA-C-N 121.939 2.154 . . . . 0.0 107.638 -174.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.76 -135.4 28.5 Favored Glycine 0 CA--C 1.555 2.548 0 CA-C-N 120.448 1.476 . . . . 0.0 115.2 174.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -64.34 -11.53 28.59 Favored 'Trans proline' 0 CA--C 1.567 2.127 0 C-N-CA 123.488 2.792 . . . . 0.0 118.504 170.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -123.86 81.49 1.92 Allowed 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 163.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -85.99 -82.48 0.19 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 160.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.22 -92.03 0.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 104.67 -2.345 . . . . 0.0 104.67 168.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.54 63.56 1.6 Allowed 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 166.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.4 t -66.45 145.1 56.04 Favored 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 168.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -88.84 158.8 17.99 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 118.199 2.666 . . . . 0.0 118.199 -166.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.8 t -75.01 6.11 4.48 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 162.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.92 -6.79 60.73 Favored Glycine 0 CA--C 1.563 3.078 0 N-CA-C 118.137 2.015 . . . . 0.0 118.137 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.7 m -79.07 161.14 26.75 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.279 1.431 . . . . 0.0 114.632 -169.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -85.52 -72.95 0.46 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.797 169.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.1 p -101.71 133.51 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.498 0 CA-C-N 113.136 -1.847 . . . . 0.0 109.318 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.02 86.95 1.08 Allowed Glycine 0 N--CA 1.481 1.673 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.64 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.443 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 0.7 OUTLIER -125.5 169.7 12.15 Favored 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -177.101 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -76.82 -33.53 57.96 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.443 ' SG ' ' HG2' ' A' ' 20' ' ' ARG . 14.0 t -90.4 -22.06 21.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -89.69 -41.28 12.01 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.69 1.196 . . . . 0.0 111.884 169.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -70.8 132.34 45.17 Favored 'General case' 0 CA--C 1.564 1.518 0 CA-C-O 116.696 -1.621 . . . . 0.0 110.809 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.0 t -78.58 -65.43 0.99 Allowed 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.35 -97.79 0.11 Allowed Glycine 0 N--CA 1.478 1.438 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.03 -99.18 0.12 Allowed Glycine 0 CA--C 1.537 1.421 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.458 0 O-C-N 120.503 -1.587 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.446 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 40.9 t -87.14 -107.99 0.06 Allowed 'General case' 0 CA--C 1.562 1.42 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.462 ' SG ' ' HA ' ' A' ' 7' ' ' HYP . 16.8 t -150.74 -76.87 0.14 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 171.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.87 -142.67 47.97 Favored Glycine 0 CA--C 1.561 2.934 0 CA-C-O 118.721 -1.044 . . . . 0.0 115.102 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.44 -14.57 37.33 Favored 'Trans proline' 0 CA--C 1.569 2.262 0 C-N-CA 123.249 2.632 . . . . 0.0 118.114 169.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -131.98 95.52 3.71 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HYP . . . . . 0.462 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -141.4 -111.1 0.14 Allowed 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 172.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.12 -44.32 9.34 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 118.489 2.774 . . . . 0.0 118.489 -169.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.79 71.98 0.76 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.775 0.83 . . . . 0.0 110.237 -169.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.06 93.19 8.93 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 124.004 1.859 . . . . 0.0 111.887 -169.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -150.2 156.04 40.87 Favored 'General case' 0 CA--C 1.575 1.914 0 CA-C-N 111.265 -2.698 . . . . 0.0 106.122 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 1.244 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 50.9 t -116.63 74.2 0.9 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.153 0.978 . . . . 0.0 112.009 161.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.0 -0.28 90.22 Favored Glycine 1 CA--C 1.582 4.263 0 CA-C-N 115.066 -0.97 . . . . 0.0 113.509 166.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . 44.9 m -90.64 168.6 11.66 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 117.427 2.381 . . . . 0.0 117.427 -169.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -88.77 -63.36 1.31 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 112.911 -1.95 . . . . 0.0 109.46 168.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.8 p -110.55 133.93 54.43 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.28 169.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.88 82.62 1.59 Allowed Glycine 0 N--CA 1.487 2.065 0 C-N-CA 123.154 0.407 . . . . 0.0 113.37 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 1.244 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -166.91 152.43 7.8 Favored 'General case' 0 CA--C 1.57 1.713 0 CA-C-O 118.193 -0.908 . . . . 0.0 112.482 -169.591 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -62.13 -28.72 69.84 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.445 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 12.2 t -85.1 -22.97 28.68 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -89.12 -31.49 17.97 Favored 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 124.7 1.2 . . . . 0.0 112.227 169.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -69.12 170.84 9.26 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 120.056 1.298 . . . . 0.0 113.164 169.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.7 p -76.47 -58.56 3.21 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.45 97.77 0.11 Allowed Glycine 0 N--CA 1.478 1.461 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 178.82 99.24 0.12 Allowed Glycine 0 CA--C 1.537 1.413 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.469 0 O-C-N 120.497 -1.59 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.394 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.7 t -124.39 -121.36 0.27 Allowed 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.8 t -150.82 -80.83 0.11 Allowed 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 117.334 -1.317 . . . . 0.0 108.319 172.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.58 -174.97 19.21 Favored Glycine 0 CA--C 1.556 2.648 0 CA-C-N 120.354 1.434 . . . . 0.0 116.522 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -46.87 -26.76 5.03 Favored 'Trans proline' 0 CA--C 1.559 1.725 1 N-CA-C 123.352 4.328 . . . . 0.0 123.352 -174.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -91.93 113.91 26.3 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 116.937 -1.506 . . . . 0.0 109.06 -169.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -152.99 -83.95 0.08 Allowed 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 170.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.75 -93.72 0.13 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 119.788 1.176 . . . . 0.0 110.62 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -107.41 54.19 0.67 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 118.863 0.756 . . . . 0.0 110.705 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 t -107.01 92.26 4.01 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 122.232 1.015 . . . . 0.0 109.575 -169.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -122.81 149.92 43.52 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.188 -172.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 1.537 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 35.7 t -114.56 54.86 0.76 Allowed 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 165.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.91 -29.82 49.98 Favored Glycine 0 CA--C 1.565 3.162 0 O-C-N 121.781 -0.574 . . . . 0.0 113.268 167.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 m -62.72 167.34 4.61 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 126.455 1.902 . . . . 0.0 115.859 173.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -79.8 -72.19 0.41 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.876 169.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.9 m -94.54 141.05 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 113.732 -1.577 . . . . 0.0 110.872 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.77 76.92 1.01 Allowed Glycine 0 CA--C 1.543 1.799 0 N-CA-C 114.426 0.531 . . . . 0.0 114.426 173.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 1.537 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -153.82 166.1 33.97 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HYP . . . . . 0.585 HD22 ' HB2' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -69.82 -29.56 66.86 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.3 t -81.81 -32.16 31.4 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -89.78 -29.04 18.94 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 123.916 0.886 . . . . 0.0 113.204 169.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -69.05 122.14 18.11 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 116.418 -1.753 . . . . 0.0 110.235 169.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 89.3 p -75.01 -57.95 3.58 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -176.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.16 -96.96 0.1 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.0 -101.5 2.67 Favored Glycine 0 N--CA 1.48 1.618 0 CA-C-O 121.346 0.415 . . . . 0.0 112.367 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.459 0 O-C-N 120.556 -1.556 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.381 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 41.3 t -98.59 -110.39 0.17 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 38.2 t -150.45 -75.26 0.15 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.825 1.193 . . . . 0.0 108.697 170.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.27 -170.93 13.5 Favored Glycine 0 CA--C 1.557 2.713 0 N-CA-C 116.863 1.505 . . . . 0.0 116.863 172.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.86 63.58 8.4 Favored 'Trans proline' 0 CA--C 1.566 2.082 0 C-N-CA 123.501 2.801 . . . . 0.0 116.84 -169.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -138.04 84.41 2.04 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 162.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -140.54 -82.14 0.25 Allowed 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 166.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.71 -95.45 0.12 Allowed 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 118.97 0.804 . . . . 0.0 111.003 175.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.95 6.47 41.92 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.83 100.38 4.75 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 120.506 1.503 . . . . 0.0 112.832 -168.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -150.3 152.69 34.89 Favored 'General case' 0 CA--C 1.569 1.706 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.948 -172.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.9 t -92.13 30.14 1.5 Allowed 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 171.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.54 -7.04 88.04 Favored Glycine 0 CA--C 1.568 3.359 0 N-CA-C 115.728 1.051 . . . . 0.0 115.728 168.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.2 m -60.7 158.33 12.89 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -85.69 -50.36 7.24 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.208 -1.36 . . . . 0.0 113.525 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 p -137.16 126.89 37.68 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 170.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.08 83.86 1.75 Allowed Glycine 0 N--CA 1.483 1.823 0 CA-C-N 116.505 -0.316 . . . . 0.0 113.039 176.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.924 ' HB2' ' HB2' ' A' ' 25' ' ' ASP . 6.7 mpt_? -116.17 168.54 10.02 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -175.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HYP . . . . . 1.098 ' O ' ' HB3' ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -79.06 -39.65 33.3 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 169.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.497 ' HB3' ' HG2' ' A' ' 20' ' ' ARG . 1.7 m -90.74 -8.09 50.73 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.924 ' HB2' ' HB2' ' A' ' 20' ' ' ARG . 13.2 t70 -132.45 -38.44 1.05 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.226 1.41 . . . . 0.0 112.019 175.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 1.098 ' HB3' ' O ' ' A' ' 22' ' ' HYP . 24.2 tpt180 -70.14 128.92 37.94 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-O 116.549 -1.691 . . . . 0.0 110.423 169.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.1 p -84.6 -61.71 1.73 Allowed 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.38 -96.67 0.1 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.01 -99.32 0.12 Allowed Glycine 0 N--CA 1.478 1.468 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.431 0 O-C-N 120.531 -1.57 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.393 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 5.7 t -81.54 -87.04 0.09 Allowed 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 117.835 -1.078 . . . . 0.0 112.146 -177.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.07 -95.86 0.11 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -169.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.94 -166.3 37.06 Favored Glycine 0 CA--C 1.556 2.651 0 CA-C-N 120.35 1.432 . . . . 0.0 116.355 170.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.88 3.51 3.82 Favored 'Trans proline' 0 CA--C 1.57 2.3 0 C-N-CA 123.117 2.545 . . . . 0.0 118.535 172.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -89.86 -46.55 8.48 Favored 'General case' 0 CA--C 1.571 1.77 0 CA-C-O 115.164 -2.35 . . . . 0.0 112.795 -176.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -66.03 -57.9 6.7 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -169.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.26 40.43 1.01 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.931 2.197 . . . . 0.0 116.931 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 31.33 64.37 0.2 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.2 t -50.78 152.96 1.88 Allowed 'General case' 0 CA--C 1.574 1.885 0 CA-C-N 113.251 -1.795 . . . . 0.0 110.833 169.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 60.3 m170 -88.32 140.07 29.85 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.423 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 3.1 t -97.76 38.58 1.28 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 171.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.45 3.04 87.78 Favored Glycine 0 CA--C 1.566 3.243 0 N-CA-C 116.309 1.284 . . . . 0.0 116.309 168.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.6 m -90.83 -167.22 1.76 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.281 1.432 . . . . 0.0 113.295 -172.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -116.54 -74.72 0.6 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 169.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 p -91.62 127.2 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.707 173.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.16 46.3 4.77 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 118.425 2.13 . . . . 0.0 118.425 170.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.616 ' HB3' HD22 ' A' ' 21' ' ' HYP 0.304 4.9 mpt_? -85.14 -176.09 6.02 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.73 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HYP . . . . . 0.616 HD22 ' HB3' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HYP . . . . . 1.059 ' O ' ' HB3' ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -83.1 -39.84 20.61 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 173.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.8 m -90.98 -10.65 41.53 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 20' ' ' ARG . 17.2 t70 -134.98 -37.68 0.8 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.9 1.28 . . . . 0.0 112.559 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 1.059 ' HB3' ' O ' ' A' ' 22' ' ' HYP . 23.6 tpt180 -68.61 132.85 47.6 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-O 116.668 -1.634 . . . . 0.0 111.081 169.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.6 p -96.26 87.29 4.45 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.759 -174.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.58 97.9 0.11 Allowed Glycine 0 N--CA 1.479 1.529 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.09 99.3 0.12 Allowed Glycine 0 N--CA 1.477 1.414 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.435 0 O-C-N 120.472 -1.605 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.389 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 23.1 t -160.57 94.45 1.06 Allowed 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 61.6 m -134.9 61.47 1.67 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 168.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.81 -172.27 53.04 Favored Glycine 0 CA--C 1.558 2.768 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.022 -168.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.04 -16.75 28.78 Favored 'Trans proline' 0 CA--C 1.573 2.462 0 C-N-CA 122.672 2.248 . . . . 0.0 116.598 169.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.549 ' H ' HD22 ' A' ' 7' ' ' HYP . 83.7 m-85 -150.38 -46.21 0.12 Allowed 'General case' 0 CA--C 1.575 1.941 0 CA-C-O 115.036 -2.411 . . . . 0.0 112.68 -171.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HYP . . . . . 0.549 HD22 ' H ' ' A' ' 6' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -139.61 -53.46 0.54 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.858 1.263 . . . . 0.0 109.355 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.26 -26.9 68.99 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.73 53.36 2.39 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 119.894 1.224 . . . . 0.0 113.119 169.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 1.8 t -80.6 121.72 26.18 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.224 0.61 . . . . 0.0 112.109 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -128.77 123.13 32.14 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 171.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.65 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 1.3 t -108.8 64.89 0.61 Allowed 'General case' 0 CA--C 1.557 1.219 0 CA-C-O 122.742 1.258 . . . . 0.0 111.444 172.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.04 -4.03 14.84 Favored Glycine 0 CA--C 1.567 3.305 0 CA-C-N 114.427 -1.26 . . . . 0.0 114.027 167.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.709 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 80.0 m -90.6 -100.42 0.1 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.905 1.352 . . . . 0.0 111.18 -169.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.709 ' HB2' ' O ' ' A' ' 16' ' ' CYS . 48.5 tptt 164.6 -82.87 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -170.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.448 ' H ' ' HB3' ' A' ' 17' ' ' LYS . 13.4 p -92.03 118.15 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 113.375 -1.739 . . . . 0.0 108.61 174.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.97 93.9 0.67 Allowed Glycine 0 CA--C 1.541 1.657 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -172.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.657 ' HG3' HD22 ' A' ' 21' ' ' HYP . 29.8 ttp180 -166.71 150.52 7.08 Favored 'General case' 0 CA--C 1.568 1.659 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.374 -169.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HYP . . . . . 0.657 HD22 ' HG3' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -70.61 -35.67 73.09 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.8 m -90.59 -19.25 23.93 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.78 -38.48 13.77 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.355 1.062 . . . . 0.0 111.743 169.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -68.95 152.76 44.86 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 119.601 1.092 . . . . 0.0 111.139 169.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.3 t -78.66 -65.67 0.96 Allowed 'General case' 0 CA--C 1.561 1.388 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.98 -175.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.74 -96.75 0.1 Allowed Glycine 0 N--CA 1.477 1.409 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.53 -98.16 1.28 Allowed Glycine 0 N--CA 1.48 1.628 0 N-CA-C 112.267 -0.333 . . . . 0.0 112.267 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.474 0 O-C-N 120.461 -1.611 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.338 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 38.7 t -134.08 -88.99 0.38 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.213 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 m -137.28 -71.44 0.44 Allowed 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 116.806 -1.569 . . . . 0.0 109.265 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.72 178.93 20.56 Favored Glycine 0 CA--C 1.555 2.592 0 CA-C-N 121.275 1.852 . . . . 0.0 115.556 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.2 85.68 1.74 Allowed 'Trans proline' 0 CA--C 1.562 1.895 0 C-N-CA 123.478 2.786 . . . . 0.0 113.286 -177.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -132.37 112.1 11.89 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -141.83 -72.6 0.33 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 156.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.28 -31.64 20.13 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 168.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 48.36 53.24 12.25 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -169.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.77 134.92 57.0 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.443 168.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -89.4 165.19 14.51 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -168.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.513 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 11.7 t -87.85 30.31 0.85 Allowed 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 162.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.63 -29.81 62.98 Favored Glycine 0 CA--C 1.564 3.147 0 O-C-N 120.95 -1.094 . . . . 0.0 115.299 168.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.2 m -62.34 178.18 0.42 Allowed 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 116.866 2.172 . . . . 0.0 116.866 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -108.09 -71.75 0.75 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.941 168.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -95.84 136.13 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.61 169.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.11 82.81 1.04 Allowed Glycine 0 N--CA 1.486 1.972 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.513 ' HD2' ' HA ' ' A' ' 14' ' ' CYS . 17.2 ttp180 -160.95 153.41 20.52 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.362 -168.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HYP . . . . . 0.418 HD22 ' HG3' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HYP . . . . . 0.474 ' O ' ' CB ' ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -73.98 -37.35 64.49 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.2 m -90.41 -22.6 21.37 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -89.69 -35.31 15.87 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.19 0.996 . . . . 0.0 112.579 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.474 ' CB ' ' O ' ' A' ' 22' ' ' HYP . 22.8 tpp180 -68.37 132.45 47.07 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-O 116.875 -1.536 . . . . 0.0 110.142 169.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 m -86.73 99.49 11.81 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.587 -171.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.82 -96.6 0.1 Allowed Glycine 0 CA--C 1.538 1.469 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.17 101.11 2.66 Favored Glycine 0 N--CA 1.48 1.614 0 CA-C-O 121.401 0.445 . . . . 0.0 112.148 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.448 0 O-C-N 120.496 -1.591 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.438 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 47.9 t -87.57 -62.11 1.57 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -176.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.66 -80.88 0.6 Allowed 'General case' 0 CA--C 1.561 1.366 0 CA-C-O 117.049 -1.453 . . . . 0.0 107.561 -169.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.04 -168.07 40.59 Favored Glycine 0 CA--C 1.554 2.484 0 CA-C-N 121.764 2.075 . . . . 0.0 118.195 169.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.84 11.75 1.89 Allowed 'Trans proline' 0 CA--C 1.57 2.278 0 C-N-CA 123.482 2.788 . . . . 0.0 118.398 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -89.69 -54.6 3.99 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-O 115.474 -2.203 . . . . 0.0 110.858 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -75.34 -65.63 0.87 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -159.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.51 55.5 3.03 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -170.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 30.46 62.7 0.19 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 -169.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.0 t -70.8 118.02 13.06 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 168.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -93.76 162.93 13.73 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -168.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.2 t -74.41 -3.66 31.86 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 115.419 1.636 . . . . 0.0 115.419 161.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.8 -29.77 73.18 Favored Glycine 0 CA--C 1.564 3.137 0 CA-C-N 120.776 1.625 . . . . 0.0 115.563 168.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.2 m -62.81 137.9 58.39 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.882 1.273 . . . . 0.0 114.014 169.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -93.23 -2.57 55.0 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 169.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -150.15 115.4 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.345 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.02 86.16 0.6 Allowed Glycine 0 CA--C 1.543 1.79 0 CA-C-O 119.871 -0.405 . . . . 0.0 113.662 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.805 ' HB2' HD22 ' A' ' 21' ' ' HYP . 0.0 OUTLIER -157.23 174.0 16.12 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -171.508 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' HYP . . . . . 0.805 HD22 ' HB2' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -69.15 -38.61 78.88 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.9 m -90.6 -18.11 25.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -89.5 -28.58 19.56 Favored 'General case' 0 CA--C 1.565 1.552 0 C-N-CA 124.197 0.999 . . . . 0.0 112.608 169.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -63.4 152.54 37.87 Favored 'General case' 0 CA--C 1.572 1.79 0 CA-C-O 117.695 -1.145 . . . . 0.0 112.92 169.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.8 t -86.49 98.34 10.99 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.537 -176.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.71 -97.69 0.11 Allowed Glycine 0 N--CA 1.478 1.458 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.04 -99.35 0.12 Allowed Glycine 0 N--CA 1.477 1.408 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.436 0 O-C-N 120.479 -1.601 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.417 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 28.3 t -91.37 -81.49 0.32 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 118.733 -0.651 . . . . 0.0 109.431 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.5 t -149.21 -73.82 0.18 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 169.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.58 -174.61 15.83 Favored Glycine 0 CA--C 1.556 2.609 0 N-CA-C 116.41 1.324 . . . . 0.0 116.41 169.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.6 66.11 8.58 Favored 'Trans proline' 0 CA--C 1.566 2.118 0 C-N-CA 123.468 2.779 . . . . 0.0 117.341 -169.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -143.03 86.63 1.93 Allowed 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 163.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -139.14 -85.7 0.24 Allowed 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.73 -91.38 0.15 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 119.166 0.894 . . . . 0.0 110.256 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -107.74 46.0 0.97 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.836 0.743 . . . . 0.0 112.495 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 t -92.14 97.49 10.95 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 122.197 0.999 . . . . 0.0 109.094 -169.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -149.97 153.29 36.33 Favored 'General case' 0 CA--C 1.568 1.653 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.392 -169.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 1.007 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 35.3 t -108.13 59.15 0.61 Allowed 'General case' 0 CA--C 1.553 1.076 0 CA-C-O 122.242 1.02 . . . . 0.0 112.493 165.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.65 -34.51 56.64 Favored Glycine 0 CA--C 1.57 3.481 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.645 167.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -69.99 151.84 45.12 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 125.732 1.613 . . . . 0.0 114.504 169.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -98.39 3.54 48.48 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 168.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.0 p -150.12 118.4 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.16 80.39 0.82 Allowed Glycine 0 N--CA 1.487 2.065 0 CA-C-O 119.938 -0.368 . . . . 0.0 112.61 -175.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 1.007 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -162.94 168.18 21.52 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -169.462 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' HYP . . . . . 0.534 HD22 ' HB2' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -64.69 -31.97 73.43 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 175.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.5 t -82.0 -26.49 33.82 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -89.31 -28.48 19.83 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 124.36 1.064 . . . . 0.0 111.761 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -66.63 149.64 50.19 Favored 'General case' 0 CA--C 1.572 1.789 0 CA-C-O 117.632 -1.175 . . . . 0.0 112.23 169.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.9 p -85.93 93.98 9.08 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 123.317 0.647 . . . . 0.0 111.163 -176.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.24 97.79 0.11 Allowed Glycine 0 N--CA 1.478 1.478 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.17 -97.87 1.35 Allowed Glycine 0 N--CA 1.481 1.66 0 CA-C-O 121.222 0.346 . . . . 0.0 112.366 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.406 0 O-C-N 120.434 -1.627 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.364 0 N-CA-C 111.389 -0.685 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 41.1 t -108.22 -118.01 0.27 Allowed 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 45.2 t -150.68 -75.02 0.15 Allowed 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 118.092 -0.956 . . . . 0.0 108.694 169.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.61 -170.44 13.3 Favored Glycine 0 CA--C 1.556 2.599 0 CA-C-N 119.351 0.978 . . . . 0.0 115.53 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.2 85.82 1.76 Allowed 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 123.634 2.889 . . . . 0.0 113.838 -174.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -144.02 151.28 39.49 Favored 'General case' 0 CA--C 1.573 1.849 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.193 -176.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -153.47 160.4 42.54 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 172.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.84 -52.51 65.19 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.73 -30.87 66.09 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 169.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.88 104.42 4.75 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 122.017 0.913 . . . . 0.0 113.075 -168.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -143.64 146.88 33.59 Favored 'General case' 0 CA--C 1.567 1.62 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.132 -176.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.533 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . 48.5 t -82.67 13.72 3.6 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 167.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.6 -21.72 77.79 Favored Glycine 0 CA--C 1.554 2.482 0 N-CA-C 118.44 2.136 . . . . 0.0 118.44 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.9 m -59.92 167.51 2.2 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -76.55 -70.75 0.43 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.304 169.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.86 84.64 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.406 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.353 175.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 163.98 74.4 0.03 OUTLIER Glycine 0 N--CA 1.481 1.642 0 CA-C-O 119.725 -0.486 . . . . 0.0 112.972 176.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.633 ' HB3' HD22 ' A' ' 21' ' ' HYP 0.305 2.6 mpt_? -130.68 179.79 5.74 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.173 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' HYP . . . . . 0.633 HD22 ' HB3' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -77.48 -36.63 52.55 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.7 t -91.01 -26.74 19.05 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -93.42 -33.45 13.83 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 1.021 ' HB3' HD22 ' A' ' 27' ' ' HYP . 99.3 mtt180 -76.31 -162.55 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 119.84 1.2 . . . . 0.0 113.357 171.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HYP . . . . . 1.021 HD22 ' HB3' ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.1 m -91.17 95.82 10.26 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 123.125 0.57 . . . . 0.0 110.382 -172.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.61 -96.49 0.1 Allowed Glycine 0 N--CA 1.479 1.547 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.03 101.02 2.65 Favored Glycine 0 N--CA 1.48 1.625 0 CA-C-O 121.366 0.425 . . . . 0.0 112.195 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.461 0 O-C-N 120.52 -1.576 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.179 0 CA-C-O 118.753 -1.026 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.2 t -90.78 -71.36 0.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 123.589 3.694 . . . . 0.0 111.807 5.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 99.7 m -137.37 -89.73 0.25 Allowed 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.87 -142.8 33.93 Favored Glycine 0 CA--C 1.557 2.668 0 CA-C-N 121.741 2.064 . . . . 0.0 116.011 169.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -46.33 -24.31 2.51 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 124.476 3.45 . . . . 0.0 120.319 169.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -119.89 83.53 2.06 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 171.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -86.32 -82.94 0.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 157.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.47 -88.73 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 168.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.75 62.83 1.64 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 166.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.8 t -68.06 137.59 55.14 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 168.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -98.09 166.89 11.21 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -169.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.6 t -75.65 11.09 1.43 Allowed 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 161.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.2 -31.36 80.57 Favored Glycine 0 CA--C 1.566 3.241 0 CA-C-N 120.458 1.481 . . . . 0.0 114.531 167.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 m -47.08 140.15 5.26 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 169.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -99.6 -15.02 18.74 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.223 -1.353 . . . . 0.0 114.631 168.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 p -150.04 116.48 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 172.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.36 78.71 1.4 Allowed Glycine 0 N--CA 1.484 1.874 0 C-N-CA 122.778 0.228 . . . . 0.0 113.559 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.452 ' HG2' ' HB3' ' A' ' 24' ' ' CYS 0.324 2.8 mpt_? -122.66 177.73 5.32 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.242 1.017 . . . . 0.0 113.18 -175.651 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -90.05 -37.69 14.1 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.452 ' HB3' ' HG2' ' A' ' 20' ' ' ARG . 4.9 m -90.49 -15.48 30.69 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.41 -36.54 15.41 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 124.277 1.031 . . . . 0.0 110.772 169.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -65.48 155.16 36.45 Favored 'General case' 0 CA--C 1.572 1.808 0 CA-C-O 117.62 -1.181 . . . . 0.0 112.498 169.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.8 m -80.68 -65.98 0.94 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 118.558 -0.734 . . . . 0.0 112.293 -171.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -95.76 84.17 0.87 Allowed Glycine 0 N--CA 1.482 1.709 0 CA-C-N 118.846 0.748 . . . . 0.0 111.551 170.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.32 -95.05 0.12 Allowed Glycine 0 CA--C 1.536 1.375 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -176.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.419 0 O-C-N 120.467 -1.607 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.303 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 18.0 t -115.01 -121.09 0.3 Allowed 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 47.4 t -150.83 -77.59 0.13 Allowed 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 117.757 -1.116 . . . . 0.0 109.021 171.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 11' ' ' CYS . . . 114.93 -163.32 12.2 Favored Glycine 0 CA--C 1.558 2.751 0 CA-C-N 119.731 1.151 . . . . 0.0 115.276 -177.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.87 7.01 5.15 Favored 'Trans proline' 0 CA--C 1.569 2.257 0 N-CA-C 119.787 2.956 . . . . 0.0 119.787 -175.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -93.53 -75.55 0.5 Allowed 'General case' 0 CA--C 1.574 1.869 0 CA-C-O 114.377 -2.725 . . . . 0.0 111.224 -164.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -113.46 -52.47 2.76 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.632 1.715 . . . . 0.0 115.632 -155.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.28 -83.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -169.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.63 -14.47 60.77 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 171.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 4' ' ' GLY . 1.3 t -75.46 110.39 9.79 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -168.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -135.06 139.93 45.15 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.078 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.6 t -92.7 28.25 2.1 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 170.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.36 -30.89 57.89 Favored Glycine 0 CA--C 1.559 2.825 0 O-C-N 120.745 -1.222 . . . . 0.0 115.22 168.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.8 m -68.7 160.86 29.47 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -84.56 -72.55 0.47 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.295 169.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.45 134.67 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 CA-C-N 113.458 -1.701 . . . . 0.0 109.587 169.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.51 79.36 1.33 Allowed Glycine 0 N--CA 1.482 1.763 0 C-N-CA 123.037 0.351 . . . . 0.0 113.562 177.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.707 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -151.27 155.48 38.85 Favored 'General case' 0 CA--C 1.571 1.768 0 C-N-CA 123.669 0.788 . . . . 0.0 112.455 -174.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -71.08 -31.29 67.64 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 170.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.707 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 18.3 t -84.02 -24.38 30.54 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -89.37 -37.36 14.91 Favored 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 124.58 1.152 . . . . 0.0 111.332 168.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -69.28 164.85 21.87 Favored 'General case' 0 CA--C 1.568 1.648 0 CA-C-N 119.606 1.093 . . . . 0.0 112.771 169.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.3 m -82.5 -66.08 0.93 Allowed 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.69 -171.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -95.25 98.26 2.24 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-N 118.977 0.808 . . . . 0.0 111.989 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 178.96 99.38 0.12 Allowed Glycine 0 CA--C 1.535 1.331 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.464 0 O-C-N 120.458 -1.613 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.471 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.8 t -159.67 104.62 1.59 Allowed 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 100.721 -3.807 . . . . 0.0 100.721 167.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 78.4 m -92.53 80.25 4.86 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -173.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.16 -132.79 0.43 Allowed Glycine 0 CA--C 1.557 2.692 0 N-CA-C 117.792 1.877 . . . . 0.0 117.792 -169.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -34.98 -38.27 0.16 Allowed 'Trans proline' 0 CA--C 1.557 1.634 1 C-N-CA 125.502 4.135 . . . . 0.0 121.468 175.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -115.5 97.59 6.24 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 169.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -172.31 -52.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.889 1.275 . . . . 0.0 109.413 -172.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.5 -47.63 32.01 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.08 65.28 0.82 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 118.784 0.72 . . . . 0.0 111.596 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.5 t -79.43 110.29 14.6 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.111 0.481 . . . . 0.0 109.798 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -144.14 133.3 22.96 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 117.373 -1.299 . . . . 0.0 108.796 -169.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.2 t -89.9 35.08 0.84 Allowed 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 167.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.06 -33.7 6.21 Favored Glycine 0 CA--C 1.566 3.274 0 O-C-N 121.456 -0.778 . . . . 0.0 111.233 168.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 m -45.93 131.92 9.41 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 126.485 1.914 . . . . 0.0 115.027 168.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -93.12 -14.6 27.02 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 169.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 m -145.41 115.03 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.99 84.46 0.72 Allowed Glycine 0 CA--C 1.543 1.783 0 O-C-N 122.186 -0.321 . . . . 0.0 113.48 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 1.01 ' HB3' HD22 ' A' ' 21' ' ' HYP 0.318 1.3 mpt_? -125.65 -170.59 2.21 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -176.739 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' HYP . . . . . 1.01 HD22 ' HB3' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -75.06 -34.32 61.81 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 116.374 1.99 . . . . 0.0 116.374 174.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.7 t -90.24 -20.87 22.48 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -89.55 -35.06 16.13 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.15 0.98 . . . . 0.0 112.44 169.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.969 ' HB3' HD22 ' A' ' 27' ' ' HYP . 99.8 mtt180 -77.53 -160.91 0.2 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 119.683 1.128 . . . . 0.0 112.304 169.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HYP . . . . . 0.969 HD22 ' HB3' ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.3 t -81.93 -65.46 1.01 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -173.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.67 -97.82 0.11 Allowed Glycine 0 N--CA 1.477 1.43 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.04 -99.2 0.12 Allowed Glycine 0 CA--C 1.536 1.398 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.464 0 O-C-N 120.474 -1.603 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.415 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.9 t -113.31 -116.77 0.32 Allowed 'General case' 0 CA--C 1.559 1.294 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.5 t -150.64 -90.25 0.06 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.84 178.51 31.95 Favored Glycine 0 CA--C 1.554 2.495 0 N-CA-C 115.928 1.131 . . . . 0.0 115.928 -175.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.07 -14.41 35.06 Favored 'Trans proline' 0 CA--C 1.563 1.95 0 N-CA-C 119.791 2.958 . . . . 0.0 119.791 -173.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -90.99 116.28 28.66 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-O 117.288 -1.339 . . . . 0.0 108.443 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -135.64 -104.8 0.22 Allowed 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 169.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.89 -81.07 0.32 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.564 1.075 . . . . 0.0 111.019 172.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.62 -9.73 59.48 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 173.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.5 t -74.03 117.35 15.72 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 119.341 0.973 . . . . 0.0 112.165 -168.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -144.88 151.07 38.15 Favored 'General case' 0 CA--C 1.566 1.589 0 C-N-CA 123.935 0.894 . . . . 0.0 109.835 -173.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.977 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 49.8 t -114.76 64.45 0.67 Allowed 'General case' 0 CA--C 1.552 1.047 0 CA-C-O 121.781 0.8 . . . . 0.0 112.188 165.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.35 -2.54 87.72 Favored Glycine 0 CA--C 1.576 3.856 0 N-CA-C 114.771 0.668 . . . . 0.0 114.771 167.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.9 m -90.11 172.2 8.99 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.59 1.956 . . . . 0.0 115.772 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -87.44 -67.69 0.8 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.055 168.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 p -106.57 133.41 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 CA-C-N 113.869 -1.514 . . . . 0.0 108.874 169.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.87 88.05 1.97 Allowed Glycine 0 N--CA 1.484 1.857 0 C-N-CA 123.167 0.413 . . . . 0.0 113.238 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.977 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -160.82 160.48 31.19 Favored 'General case' 0 CA--C 1.562 1.404 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -173.435 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 22' ' ' HYP . . . . . 0.628 ' HA ' HH21 ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -63.54 -33.06 74.76 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.462 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 30.8 t -78.8 -27.21 44.39 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -174.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -89.37 -32.25 17.39 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.046 0.938 . . . . 0.0 112.358 169.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 1.075 ' HB3' ' CD ' ' A' ' 27' ' ' HYP . 0.7 OUTLIER -86.37 -150.2 0.15 Allowed 'General case' 0 CA--C 1.565 1.537 0 CA-C-N 119.541 1.064 . . . . 0.0 110.454 169.499 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HYP . . . . . 1.075 ' CD ' ' HB3' ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.2 t -75.99 -63.25 1.35 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.96 -96.74 0.1 Allowed Glycine 0 N--CA 1.478 1.476 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.5 -98.3 1.27 Allowed Glycine 0 N--CA 1.481 1.67 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.44 0 O-C-N 120.521 -1.576 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.424 0 CA-C-O 119.968 -0.351 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 45.8 t -115.26 65.8 0.69 Allowed 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 123.624 0.77 . . . . 0.0 109.909 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 99.3 m -91.85 72.72 5.7 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 169.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.86 -128.1 0.42 Allowed Glycine 0 CA--C 1.553 2.423 0 CA-C-O 117.846 -1.53 . . . . 0.0 116.622 -169.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -38.1 -30.75 0.17 Allowed 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 125.144 3.896 . . . . 0.0 121.474 172.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -116.85 89.59 3.15 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 170.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -170.52 -53.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.565 1.146 . . . . 0.0 109.736 -168.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.05 -49.13 60.2 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 172.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.73 64.27 0.77 Allowed 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 118.496 0.589 . . . . 0.0 110.886 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.0 t -83.22 106.6 15.13 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.312 0.645 . . . . 0.0 109.61 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -141.58 128.55 20.69 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 116.989 -1.481 . . . . 0.0 108.276 -169.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.537 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -117.67 56.01 0.85 Allowed 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 124.612 1.165 . . . . 0.0 112.451 174.363 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.23 13.32 67.91 Favored Glycine 0 CA--C 1.577 3.945 0 O-C-N 120.454 -1.404 . . . . 0.0 113.563 166.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -91.54 163.79 14.02 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.16 2.184 . . . . 0.0 115.158 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -91.2 -62.67 1.39 Allowed 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 113.042 -1.89 . . . . 0.0 109.206 167.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.23 139.58 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.233 169.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.66 84.41 1.4 Allowed Glycine 0 N--CA 1.486 1.977 0 C-N-CA 123.188 0.423 . . . . 0.0 113.065 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.18 161.27 33.56 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -169.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -72.11 -33.66 68.0 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 173.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.2 m -90.23 -19.41 24.18 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.48 2.029 . . . . 0.0 116.48 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.34 -35.53 16.04 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 124.677 1.191 . . . . 0.0 112.305 169.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -70.95 145.26 50.2 Favored 'General case' 0 CA--C 1.569 1.711 0 CA-C-O 117.253 -1.356 . . . . 0.0 111.201 169.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.9 m -88.0 99.31 12.06 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.563 -171.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.72 -97.29 0.11 Allowed Glycine 0 N--CA 1.479 1.552 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.82 99.29 0.12 Allowed Glycine 0 N--CA 1.477 1.399 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.46 0 O-C-N 120.535 -1.567 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.23 -167.82 21.1 Favored Glycine 0 CA--C 1.56 2.872 0 N-CA-C 117.068 1.587 . . . . 0.0 117.068 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -53.94 -12.16 3.17 Favored 'Trans proline' 0 CA--C 1.563 1.958 1 N-CA-C 123.011 4.197 . . . . 0.0 123.011 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 . . . . . 0 N--CA 1.492 1.657 0 CA-C-N 119.611 1.096 . . . . 0.0 109.463 -169.59 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 . . . . . 0 N--CA 1.503 2.194 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.36 -92.0 0.14 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 169.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.25 -9.46 50.6 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 167.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.34 115.84 26.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.172 0.989 . . . . 0.0 111.435 -168.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.825 -174.3 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 1.196 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 20.7 t . . . . . 0 CA--C 1.558 1.285 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.66 -18.16 76.05 Favored Glycine 0 CA--C 1.569 3.46 0 O-C-N 121.868 -0.52 . . . . 0.0 114.242 167.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 m -74.94 172.63 11.93 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 126.458 1.903 . . . . 0.0 114.87 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -80.53 -76.9 0.21 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.183 169.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.0 m -95.55 142.11 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.713 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.51 85.04 0.95 Allowed Glycine 0 N--CA 1.483 1.828 0 CA-C-O 119.768 -0.462 . . . . 0.0 113.013 175.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 1.196 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER . . . . . 0 CA--C 1.566 1.578 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -169.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.5 p90 . . . . . 0 N--CA 1.495 1.823 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.0 t -83.7 -24.95 31.03 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -89.24 -28.87 19.64 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 124.333 1.053 . . . . 0.0 111.579 168.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 . . . . . 0 CA--C 1.573 1.832 0 CA-C-O 117.688 -1.149 . . . . 0.0 112.188 169.213 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 CA--C 1.56 1.362 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.901 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.84 -96.55 0.1 Allowed Glycine 0 CA--C 1.537 1.448 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 112.317 -0.313 . . . . 0.0 112.317 -179.962 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.38 -143.95 16.31 Favored Glycine 0 CA--C 1.558 2.763 0 CA-C-O 118.311 -1.272 . . . . 0.0 115.01 177.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -77.51 74.99 4.9 Favored 'Trans proline' 0 CA--C 1.566 2.091 0 C-N-CA 123.941 3.094 . . . . 0.0 114.099 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.531 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 63.5 m-85 . . . . . 0 CA--C 1.58 2.114 0 C-N-CA 125.218 1.407 . . . . 0.0 109.169 -171.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 . . . . . 0 N--CA 1.499 2.002 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.33 -84.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 120.504 1.502 . . . . 0.0 114.796 -169.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.02 -13.68 60.23 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 172.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 6' ' ' TYR . 1.7 t -74.2 118.42 17.15 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -168.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 . . . . . 0 CA--C 1.565 1.551 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -175.267 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.6 t . . . . . 0 CA--C 1.569 1.685 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.95 -33.98 87.19 Favored Glycine 0 CA--C 1.554 2.474 0 N-CA-C 116.564 1.386 . . . . 0.0 116.564 169.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.7 m -62.94 157.08 22.61 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -80.43 -71.21 0.47 Allowed 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.976 169.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.9 p -99.41 134.44 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.794 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.42 88.81 0.99 Allowed Glycine 0 N--CA 1.483 1.828 0 CA-C-O 119.757 -0.468 . . . . 0.0 112.663 175.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.43 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER . . . . . 0 CA--C 1.564 1.491 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -169.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.3 p90 . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.43 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 34.3 t -88.79 -24.14 22.69 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -89.58 -37.9 14.35 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 125.058 1.343 . . . . 0.0 111.88 169.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 . . . . . 0 CA--C 1.568 1.647 0 CA-C-O 116.891 -1.528 . . . . 0.0 111.457 169.513 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.8 m . . . . . 0 N--CA 1.485 1.298 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.36 -97.61 0.11 Allowed Glycine 0 CA--C 1.537 1.429 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.512 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.933 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 54.0 t . . . . . 0 CA--C 1.551 1.006 0 CA-C-O 116.602 -1.666 . . . . 0.0 108.285 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.8 -159.1 25.5 Favored Glycine 0 CA--C 1.561 2.958 0 CA-C-N 121.668 2.031 . . . . 0.0 115.187 -169.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -76.89 65.15 7.71 Favored 'Trans proline' 0 CA--C 1.568 2.184 0 C-N-CA 123.573 2.849 . . . . 0.0 117.258 -169.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 CA--C 1.568 1.644 0 N-CA-C 102.78 -3.044 . . . . 0.0 102.78 164.207 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 . . . . . 0 CA--C 1.564 1.485 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.56 -110.0 0.09 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 168.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.49 -44.55 28.48 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.801 0.728 . . . . 0.0 110.961 167.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 t 57.82 82.34 0.13 Allowed 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 126.715 2.006 . . . . 0.0 107.726 -172.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -169.363 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.0 t . . . . . 0 CA--C 1.573 1.861 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.3 -27.39 70.61 Favored Glycine 0 CA--C 1.564 3.098 0 O-C-N 120.558 -1.339 . . . . 0.0 116.352 168.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -54.02 137.89 38.61 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 169.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -80.94 -55.16 4.98 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.982 169.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 m -113.77 125.5 71.06 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.418 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.741 171.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.36 65.43 1.47 Allowed Glycine 0 CA--C 1.543 1.826 0 N-CA-C 115.421 0.928 . . . . 0.0 115.421 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.561 1.387 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 173.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.0 p90 . . . . . 0 N--CA 1.487 1.424 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.11 -25.75 20.57 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -176.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -102.41 -44.35 5.4 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.435 1.094 . . . . 0.0 111.841 169.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 . . . . . 0 CA--C 1.561 1.397 0 CA-C-O 116.32 -1.8 . . . . 0.0 108.46 169.422 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.2 t . . . . . 0 CA--C 1.557 1.23 0 CA-C-O 118.258 -0.877 . . . . 0.0 108.723 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.73 -99.66 0.15 Allowed Glycine 0 CA--C 1.537 1.468 0 CA-C-N 119.727 1.149 . . . . 0.0 111.731 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.448 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -172.715 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 64.3 m . . . . . 0 CA--C 1.554 1.123 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.76 -135.4 28.5 Favored Glycine 0 CA--C 1.555 2.548 0 CA-C-N 120.448 1.476 . . . . 0.0 115.2 174.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -64.34 -11.53 28.59 Favored 'Trans proline' 0 CA--C 1.567 2.127 0 C-N-CA 123.488 2.792 . . . . 0.0 118.504 170.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 . . . . . 0 CA--C 1.572 1.802 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 163.808 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.7 m120 . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.22 -92.03 0.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 104.67 -2.345 . . . . 0.0 104.67 168.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.54 63.56 1.6 Allowed 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 166.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.4 t -66.45 145.1 56.04 Favored 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 168.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 118.199 2.666 . . . . 0.0 118.199 -166.946 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.8 t . . . . . 0 CA--C 1.569 1.68 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.92 -6.79 60.73 Favored Glycine 0 CA--C 1.563 3.078 0 N-CA-C 118.137 2.015 . . . . 0.0 118.137 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.7 m -79.07 161.14 26.75 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.279 1.431 . . . . 0.0 114.632 -169.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -85.52 -72.95 0.46 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.797 169.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.1 p -101.71 133.51 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.498 0 CA-C-N 113.136 -1.847 . . . . 0.0 109.318 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.02 86.95 1.08 Allowed Glycine 0 N--CA 1.481 1.673 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.64 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.443 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 0.7 OUTLIER . . . . . 0 CA--C 1.56 1.351 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.3 p90 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.443 ' SG ' ' HG2' ' A' ' 20' ' ' ARG . 14.0 t -90.4 -22.06 21.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -89.69 -41.28 12.01 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.69 1.196 . . . . 0.0 111.884 169.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 . . . . . 0 CA--C 1.564 1.518 0 CA-C-O 116.696 -1.621 . . . . 0.0 110.809 169.661 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.0 t . . . . . 0 CA--C 1.559 1.302 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.35 -97.79 0.11 Allowed Glycine 0 N--CA 1.478 1.438 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.421 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.96 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.8 t . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.87 -142.67 47.97 Favored Glycine 0 CA--C 1.561 2.934 0 CA-C-O 118.721 -1.044 . . . . 0.0 115.102 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.44 -14.57 37.33 Favored 'Trans proline' 0 CA--C 1.569 2.262 0 C-N-CA 123.249 2.632 . . . . 0.0 118.114 169.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -178.627 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 . . . . . 0 CA--C 1.567 1.6 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.12 -44.32 9.34 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 118.489 2.774 . . . . 0.0 118.489 -169.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.79 71.98 0.76 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.775 0.83 . . . . 0.0 110.237 -169.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.06 93.19 8.93 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 124.004 1.859 . . . . 0.0 111.887 -169.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 . . . . . 0 CA--C 1.575 1.914 0 CA-C-N 111.265 -2.698 . . . . 0.0 106.122 -179.534 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 1.244 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 50.9 t . . . . . 0 CA--C 1.545 0.77 0 CA-C-O 122.153 0.978 . . . . 0.0 112.009 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.0 -0.28 90.22 Favored Glycine 1 CA--C 1.582 4.263 0 CA-C-N 115.066 -0.97 . . . . 0.0 113.509 166.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . 44.9 m -90.64 168.6 11.66 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 117.427 2.381 . . . . 0.0 117.427 -169.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -88.77 -63.36 1.31 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 112.911 -1.95 . . . . 0.0 109.46 168.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.8 p -110.55 133.93 54.43 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.28 169.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.88 82.62 1.59 Allowed Glycine 0 N--CA 1.487 2.065 0 C-N-CA 123.154 0.407 . . . . 0.0 113.37 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 1.244 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.57 1.713 0 CA-C-O 118.193 -0.908 . . . . 0.0 112.482 -169.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.6 p90 . . . . . 0 N--CA 1.498 1.96 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.445 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 12.2 t -85.1 -22.97 28.68 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -89.12 -31.49 17.97 Favored 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 124.7 1.2 . . . . 0.0 112.227 169.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 . . . . . 0 CA--C 1.567 1.597 0 CA-C-N 120.056 1.298 . . . . 0.0 113.164 169.321 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.7 p . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.45 97.77 0.11 Allowed Glycine 0 N--CA 1.478 1.461 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.946 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 117.334 -1.317 . . . . 0.0 108.319 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.58 -174.97 19.21 Favored Glycine 0 CA--C 1.556 2.648 0 CA-C-N 120.354 1.434 . . . . 0.0 116.522 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -46.87 -26.76 5.03 Favored 'Trans proline' 0 CA--C 1.559 1.725 1 N-CA-C 123.352 4.328 . . . . 0.0 123.352 -174.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 116.937 -1.506 . . . . 0.0 109.06 -169.287 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.7 p30 . . . . . 0 CA--C 1.562 1.411 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.75 -93.72 0.13 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 119.788 1.176 . . . . 0.0 110.62 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -107.41 54.19 0.67 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 118.863 0.756 . . . . 0.0 110.705 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 t -107.01 92.26 4.01 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 122.232 1.015 . . . . 0.0 109.575 -169.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 . . . . . 0 CA--C 1.564 1.49 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.188 -172.955 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 1.537 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 35.7 t . . . . . 0 CA--C 1.557 1.241 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.91 -29.82 49.98 Favored Glycine 0 CA--C 1.565 3.162 0 O-C-N 121.781 -0.574 . . . . 0.0 113.268 167.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 m -62.72 167.34 4.61 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 126.455 1.902 . . . . 0.0 115.859 173.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -79.8 -72.19 0.41 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.876 169.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.9 m -94.54 141.05 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 113.732 -1.577 . . . . 0.0 110.872 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.77 76.92 1.01 Allowed Glycine 0 CA--C 1.543 1.799 0 N-CA-C 114.426 0.531 . . . . 0.0 114.426 173.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 1.537 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.572 1.793 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.8 p90 . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.3 t -81.81 -32.16 31.4 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -89.78 -29.04 18.94 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 123.916 0.886 . . . . 0.0 113.204 169.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 . . . . . 0 CA--C 1.564 1.484 0 CA-C-O 116.418 -1.753 . . . . 0.0 110.235 169.702 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 CA--C 1.562 1.439 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.16 -96.96 0.1 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.618 0 CA-C-O 121.346 0.415 . . . . 0.0 112.367 179.329 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 117.695 -1.145 . . . . 0.0 108.697 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.27 -170.93 13.5 Favored Glycine 0 CA--C 1.557 2.713 0 N-CA-C 116.863 1.505 . . . . 0.0 116.863 172.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.86 63.58 8.4 Favored 'Trans proline' 0 CA--C 1.566 2.082 0 C-N-CA 123.501 2.801 . . . . 0.0 116.84 -169.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 CA--C 1.565 1.523 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 162.95 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 . . . . . 0 CA--C 1.559 1.307 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.71 -95.45 0.12 Allowed 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 118.97 0.804 . . . . 0.0 111.003 175.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.95 6.47 41.92 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.83 100.38 4.75 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 120.506 1.503 . . . . 0.0 112.832 -168.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 . . . . . 0 CA--C 1.569 1.706 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.948 -172.192 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.9 t . . . . . 0 CA--C 1.566 1.56 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.54 -7.04 88.04 Favored Glycine 0 CA--C 1.568 3.359 0 N-CA-C 115.728 1.051 . . . . 0.0 115.728 168.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.2 m -60.7 158.33 12.89 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -85.69 -50.36 7.24 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.208 -1.36 . . . . 0.0 113.525 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 p -137.16 126.89 37.68 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 170.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.08 83.86 1.75 Allowed Glycine 0 N--CA 1.483 1.823 0 CA-C-N 116.505 -0.316 . . . . 0.0 113.039 176.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.924 ' HB2' ' HB2' ' A' ' 25' ' ' ASP . 6.7 mpt_? . . . . . 0 CA--C 1.561 1.401 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.8 p90 . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.497 ' HB3' ' HG2' ' A' ' 20' ' ' ARG . 1.7 m -90.74 -8.09 50.73 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.924 ' HB2' ' HB2' ' A' ' 20' ' ' ARG . 13.2 t70 -132.45 -38.44 1.05 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.226 1.41 . . . . 0.0 112.019 175.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 . . . . . 0 CA--C 1.57 1.722 0 CA-C-O 116.549 -1.691 . . . . 0.0 110.423 169.899 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.1 p . . . . . 0 CA--C 1.559 1.296 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.38 -96.67 0.1 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.468 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.926 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.94 -166.3 37.06 Favored Glycine 0 CA--C 1.556 2.651 0 CA-C-N 120.35 1.432 . . . . 0.0 116.355 170.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.88 3.51 3.82 Favored 'Trans proline' 0 CA--C 1.57 2.3 0 C-N-CA 123.117 2.545 . . . . 0.0 118.535 172.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 . . . . . 0 CA--C 1.571 1.77 0 CA-C-O 115.164 -2.35 . . . . 0.0 112.795 -176.805 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.26 40.43 1.01 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.931 2.197 . . . . 0.0 116.931 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 31.33 64.37 0.2 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.2 t -50.78 152.96 1.88 Allowed 'General case' 0 CA--C 1.574 1.885 0 CA-C-N 113.251 -1.795 . . . . 0.0 110.833 169.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 60.3 m170 . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.234 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.423 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 3.1 t . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.45 3.04 87.78 Favored Glycine 0 CA--C 1.566 3.243 0 N-CA-C 116.309 1.284 . . . . 0.0 116.309 168.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.6 m -90.83 -167.22 1.76 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.281 1.432 . . . . 0.0 113.295 -172.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -116.54 -74.72 0.6 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 169.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 p -91.62 127.2 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.707 173.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.16 46.3 4.77 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 118.425 2.13 . . . . 0.0 118.425 170.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.456 ' HB2' ' HB2' ' A' ' 25' ' ' ASP 0.304 4.9 mpt_? . . . . . 0 CA--C 1.555 1.145 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.5 p90 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.8 m -90.98 -10.65 41.53 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 20' ' ' ARG . 17.2 t70 -134.98 -37.68 0.8 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.9 1.28 . . . . 0.0 112.559 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 . . . . . 0 CA--C 1.57 1.733 0 CA-C-O 116.668 -1.634 . . . . 0.0 111.081 169.911 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 CA--C 1.562 1.428 0 N-CA-C 110.759 -0.089 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.58 97.9 0.11 Allowed Glycine 0 N--CA 1.479 1.529 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.414 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.89 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 61.6 m . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.81 -172.27 53.04 Favored Glycine 0 CA--C 1.558 2.768 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.022 -168.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.04 -16.75 28.78 Favored 'Trans proline' 0 CA--C 1.573 2.462 0 C-N-CA 122.672 2.248 . . . . 0.0 116.598 169.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 CA--C 1.575 1.941 0 CA-C-O 115.036 -2.411 . . . . 0.0 112.68 -171.061 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.0 m120 . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.26 -26.9 68.99 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.73 53.36 2.39 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 119.894 1.224 . . . . 0.0 113.119 169.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 1.8 t -80.6 121.72 26.18 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.224 0.61 . . . . 0.0 112.109 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 171.128 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.65 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 1.3 t . . . . . 0 CA--C 1.557 1.219 0 CA-C-O 122.742 1.258 . . . . 0.0 111.444 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.04 -4.03 14.84 Favored Glycine 0 CA--C 1.567 3.305 0 CA-C-N 114.427 -1.26 . . . . 0.0 114.027 167.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.709 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 80.0 m -90.6 -100.42 0.1 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.905 1.352 . . . . 0.0 111.18 -169.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.709 ' HB2' ' O ' ' A' ' 16' ' ' CYS . 48.5 tptt 164.6 -82.87 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -170.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.448 ' H ' ' HB3' ' A' ' 17' ' ' LYS . 13.4 p -92.03 118.15 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 113.375 -1.739 . . . . 0.0 108.61 174.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.97 93.9 0.67 Allowed Glycine 0 CA--C 1.541 1.657 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -172.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.65 ' HD2' ' HA ' ' A' ' 14' ' ' CYS . 29.8 ttp180 . . . . . 0 CA--C 1.568 1.659 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.374 -169.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.7 p90 . . . . . 0 N--CA 1.494 1.725 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.8 m -90.59 -19.25 23.93 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.78 -38.48 13.77 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.355 1.062 . . . . 0.0 111.743 169.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 . . . . . 0 CA--C 1.568 1.645 0 CA-C-N 119.601 1.092 . . . . 0.0 111.139 169.01 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 CA--C 1.561 1.388 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.74 -96.75 0.1 Allowed Glycine 0 N--CA 1.477 1.409 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 112.267 -0.333 . . . . 0.0 112.267 -179.913 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 116.806 -1.569 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.72 178.93 20.56 Favored Glycine 0 CA--C 1.555 2.592 0 CA-C-N 121.275 1.852 . . . . 0.0 115.556 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.2 85.68 1.74 Allowed 'Trans proline' 0 CA--C 1.562 1.895 0 C-N-CA 123.478 2.786 . . . . 0.0 113.286 -177.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 . . . . . 0 CA--C 1.564 1.499 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -176.507 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.28 -31.64 20.13 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 168.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 48.36 53.24 12.25 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -169.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.77 134.92 57.0 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.443 168.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -168.931 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.513 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 11.7 t . . . . . 0 CA--C 1.568 1.671 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.63 -29.81 62.98 Favored Glycine 0 CA--C 1.564 3.147 0 O-C-N 120.95 -1.094 . . . . 0.0 115.299 168.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.2 m -62.34 178.18 0.42 Allowed 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 116.866 2.172 . . . . 0.0 116.866 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -108.09 -71.75 0.75 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.941 168.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -95.84 136.13 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.61 169.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.11 82.81 1.04 Allowed Glycine 0 N--CA 1.486 1.972 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.513 ' HD2' ' HA ' ' A' ' 14' ' ' CYS . 17.2 ttp180 . . . . . 0 CA--C 1.566 1.584 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.362 -168.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.0 p90 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.2 m -90.41 -22.6 21.37 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -89.69 -35.31 15.87 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.19 0.996 . . . . 0.0 112.579 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 . . . . . 0 CA--C 1.571 1.763 0 CA-C-O 116.875 -1.536 . . . . 0.0 110.142 169.497 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 m . . . . . 0 CA--C 1.562 1.439 0 CA-C-O 119.665 -0.207 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.82 -96.6 0.1 Allowed Glycine 0 CA--C 1.538 1.469 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 CA-C-O 121.401 0.445 . . . . 0.0 112.148 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.561 1.366 0 CA-C-O 117.049 -1.453 . . . . 0.0 107.561 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.04 -168.07 40.59 Favored Glycine 0 CA--C 1.554 2.484 0 CA-C-N 121.764 2.075 . . . . 0.0 118.195 169.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.84 11.75 1.89 Allowed 'Trans proline' 0 CA--C 1.57 2.278 0 C-N-CA 123.482 2.788 . . . . 0.0 118.398 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 CA--C 1.568 1.649 0 CA-C-O 115.474 -2.203 . . . . 0.0 110.858 179.688 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.51 55.5 3.03 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -170.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 30.46 62.7 0.19 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 -169.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.0 t -70.8 118.02 13.06 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 168.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 . . . . . 0 N--CA 1.497 1.921 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -168.894 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 115.419 1.636 . . . . 0.0 115.419 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.8 -29.77 73.18 Favored Glycine 0 CA--C 1.564 3.137 0 CA-C-N 120.776 1.625 . . . . 0.0 115.563 168.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.2 m -62.81 137.9 58.39 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.882 1.273 . . . . 0.0 114.014 169.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -93.23 -2.57 55.0 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 169.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -150.15 115.4 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.345 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.02 86.16 0.6 Allowed Glycine 0 CA--C 1.543 1.79 0 CA-C-O 119.871 -0.405 . . . . 0.0 113.662 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.559 1.305 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -171.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.9 p90 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.9 m -90.6 -18.11 25.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -89.5 -28.58 19.56 Favored 'General case' 0 CA--C 1.565 1.552 0 C-N-CA 124.197 0.999 . . . . 0.0 112.608 169.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 . . . . . 0 CA--C 1.572 1.79 0 CA-C-O 117.695 -1.145 . . . . 0.0 112.92 169.157 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.8 t . . . . . 0 CA--C 1.564 1.5 0 CA-C-O 119.614 -0.231 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.71 -97.69 0.11 Allowed Glycine 0 N--CA 1.478 1.458 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.408 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.874 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.58 -174.61 15.83 Favored Glycine 0 CA--C 1.556 2.609 0 N-CA-C 116.41 1.324 . . . . 0.0 116.41 169.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.6 66.11 8.58 Favored 'Trans proline' 0 CA--C 1.566 2.118 0 C-N-CA 123.468 2.779 . . . . 0.0 117.341 -169.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 . . . . . 0 CA--C 1.568 1.668 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 163.002 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.7 m120 . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.73 -91.38 0.15 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 119.166 0.894 . . . . 0.0 110.256 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -107.74 46.0 0.97 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.836 0.743 . . . . 0.0 112.495 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 t -92.14 97.49 10.95 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 122.197 0.999 . . . . 0.0 109.094 -169.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 . . . . . 0 CA--C 1.568 1.653 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.392 -169.955 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 1.007 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 35.3 t . . . . . 0 CA--C 1.553 1.076 0 CA-C-O 122.242 1.02 . . . . 0.0 112.493 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.65 -34.51 56.64 Favored Glycine 0 CA--C 1.57 3.481 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.645 167.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -69.99 151.84 45.12 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 125.732 1.613 . . . . 0.0 114.504 169.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -98.39 3.54 48.48 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 168.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.0 p -150.12 118.4 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.16 80.39 0.82 Allowed Glycine 0 N--CA 1.487 2.065 0 CA-C-O 119.938 -0.368 . . . . 0.0 112.61 -175.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 1.007 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER . . . . . 0 CA--C 1.566 1.581 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -169.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.3 p90 . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.5 t -82.0 -26.49 33.82 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -89.31 -28.48 19.83 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 124.36 1.064 . . . . 0.0 111.761 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 . . . . . 0 CA--C 1.572 1.789 0 CA-C-O 117.632 -1.175 . . . . 0.0 112.23 169.311 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 CA--C 1.565 1.535 0 CA-C-O 119.867 -0.111 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.24 97.79 0.11 Allowed Glycine 0 N--CA 1.478 1.478 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.66 0 CA-C-O 121.222 0.346 . . . . 0.0 112.366 -179.224 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 118.092 -0.956 . . . . 0.0 108.694 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.61 -170.44 13.3 Favored Glycine 0 CA--C 1.556 2.599 0 CA-C-N 119.351 0.978 . . . . 0.0 115.53 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.2 85.82 1.76 Allowed 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 123.634 2.889 . . . . 0.0 113.838 -174.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 . . . . . 0 CA--C 1.573 1.849 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.193 -176.997 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.7 m120 . . . . . 0 CA--C 1.566 1.586 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.84 -52.51 65.19 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.73 -30.87 66.09 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 169.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.88 104.42 4.75 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 122.017 0.913 . . . . 0.0 113.075 -168.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 . . . . . 0 CA--C 1.567 1.62 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.132 -176.637 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.533 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . 48.5 t . . . . . 0 CA--C 1.569 1.701 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.6 -21.72 77.79 Favored Glycine 0 CA--C 1.554 2.482 0 N-CA-C 118.44 2.136 . . . . 0.0 118.44 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.9 m -59.92 167.51 2.2 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -76.55 -70.75 0.43 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.304 169.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.86 84.64 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.406 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.353 175.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 163.98 74.4 0.03 OUTLIER Glycine 0 N--CA 1.481 1.642 0 CA-C-O 119.725 -0.486 . . . . 0.0 112.972 176.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.533 ' HG2' ' HA ' ' A' ' 14' ' ' CYS 0.305 2.6 mpt_? . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.7 p90 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.7 t -91.01 -26.74 19.05 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -93.42 -33.45 13.83 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 N--CA 1.49 1.564 0 CA-C-N 119.84 1.2 . . . . 0.0 113.357 171.107 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 CA--C 1.561 1.393 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.61 -96.49 0.1 Allowed Glycine 0 N--CA 1.479 1.547 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 CA-C-O 121.366 0.425 . . . . 0.0 112.195 179.957 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 99.7 m . . . . . 0 CA--C 1.552 1.033 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.87 -142.8 33.93 Favored Glycine 0 CA--C 1.557 2.668 0 CA-C-N 121.741 2.064 . . . . 0.0 116.011 169.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -46.33 -24.31 2.51 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 124.476 3.45 . . . . 0.0 120.319 169.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 CA--C 1.571 1.782 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 171.152 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.47 -88.73 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 168.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.75 62.83 1.64 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 166.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.8 t -68.06 137.59 55.14 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 168.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -169.374 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.6 t . . . . . 0 CA--C 1.565 1.547 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.2 -31.36 80.57 Favored Glycine 0 CA--C 1.566 3.241 0 CA-C-N 120.458 1.481 . . . . 0.0 114.531 167.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 m -47.08 140.15 5.26 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 169.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -99.6 -15.02 18.74 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.223 -1.353 . . . . 0.0 114.631 168.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 p -150.04 116.48 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 172.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.36 78.71 1.4 Allowed Glycine 0 N--CA 1.484 1.874 0 C-N-CA 122.778 0.228 . . . . 0.0 113.559 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.452 ' HG2' ' HB3' ' A' ' 24' ' ' CYS 0.324 2.8 mpt_? . . . . . 0 N--CA 1.483 1.207 0 C-N-CA 124.242 1.017 . . . . 0.0 113.18 -175.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.0 p90 . . . . . 0 CA--C 1.563 1.463 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.452 ' HB3' ' HG2' ' A' ' 20' ' ' ARG . 4.9 m -90.49 -15.48 30.69 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.41 -36.54 15.41 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 124.277 1.031 . . . . 0.0 110.772 169.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 . . . . . 0 CA--C 1.572 1.808 0 CA-C-O 117.62 -1.181 . . . . 0.0 112.498 169.033 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 118.558 -0.734 . . . . 0.0 112.293 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -95.76 84.17 0.87 Allowed Glycine 0 N--CA 1.482 1.709 0 CA-C-N 118.846 0.748 . . . . 0.0 111.551 170.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.375 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -176.446 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 117.757 -1.116 . . . . 0.0 109.021 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 11' ' ' CYS . . . 114.93 -163.32 12.2 Favored Glycine 0 CA--C 1.558 2.751 0 CA-C-N 119.731 1.151 . . . . 0.0 115.276 -177.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.87 7.01 5.15 Favored 'Trans proline' 0 CA--C 1.569 2.257 0 N-CA-C 119.787 2.956 . . . . 0.0 119.787 -175.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 . . . . . 0 CA--C 1.574 1.869 0 CA-C-O 114.377 -2.725 . . . . 0.0 111.224 -164.592 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.8 m120 . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 115.632 1.715 . . . . 0.0 115.632 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.28 -83.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -169.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.63 -14.47 60.77 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 171.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 4' ' ' GLY . 1.3 t -75.46 110.39 9.79 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -168.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 . . . . . 0 CA--C 1.564 1.512 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.078 -179.98 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.6 t . . . . . 0 CA--C 1.566 1.578 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.36 -30.89 57.89 Favored Glycine 0 CA--C 1.559 2.825 0 O-C-N 120.745 -1.222 . . . . 0.0 115.22 168.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.8 m -68.7 160.86 29.47 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -84.56 -72.55 0.47 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.295 169.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.45 134.67 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 CA-C-N 113.458 -1.701 . . . . 0.0 109.587 169.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.51 79.36 1.33 Allowed Glycine 0 N--CA 1.482 1.763 0 C-N-CA 123.037 0.351 . . . . 0.0 113.562 177.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.707 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.571 1.768 0 C-N-CA 123.669 0.788 . . . . 0.0 112.455 -174.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.3 p90 . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.707 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 18.3 t -84.02 -24.38 30.54 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -89.37 -37.36 14.91 Favored 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 124.58 1.152 . . . . 0.0 111.332 168.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 . . . . . 0 CA--C 1.568 1.648 0 CA-C-N 119.606 1.093 . . . . 0.0 112.771 169.444 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 118.663 -0.684 . . . . 0.0 112.69 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -95.25 98.26 2.24 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-N 118.977 0.808 . . . . 0.0 111.989 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.331 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -179.782 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 78.4 m . . . . . 0 N--CA 1.485 1.295 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.16 -132.79 0.43 Allowed Glycine 0 CA--C 1.557 2.692 0 N-CA-C 117.792 1.877 . . . . 0.0 117.792 -169.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -34.98 -38.27 0.16 Allowed 'Trans proline' 0 CA--C 1.557 1.634 1 C-N-CA 125.502 4.135 . . . . 0.0 121.468 175.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 . . . . . 0 CA--C 1.566 1.579 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 169.195 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 p30 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.5 -47.63 32.01 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.08 65.28 0.82 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 118.784 0.72 . . . . 0.0 111.596 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.5 t -79.43 110.29 14.6 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.111 0.481 . . . . 0.0 109.798 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.373 -1.299 . . . . 0.0 108.796 -169.943 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.2 t . . . . . 0 CA--C 1.569 1.711 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.06 -33.7 6.21 Favored Glycine 0 CA--C 1.566 3.274 0 O-C-N 121.456 -0.778 . . . . 0.0 111.233 168.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 m -45.93 131.92 9.41 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 126.485 1.914 . . . . 0.0 115.027 168.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -93.12 -14.6 27.02 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 169.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 m -145.41 115.03 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.99 84.46 0.72 Allowed Glycine 0 CA--C 1.543 1.783 0 O-C-N 122.186 -0.321 . . . . 0.0 113.48 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . 0.318 1.3 mpt_? . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -176.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.2 p90 . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 116.374 1.99 . . . . 0.0 116.374 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.7 t -90.24 -20.87 22.48 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -89.55 -35.06 16.13 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.15 0.98 . . . . 0.0 112.44 169.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 . . . . . 0 N--CA 1.487 1.4 0 CA-C-N 119.683 1.128 . . . . 0.0 112.304 169.245 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.67 -97.82 0.11 Allowed Glycine 0 N--CA 1.477 1.43 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.398 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.91 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.84 178.51 31.95 Favored Glycine 0 CA--C 1.554 2.495 0 N-CA-C 115.928 1.131 . . . . 0.0 115.928 -175.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.07 -14.41 35.06 Favored 'Trans proline' 0 CA--C 1.563 1.95 0 N-CA-C 119.791 2.958 . . . . 0.0 119.791 -173.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 CA--C 1.566 1.589 0 CA-C-O 117.288 -1.339 . . . . 0.0 108.443 -177.606 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 . . . . . 0 CA--C 1.562 1.412 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.89 -81.07 0.32 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.564 1.075 . . . . 0.0 111.019 172.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.62 -9.73 59.48 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 173.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.5 t -74.03 117.35 15.72 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 119.341 0.973 . . . . 0.0 112.165 -168.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 . . . . . 0 CA--C 1.566 1.589 0 C-N-CA 123.935 0.894 . . . . 0.0 109.835 -173.357 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.977 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 49.8 t . . . . . 0 CA--C 1.552 1.047 0 CA-C-O 121.781 0.8 . . . . 0.0 112.188 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.35 -2.54 87.72 Favored Glycine 0 CA--C 1.576 3.856 0 N-CA-C 114.771 0.668 . . . . 0.0 114.771 167.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.9 m -90.11 172.2 8.99 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.59 1.956 . . . . 0.0 115.772 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -87.44 -67.69 0.8 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.055 168.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 p -106.57 133.41 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 CA-C-N 113.869 -1.514 . . . . 0.0 108.874 169.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.87 88.05 1.97 Allowed Glycine 0 N--CA 1.484 1.857 0 C-N-CA 123.167 0.413 . . . . 0.0 113.238 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.977 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.562 1.404 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -173.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.5 p90 . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.462 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 30.8 t -78.8 -27.21 44.39 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -174.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -89.37 -32.25 17.39 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.046 0.938 . . . . 0.0 112.358 169.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.565 1.537 0 CA-C-N 119.541 1.064 . . . . 0.0 110.454 169.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.96 -96.74 0.1 Allowed Glycine 0 N--CA 1.478 1.476 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 -179.909 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 99.3 m . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.86 -128.1 0.42 Allowed Glycine 0 CA--C 1.553 2.423 0 CA-C-O 117.846 -1.53 . . . . 0.0 116.622 -169.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -38.1 -30.75 0.17 Allowed 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 125.144 3.896 . . . . 0.0 121.474 172.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 CA--C 1.568 1.652 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 170.069 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 119.077 -0.487 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.05 -49.13 60.2 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 172.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.73 64.27 0.77 Allowed 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 118.496 0.589 . . . . 0.0 110.886 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.0 t -83.22 106.6 15.13 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.312 0.645 . . . . 0.0 109.61 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 116.989 -1.481 . . . . 0.0 108.276 -169.965 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.537 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.356 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.23 13.32 67.91 Favored Glycine 0 CA--C 1.577 3.945 0 O-C-N 120.454 -1.404 . . . . 0.0 113.563 166.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -91.54 163.79 14.02 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.16 2.184 . . . . 0.0 115.158 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -91.2 -62.67 1.39 Allowed 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 113.042 -1.89 . . . . 0.0 109.206 167.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.23 139.58 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.233 169.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.66 84.41 1.4 Allowed Glycine 0 N--CA 1.486 1.977 0 C-N-CA 123.188 0.423 . . . . 0.0 113.065 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.563 1.466 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -169.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.9 p90 . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.2 m -90.23 -19.41 24.18 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.48 2.029 . . . . 0.0 116.48 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.34 -35.53 16.04 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 124.677 1.191 . . . . 0.0 112.305 169.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 . . . . . 0 CA--C 1.569 1.711 0 CA-C-O 117.253 -1.356 . . . . 0.0 111.201 169.338 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.9 m . . . . . 0 CA--C 1.561 1.387 0 CA-C-O 119.682 -0.199 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.72 -97.29 0.11 Allowed Glycine 0 N--CA 1.479 1.552 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.399 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.926 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.434 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.6 t -124.15 -121.34 0.27 Allowed 'General case' 0 CA--C 1.562 1.409 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.1 t -150.77 -86.86 0.07 Allowed 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.23 -167.82 21.1 Favored Glycine 0 CA--C 1.56 2.872 0 N-CA-C 117.068 1.587 . . . . 0.0 117.068 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -53.94 -12.16 3.17 Favored 'Trans proline' 0 CA--C 1.563 1.958 1 N-CA-C 123.011 4.197 . . . . 0.0 123.011 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -89.19 131.6 35.24 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 119.611 1.096 . . . . 0.0 109.463 -169.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -143.11 39.09 1.45 Allowed 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -155.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.36 -92.0 0.14 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 169.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.25 -9.46 50.6 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 167.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.34 115.84 26.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.172 0.989 . . . . 0.0 111.435 -168.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -134.94 145.97 48.68 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.825 -174.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 1.196 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 20.7 t -116.87 56.07 0.81 Allowed 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 168.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.66 -18.16 76.05 Favored Glycine 0 CA--C 1.569 3.46 0 O-C-N 121.868 -0.52 . . . . 0.0 114.242 167.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 m -74.94 172.63 11.93 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 126.458 1.903 . . . . 0.0 114.87 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -80.53 -76.9 0.21 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.183 169.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.0 m -95.55 142.11 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.713 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.51 85.04 0.95 Allowed Glycine 0 N--CA 1.483 1.828 0 CA-C-O 119.768 -0.462 . . . . 0.0 113.013 175.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 1.196 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -163.58 160.08 22.58 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -169.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -63.65 -33.24 75.18 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 175.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.0 t -83.7 -24.95 31.03 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -89.24 -28.87 19.64 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 124.333 1.053 . . . . 0.0 111.579 168.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -66.48 151.51 47.07 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-O 117.688 -1.149 . . . . 0.0 112.188 169.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -78.26 -66.09 0.9 Allowed 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.901 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.84 -96.55 0.1 Allowed Glycine 0 CA--C 1.537 1.448 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.39 -98.26 1.26 Allowed Glycine 0 N--CA 1.48 1.599 0 N-CA-C 112.317 -0.313 . . . . 0.0 112.317 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.485 0 O-C-N 120.516 -1.579 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.326 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 39.3 t -119.32 -123.04 0.29 Allowed 'General case' 0 CA--C 1.562 1.404 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.6 t -150.75 -79.81 0.12 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 169.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.38 -143.95 16.31 Favored Glycine 0 CA--C 1.558 2.763 0 CA-C-O 118.311 -1.272 . . . . 0.0 115.01 177.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -77.51 74.99 4.9 Favored 'Trans proline' 0 CA--C 1.566 2.091 0 C-N-CA 123.941 3.094 . . . . 0.0 114.099 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.531 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 63.5 m-85 -150.11 161.13 42.98 Favored 'General case' 0 CA--C 1.58 2.114 0 C-N-CA 125.218 1.407 . . . . 0.0 109.169 -171.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -133.51 -52.15 0.87 Allowed 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -155.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.33 -84.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 120.504 1.502 . . . . 0.0 114.796 -169.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.02 -13.68 60.23 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 172.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 6' ' ' TYR . 1.7 t -74.2 118.42 17.15 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -168.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -149.32 132.53 16.41 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.6 t -85.68 16.45 3.95 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 168.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.95 -33.98 87.19 Favored Glycine 0 CA--C 1.554 2.474 0 N-CA-C 116.564 1.386 . . . . 0.0 116.564 169.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.7 m -62.94 157.08 22.61 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -80.43 -71.21 0.47 Allowed 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.976 169.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.9 p -99.41 134.44 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.794 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.42 88.81 0.99 Allowed Glycine 0 N--CA 1.483 1.828 0 CA-C-O 119.757 -0.468 . . . . 0.0 112.663 175.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.846 ' HB2' HD22 ' A' ' 21' ' ' HYP . 0.1 OUTLIER -160.87 173.73 14.91 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -169.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HYP . . . . . 0.846 HD22 ' HB2' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -71.88 -31.51 66.52 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.43 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 34.3 t -88.79 -24.14 22.69 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -89.58 -37.9 14.35 Favored 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 125.058 1.343 . . . . 0.0 111.88 169.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -67.42 139.18 57.11 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-O 116.891 -1.528 . . . . 0.0 111.457 169.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.8 m -79.45 -64.57 1.16 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.228 -171.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.36 -97.61 0.11 Allowed Glycine 0 CA--C 1.537 1.429 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.65 -99.33 0.12 Allowed Glycine 0 N--CA 1.479 1.512 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.462 0 O-C-N 120.455 -1.615 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.364 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.7 t -71.99 -50.8 25.69 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 54.0 t -133.29 -85.91 0.44 Allowed 'General case' 0 CA--C 1.551 1.006 0 CA-C-O 116.602 -1.666 . . . . 0.0 108.285 169.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.8 -159.1 25.5 Favored Glycine 0 CA--C 1.561 2.958 0 CA-C-N 121.668 2.031 . . . . 0.0 115.187 -169.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -76.89 65.15 7.71 Favored 'Trans proline' 0 CA--C 1.568 2.184 0 C-N-CA 123.573 2.849 . . . . 0.0 117.258 -169.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -140.61 91.12 2.4 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 102.78 -3.044 . . . . 0.0 102.78 164.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -101.19 -76.07 0.57 Allowed 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 151.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.56 -110.0 0.09 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 168.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.49 -44.55 28.48 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.801 0.728 . . . . 0.0 110.961 167.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 t 57.82 82.34 0.13 Allowed 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 126.715 2.006 . . . . 0.0 107.726 -172.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -106.19 153.84 21.55 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -169.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.0 t -78.79 18.02 0.65 Allowed 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 162.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.3 -27.39 70.61 Favored Glycine 0 CA--C 1.564 3.098 0 O-C-N 120.558 -1.339 . . . . 0.0 116.352 168.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -54.02 137.89 38.61 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 169.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -80.94 -55.16 4.98 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.982 169.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 m -113.77 125.5 71.06 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.418 0 CA-C-N 114.194 -1.366 . . . . 0.0 107.741 171.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.36 65.43 1.47 Allowed Glycine 0 CA--C 1.543 1.826 0 N-CA-C 115.421 0.928 . . . . 0.0 115.421 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.89 ' HB3' HD22 ' A' ' 21' ' ' HYP . 0.7 OUTLIER -94.44 -173.27 3.0 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 173.136 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HYP . . . . . 0.89 HD22 ' HB3' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HYP . . . . . 1.276 ' O ' ' HB3' ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -87.54 -35.74 17.99 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 170.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.11 -25.75 20.57 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -176.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -102.41 -44.35 5.4 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.435 1.094 . . . . 0.0 111.841 169.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 1.276 ' HB3' ' O ' ' A' ' 22' ' ' HYP . 78.1 ttt180 -74.16 119.42 18.35 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-O 116.32 -1.8 . . . . 0.0 108.46 169.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.2 t -150.68 -83.55 0.09 Allowed 'General case' 0 CA--C 1.557 1.23 0 CA-C-O 118.258 -0.877 . . . . 0.0 108.723 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.73 -99.66 0.15 Allowed Glycine 0 CA--C 1.537 1.468 0 CA-C-N 119.727 1.149 . . . . 0.0 111.731 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.22 98.3 0.17 Allowed Glycine 0 N--CA 1.478 1.448 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -172.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.405 0 O-C-N 120.35 -1.677 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.406 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -99.19 -98.61 0.23 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 116.654 -1.641 . . . . 0.0 108.312 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 64.3 m -139.88 -108.61 0.16 Allowed 'General case' 0 CA--C 1.554 1.123 0 CA-C-N 121.939 2.154 . . . . 0.0 107.638 -174.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.76 -135.4 28.5 Favored Glycine 0 CA--C 1.555 2.548 0 CA-C-N 120.448 1.476 . . . . 0.0 115.2 174.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -64.34 -11.53 28.59 Favored 'Trans proline' 0 CA--C 1.567 2.127 0 C-N-CA 123.488 2.792 . . . . 0.0 118.504 170.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -123.86 81.49 1.92 Allowed 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 163.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -85.99 -82.48 0.19 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 160.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.22 -92.03 0.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 104.67 -2.345 . . . . 0.0 104.67 168.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.54 63.56 1.6 Allowed 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 166.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.4 t -66.45 145.1 56.04 Favored 'General case' 0 CA--C 1.577 2.002 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 168.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -88.84 158.8 17.99 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 118.199 2.666 . . . . 0.0 118.199 -166.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.8 t -75.01 6.11 4.48 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 162.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.92 -6.79 60.73 Favored Glycine 0 CA--C 1.563 3.078 0 N-CA-C 118.137 2.015 . . . . 0.0 118.137 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.7 m -79.07 161.14 26.75 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.279 1.431 . . . . 0.0 114.632 -169.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -85.52 -72.95 0.46 Allowed 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.797 169.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.1 p -101.71 133.51 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.498 0 CA-C-N 113.136 -1.847 . . . . 0.0 109.318 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.02 86.95 1.08 Allowed Glycine 0 N--CA 1.481 1.673 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.64 173.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.443 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 0.7 OUTLIER -125.5 169.7 12.15 Favored 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -177.101 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -76.82 -33.53 57.96 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.443 ' SG ' ' HG2' ' A' ' 20' ' ' ARG . 14.0 t -90.4 -22.06 21.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -89.69 -41.28 12.01 Favored 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 124.69 1.196 . . . . 0.0 111.884 169.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -70.8 132.34 45.17 Favored 'General case' 0 CA--C 1.564 1.518 0 CA-C-O 116.696 -1.621 . . . . 0.0 110.809 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.0 t -78.58 -65.43 0.99 Allowed 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.35 -97.79 0.11 Allowed Glycine 0 N--CA 1.478 1.438 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.03 -99.18 0.12 Allowed Glycine 0 CA--C 1.537 1.421 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.458 0 O-C-N 120.503 -1.587 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.446 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 40.9 t -87.14 -107.99 0.06 Allowed 'General case' 0 CA--C 1.562 1.42 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.462 ' SG ' ' HA ' ' A' ' 7' ' ' HYP . 16.8 t -150.74 -76.87 0.14 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 171.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.87 -142.67 47.97 Favored Glycine 0 CA--C 1.561 2.934 0 CA-C-O 118.721 -1.044 . . . . 0.0 115.102 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.44 -14.57 37.33 Favored 'Trans proline' 0 CA--C 1.569 2.262 0 C-N-CA 123.249 2.632 . . . . 0.0 118.114 169.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -131.98 95.52 3.71 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HYP . . . . . 0.462 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -141.4 -111.1 0.14 Allowed 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 172.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.12 -44.32 9.34 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 118.489 2.774 . . . . 0.0 118.489 -169.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.79 71.98 0.76 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.775 0.83 . . . . 0.0 110.237 -169.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 t -86.06 93.19 8.93 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 124.004 1.859 . . . . 0.0 111.887 -169.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -150.2 156.04 40.87 Favored 'General case' 0 CA--C 1.575 1.914 0 CA-C-N 111.265 -2.698 . . . . 0.0 106.122 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 1.244 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 50.9 t -116.63 74.2 0.9 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.153 0.978 . . . . 0.0 112.009 161.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.0 -0.28 90.22 Favored Glycine 1 CA--C 1.582 4.263 0 CA-C-N 115.066 -0.97 . . . . 0.0 113.509 166.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . 44.9 m -90.64 168.6 11.66 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 117.427 2.381 . . . . 0.0 117.427 -169.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -88.77 -63.36 1.31 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 112.911 -1.95 . . . . 0.0 109.46 168.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.8 p -110.55 133.93 54.43 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.28 169.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.88 82.62 1.59 Allowed Glycine 0 N--CA 1.487 2.065 0 C-N-CA 123.154 0.407 . . . . 0.0 113.37 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 1.244 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -166.91 152.43 7.8 Favored 'General case' 0 CA--C 1.57 1.713 0 CA-C-O 118.193 -0.908 . . . . 0.0 112.482 -169.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -62.13 -28.72 69.84 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.445 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 12.2 t -85.1 -22.97 28.68 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -89.12 -31.49 17.97 Favored 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 124.7 1.2 . . . . 0.0 112.227 169.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -69.12 170.84 9.26 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 120.056 1.298 . . . . 0.0 113.164 169.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.7 p -76.47 -58.56 3.21 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.45 97.77 0.11 Allowed Glycine 0 N--CA 1.478 1.461 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 178.82 99.24 0.12 Allowed Glycine 0 CA--C 1.537 1.413 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.469 0 O-C-N 120.497 -1.59 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.394 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.7 t -124.39 -121.36 0.27 Allowed 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.8 t -150.82 -80.83 0.11 Allowed 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 117.334 -1.317 . . . . 0.0 108.319 172.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.58 -174.97 19.21 Favored Glycine 0 CA--C 1.556 2.648 0 CA-C-N 120.354 1.434 . . . . 0.0 116.522 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -46.87 -26.76 5.03 Favored 'Trans proline' 0 CA--C 1.559 1.725 1 N-CA-C 123.352 4.328 . . . . 0.0 123.352 -174.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -91.93 113.91 26.3 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 116.937 -1.506 . . . . 0.0 109.06 -169.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -152.99 -83.95 0.08 Allowed 'General case' 0 CA--C 1.562 1.411 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 170.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.75 -93.72 0.13 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 119.788 1.176 . . . . 0.0 110.62 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -107.41 54.19 0.67 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 118.863 0.756 . . . . 0.0 110.705 169.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 t -107.01 92.26 4.01 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 122.232 1.015 . . . . 0.0 109.575 -169.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -122.81 149.92 43.52 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.188 -172.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 1.537 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 35.7 t -114.56 54.86 0.76 Allowed 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 165.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.91 -29.82 49.98 Favored Glycine 0 CA--C 1.565 3.162 0 O-C-N 121.781 -0.574 . . . . 0.0 113.268 167.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 m -62.72 167.34 4.61 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 126.455 1.902 . . . . 0.0 115.859 173.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -79.8 -72.19 0.41 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.876 169.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.9 m -94.54 141.05 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 113.732 -1.577 . . . . 0.0 110.872 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.77 76.92 1.01 Allowed Glycine 0 CA--C 1.543 1.799 0 N-CA-C 114.426 0.531 . . . . 0.0 114.426 173.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 1.537 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -153.82 166.1 33.97 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HYP . . . . . 0.585 HD22 ' HB2' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -69.82 -29.56 66.86 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.3 t -81.81 -32.16 31.4 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -89.78 -29.04 18.94 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 123.916 0.886 . . . . 0.0 113.204 169.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -69.05 122.14 18.11 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 116.418 -1.753 . . . . 0.0 110.235 169.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 89.3 p -75.01 -57.95 3.58 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -176.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.16 -96.96 0.1 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.0 -101.5 2.67 Favored Glycine 0 N--CA 1.48 1.618 0 CA-C-O 121.346 0.415 . . . . 0.0 112.367 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.459 0 O-C-N 120.556 -1.556 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.381 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 41.3 t -98.59 -110.39 0.17 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 38.2 t -150.45 -75.26 0.15 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.825 1.193 . . . . 0.0 108.697 170.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.27 -170.93 13.5 Favored Glycine 0 CA--C 1.557 2.713 0 N-CA-C 116.863 1.505 . . . . 0.0 116.863 172.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.86 63.58 8.4 Favored 'Trans proline' 0 CA--C 1.566 2.082 0 C-N-CA 123.501 2.801 . . . . 0.0 116.84 -169.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -138.04 84.41 2.04 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 162.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -140.54 -82.14 0.25 Allowed 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 166.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.71 -95.45 0.12 Allowed 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 118.97 0.804 . . . . 0.0 111.003 175.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.95 6.47 41.92 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.83 100.38 4.75 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 120.506 1.503 . . . . 0.0 112.832 -168.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -150.3 152.69 34.89 Favored 'General case' 0 CA--C 1.569 1.706 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.948 -172.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.9 t -92.13 30.14 1.5 Allowed 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 171.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.54 -7.04 88.04 Favored Glycine 0 CA--C 1.568 3.359 0 N-CA-C 115.728 1.051 . . . . 0.0 115.728 168.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.2 m -60.7 158.33 12.89 Favored 'General case' 0 CA--C 1.553 1.091 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -85.69 -50.36 7.24 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.208 -1.36 . . . . 0.0 113.525 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 p -137.16 126.89 37.68 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 170.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.08 83.86 1.75 Allowed Glycine 0 N--CA 1.483 1.823 0 CA-C-N 116.505 -0.316 . . . . 0.0 113.039 176.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.924 ' HB2' ' HB2' ' A' ' 25' ' ' ASP . 6.7 mpt_? -116.17 168.54 10.02 Favored 'General case' 0 CA--C 1.561 1.401 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -175.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HYP . . . . . 1.098 ' O ' ' HB3' ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -79.06 -39.65 33.3 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 169.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.497 ' HB3' ' HG2' ' A' ' 20' ' ' ARG . 1.7 m -90.74 -8.09 50.73 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.924 ' HB2' ' HB2' ' A' ' 20' ' ' ARG . 13.2 t70 -132.45 -38.44 1.05 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.226 1.41 . . . . 0.0 112.019 175.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 1.098 ' HB3' ' O ' ' A' ' 22' ' ' HYP . 24.2 tpt180 -70.14 128.92 37.94 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-O 116.549 -1.691 . . . . 0.0 110.423 169.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.1 p -84.6 -61.71 1.73 Allowed 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.38 -96.67 0.1 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.01 -99.32 0.12 Allowed Glycine 0 N--CA 1.478 1.468 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.431 0 O-C-N 120.531 -1.57 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.393 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 5.7 t -81.54 -87.04 0.09 Allowed 'General case' 0 CA--C 1.559 1.302 0 CA-C-O 117.835 -1.078 . . . . 0.0 112.146 -177.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.07 -95.86 0.11 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -169.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.94 -166.3 37.06 Favored Glycine 0 CA--C 1.556 2.651 0 CA-C-N 120.35 1.432 . . . . 0.0 116.355 170.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.88 3.51 3.82 Favored 'Trans proline' 0 CA--C 1.57 2.3 0 C-N-CA 123.117 2.545 . . . . 0.0 118.535 172.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -89.86 -46.55 8.48 Favored 'General case' 0 CA--C 1.571 1.77 0 CA-C-O 115.164 -2.35 . . . . 0.0 112.795 -176.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -66.03 -57.9 6.7 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -169.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.26 40.43 1.01 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 116.931 2.197 . . . . 0.0 116.931 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 31.33 64.37 0.2 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -169.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.2 t -50.78 152.96 1.88 Allowed 'General case' 0 CA--C 1.574 1.885 0 CA-C-N 113.251 -1.795 . . . . 0.0 110.833 169.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 60.3 m170 -88.32 140.07 29.85 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.423 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 3.1 t -97.76 38.58 1.28 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 171.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.45 3.04 87.78 Favored Glycine 0 CA--C 1.566 3.243 0 N-CA-C 116.309 1.284 . . . . 0.0 116.309 168.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.6 m -90.83 -167.22 1.76 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.281 1.432 . . . . 0.0 113.295 -172.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -116.54 -74.72 0.6 Allowed 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 169.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 p -91.62 127.2 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.707 173.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.16 46.3 4.77 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 118.425 2.13 . . . . 0.0 118.425 170.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.616 ' HB3' HD22 ' A' ' 21' ' ' HYP 0.304 4.9 mpt_? -85.14 -176.09 6.02 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 169.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HYP . . . . . 0.616 HD22 ' HB3' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HYP . . . . . 1.059 ' O ' ' HB3' ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -83.1 -39.84 20.61 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 173.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.8 m -90.98 -10.65 41.53 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.351 2.352 . . . . 0.0 117.351 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 20' ' ' ARG . 17.2 t70 -134.98 -37.68 0.8 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.9 1.28 . . . . 0.0 112.559 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 1.059 ' HB3' ' O ' ' A' ' 22' ' ' HYP . 23.6 tpt180 -68.61 132.85 47.6 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-O 116.668 -1.634 . . . . 0.0 111.081 169.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.6 p -96.26 87.29 4.45 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.759 -174.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.58 97.9 0.11 Allowed Glycine 0 N--CA 1.479 1.529 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.09 99.3 0.12 Allowed Glycine 0 N--CA 1.477 1.414 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.435 0 O-C-N 120.472 -1.605 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.389 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 23.1 t -160.57 94.45 1.06 Allowed 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 61.6 m -134.9 61.47 1.67 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 168.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.81 -172.27 53.04 Favored Glycine 0 CA--C 1.558 2.768 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.022 -168.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.04 -16.75 28.78 Favored 'Trans proline' 0 CA--C 1.573 2.462 0 C-N-CA 122.672 2.248 . . . . 0.0 116.598 169.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.549 ' H ' HD22 ' A' ' 7' ' ' HYP . 83.7 m-85 -150.38 -46.21 0.12 Allowed 'General case' 0 CA--C 1.575 1.941 0 CA-C-O 115.036 -2.411 . . . . 0.0 112.68 -171.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HYP . . . . . 0.549 HD22 ' H ' ' A' ' 6' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -139.61 -53.46 0.54 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.858 1.263 . . . . 0.0 109.355 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.26 -26.9 68.99 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 117.382 2.364 . . . . 0.0 117.382 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.73 53.36 2.39 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 119.894 1.224 . . . . 0.0 113.119 169.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 1.8 t -80.6 121.72 26.18 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.224 0.61 . . . . 0.0 112.109 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -128.77 123.13 32.14 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 171.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.65 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 1.3 t -108.8 64.89 0.61 Allowed 'General case' 0 CA--C 1.557 1.219 0 CA-C-O 122.742 1.258 . . . . 0.0 111.444 172.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -118.04 -4.03 14.84 Favored Glycine 0 CA--C 1.567 3.305 0 CA-C-N 114.427 -1.26 . . . . 0.0 114.027 167.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.709 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 80.0 m -90.6 -100.42 0.1 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.905 1.352 . . . . 0.0 111.18 -169.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.709 ' HB2' ' O ' ' A' ' 16' ' ' CYS . 48.5 tptt 164.6 -82.87 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -170.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.448 ' H ' ' HB3' ' A' ' 17' ' ' LYS . 13.4 p -92.03 118.15 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 113.375 -1.739 . . . . 0.0 108.61 174.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.97 93.9 0.67 Allowed Glycine 0 CA--C 1.541 1.657 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -172.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.657 ' HG3' HD22 ' A' ' 21' ' ' HYP . 29.8 ttp180 -166.71 150.52 7.08 Favored 'General case' 0 CA--C 1.568 1.659 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.374 -169.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HYP . . . . . 0.657 HD22 ' HG3' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -70.61 -35.67 73.09 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.8 m -90.59 -19.25 23.93 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.78 -38.48 13.77 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.355 1.062 . . . . 0.0 111.743 169.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -68.95 152.76 44.86 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 119.601 1.092 . . . . 0.0 111.139 169.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.3 t -78.66 -65.67 0.96 Allowed 'General case' 0 CA--C 1.561 1.388 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.98 -175.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.74 -96.75 0.1 Allowed Glycine 0 N--CA 1.477 1.409 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.53 -98.16 1.28 Allowed Glycine 0 N--CA 1.48 1.628 0 N-CA-C 112.267 -0.333 . . . . 0.0 112.267 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.474 0 O-C-N 120.461 -1.611 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.338 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 38.7 t -134.08 -88.99 0.38 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.213 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 m -137.28 -71.44 0.44 Allowed 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 116.806 -1.569 . . . . 0.0 109.265 173.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.72 178.93 20.56 Favored Glycine 0 CA--C 1.555 2.592 0 CA-C-N 121.275 1.852 . . . . 0.0 115.556 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.2 85.68 1.74 Allowed 'Trans proline' 0 CA--C 1.562 1.895 0 C-N-CA 123.478 2.786 . . . . 0.0 113.286 -177.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -132.37 112.1 11.89 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -141.83 -72.6 0.33 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 156.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.28 -31.64 20.13 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 168.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 48.36 53.24 12.25 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -169.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.77 134.92 57.0 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.443 168.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -89.4 165.19 14.51 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -168.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.513 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 11.7 t -87.85 30.31 0.85 Allowed 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 162.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.63 -29.81 62.98 Favored Glycine 0 CA--C 1.564 3.147 0 O-C-N 120.95 -1.094 . . . . 0.0 115.299 168.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.2 m -62.34 178.18 0.42 Allowed 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 116.866 2.172 . . . . 0.0 116.866 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -108.09 -71.75 0.75 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.941 168.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -95.84 136.13 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-N 113.784 -1.553 . . . . 0.0 109.61 169.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.11 82.81 1.04 Allowed Glycine 0 N--CA 1.486 1.972 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.513 ' HD2' ' HA ' ' A' ' 14' ' ' CYS . 17.2 ttp180 -160.95 153.41 20.52 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 118.912 -0.566 . . . . 0.0 112.362 -168.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HYP . . . . . 0.418 HD22 ' HG3' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HYP . . . . . 0.474 ' O ' ' CB ' ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -73.98 -37.35 64.49 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.2 m -90.41 -22.6 21.37 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -89.69 -35.31 15.87 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.19 0.996 . . . . 0.0 112.579 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.474 ' CB ' ' O ' ' A' ' 22' ' ' HYP . 22.8 tpp180 -68.37 132.45 47.07 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-O 116.875 -1.536 . . . . 0.0 110.142 169.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 m -86.73 99.49 11.81 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.587 -171.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.82 -96.6 0.1 Allowed Glycine 0 CA--C 1.538 1.469 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.17 101.11 2.66 Favored Glycine 0 N--CA 1.48 1.614 0 CA-C-O 121.401 0.445 . . . . 0.0 112.148 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.448 0 O-C-N 120.496 -1.591 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.438 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 47.9 t -87.57 -62.11 1.57 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -176.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.66 -80.88 0.6 Allowed 'General case' 0 CA--C 1.561 1.366 0 CA-C-O 117.049 -1.453 . . . . 0.0 107.561 -169.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.04 -168.07 40.59 Favored Glycine 0 CA--C 1.554 2.484 0 CA-C-N 121.764 2.075 . . . . 0.0 118.195 169.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.84 11.75 1.89 Allowed 'Trans proline' 0 CA--C 1.57 2.278 0 C-N-CA 123.482 2.788 . . . . 0.0 118.398 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -89.69 -54.6 3.99 Favored 'General case' 0 CA--C 1.568 1.649 0 CA-C-O 115.474 -2.203 . . . . 0.0 110.858 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -75.34 -65.63 0.87 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -159.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.51 55.5 3.03 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -170.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 30.46 62.7 0.19 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 -169.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.0 t -70.8 118.02 13.06 Favored 'General case' 0 CA--C 1.559 1.306 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 168.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -93.76 162.93 13.73 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -168.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.2 t -74.41 -3.66 31.86 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 115.419 1.636 . . . . 0.0 115.419 161.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.8 -29.77 73.18 Favored Glycine 0 CA--C 1.564 3.137 0 CA-C-N 120.776 1.625 . . . . 0.0 115.563 168.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.2 m -62.81 137.9 58.39 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.882 1.273 . . . . 0.0 114.014 169.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -93.23 -2.57 55.0 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 169.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.2 p -150.15 115.4 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.345 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.02 86.16 0.6 Allowed Glycine 0 CA--C 1.543 1.79 0 CA-C-O 119.871 -0.405 . . . . 0.0 113.662 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.805 ' HB2' HD22 ' A' ' 21' ' ' HYP . 0.0 OUTLIER -157.23 174.0 16.12 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -171.508 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' HYP . . . . . 0.805 HD22 ' HB2' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -69.15 -38.61 78.88 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.9 m -90.6 -18.11 25.76 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -89.5 -28.58 19.56 Favored 'General case' 0 CA--C 1.565 1.552 0 C-N-CA 124.197 0.999 . . . . 0.0 112.608 169.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -63.4 152.54 37.87 Favored 'General case' 0 CA--C 1.572 1.79 0 CA-C-O 117.695 -1.145 . . . . 0.0 112.92 169.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.8 t -86.49 98.34 10.99 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.537 -176.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.71 -97.69 0.11 Allowed Glycine 0 N--CA 1.478 1.458 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.04 -99.35 0.12 Allowed Glycine 0 N--CA 1.477 1.408 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.436 0 O-C-N 120.479 -1.601 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.417 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 28.3 t -91.37 -81.49 0.32 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 118.733 -0.651 . . . . 0.0 109.431 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.5 t -149.21 -73.82 0.18 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 169.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.58 -174.61 15.83 Favored Glycine 0 CA--C 1.556 2.609 0 N-CA-C 116.41 1.324 . . . . 0.0 116.41 169.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.6 66.11 8.58 Favored 'Trans proline' 0 CA--C 1.566 2.118 0 C-N-CA 123.468 2.779 . . . . 0.0 117.341 -169.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -143.03 86.63 1.93 Allowed 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 163.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -139.14 -85.7 0.24 Allowed 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.73 -91.38 0.15 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 119.166 0.894 . . . . 0.0 110.256 175.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -107.74 46.0 0.97 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.836 0.743 . . . . 0.0 112.495 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 t -92.14 97.49 10.95 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 122.197 0.999 . . . . 0.0 109.094 -169.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -149.97 153.29 36.33 Favored 'General case' 0 CA--C 1.568 1.653 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.392 -169.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 1.007 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 35.3 t -108.13 59.15 0.61 Allowed 'General case' 0 CA--C 1.553 1.076 0 CA-C-O 122.242 1.02 . . . . 0.0 112.493 165.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.65 -34.51 56.64 Favored Glycine 0 CA--C 1.57 3.481 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.645 167.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -69.99 151.84 45.12 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 125.732 1.613 . . . . 0.0 114.504 169.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -98.39 3.54 48.48 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 168.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.0 p -150.12 118.4 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.16 80.39 0.82 Allowed Glycine 0 N--CA 1.487 2.065 0 CA-C-O 119.938 -0.368 . . . . 0.0 112.61 -175.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 1.007 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -162.94 168.18 21.52 Favored 'General case' 0 CA--C 1.566 1.581 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -169.462 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' HYP . . . . . 0.534 HD22 ' HB2' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -64.69 -31.97 73.43 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 175.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.5 t -82.0 -26.49 33.82 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -89.31 -28.48 19.83 Favored 'General case' 0 CA--C 1.568 1.646 0 C-N-CA 124.36 1.064 . . . . 0.0 111.761 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -66.63 149.64 50.19 Favored 'General case' 0 CA--C 1.572 1.789 0 CA-C-O 117.632 -1.175 . . . . 0.0 112.23 169.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.9 p -85.93 93.98 9.08 Favored 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 123.317 0.647 . . . . 0.0 111.163 -176.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 179.24 97.79 0.11 Allowed Glycine 0 N--CA 1.478 1.478 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.17 -97.87 1.35 Allowed Glycine 0 N--CA 1.481 1.66 0 CA-C-O 121.222 0.346 . . . . 0.0 112.366 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.406 0 O-C-N 120.434 -1.627 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.364 0 N-CA-C 111.389 -0.685 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 41.1 t -108.22 -118.01 0.27 Allowed 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 45.2 t -150.68 -75.02 0.15 Allowed 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 118.092 -0.956 . . . . 0.0 108.694 169.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.61 -170.44 13.3 Favored Glycine 0 CA--C 1.556 2.599 0 CA-C-N 119.351 0.978 . . . . 0.0 115.53 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.2 85.82 1.76 Allowed 'Trans proline' 0 CA--C 1.56 1.801 0 C-N-CA 123.634 2.889 . . . . 0.0 113.838 -174.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -144.02 151.28 39.49 Favored 'General case' 0 CA--C 1.573 1.849 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.193 -176.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -153.47 160.4 42.54 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 172.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.84 -52.51 65.19 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.73 -30.87 66.09 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 169.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.88 104.42 4.75 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 122.017 0.913 . . . . 0.0 113.075 -168.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -143.64 146.88 33.59 Favored 'General case' 0 CA--C 1.567 1.62 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.132 -176.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.533 ' HA ' ' HG2' ' A' ' 20' ' ' ARG . 48.5 t -82.67 13.72 3.6 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 167.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.6 -21.72 77.79 Favored Glycine 0 CA--C 1.554 2.482 0 N-CA-C 118.44 2.136 . . . . 0.0 118.44 173.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.9 m -59.92 167.51 2.2 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -176.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -76.55 -70.75 0.43 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.304 169.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.86 84.64 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.406 0 CA-C-N 113.746 -1.57 . . . . 0.0 107.353 175.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 163.98 74.4 0.03 OUTLIER Glycine 0 N--CA 1.481 1.642 0 CA-C-O 119.725 -0.486 . . . . 0.0 112.972 176.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.633 ' HB3' HD22 ' A' ' 21' ' ' HYP 0.305 2.6 mpt_? -130.68 179.79 5.74 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.173 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' HYP . . . . . 0.633 HD22 ' HB3' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -77.48 -36.63 52.55 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 18.7 t -91.01 -26.74 19.05 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -93.42 -33.45 13.83 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 1.021 ' HB3' HD22 ' A' ' 27' ' ' HYP . 99.3 mtt180 -76.31 -162.55 0.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 119.84 1.2 . . . . 0.0 113.357 171.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HYP . . . . . 1.021 HD22 ' HB3' ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.1 m -91.17 95.82 10.26 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 123.125 0.57 . . . . 0.0 110.382 -172.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.61 -96.49 0.1 Allowed Glycine 0 N--CA 1.479 1.547 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.03 101.02 2.65 Favored Glycine 0 N--CA 1.48 1.625 0 CA-C-O 121.366 0.425 . . . . 0.0 112.195 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.461 0 O-C-N 120.52 -1.576 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.179 0 CA-C-O 118.753 -1.026 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 53.2 t -90.78 -71.36 0.63 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 123.589 3.694 . . . . 0.0 111.807 5.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 99.7 m -137.37 -89.73 0.25 Allowed 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.87 -142.8 33.93 Favored Glycine 0 CA--C 1.557 2.668 0 CA-C-N 121.741 2.064 . . . . 0.0 116.011 169.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -46.33 -24.31 2.51 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 124.476 3.45 . . . . 0.0 120.319 169.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -119.89 83.53 2.06 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 171.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -86.32 -82.94 0.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 157.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.47 -88.73 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 168.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.75 62.83 1.64 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 166.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.8 t -68.06 137.59 55.14 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 168.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -98.09 166.89 11.21 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -169.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.6 t -75.65 11.09 1.43 Allowed 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 161.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.2 -31.36 80.57 Favored Glycine 0 CA--C 1.566 3.241 0 CA-C-N 120.458 1.481 . . . . 0.0 114.531 167.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 m -47.08 140.15 5.26 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 169.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -99.6 -15.02 18.74 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.223 -1.353 . . . . 0.0 114.631 168.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 p -150.04 116.48 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 172.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.36 78.71 1.4 Allowed Glycine 0 N--CA 1.484 1.874 0 C-N-CA 122.778 0.228 . . . . 0.0 113.559 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.452 ' HG2' ' HB3' ' A' ' 24' ' ' CYS 0.324 2.8 mpt_? -122.66 177.73 5.32 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.242 1.017 . . . . 0.0 113.18 -175.651 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -90.05 -37.69 14.1 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.452 ' HB3' ' HG2' ' A' ' 20' ' ' ARG . 4.9 m -90.49 -15.48 30.69 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.41 -36.54 15.41 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 124.277 1.031 . . . . 0.0 110.772 169.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -65.48 155.16 36.45 Favored 'General case' 0 CA--C 1.572 1.808 0 CA-C-O 117.62 -1.181 . . . . 0.0 112.498 169.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.8 m -80.68 -65.98 0.94 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 118.558 -0.734 . . . . 0.0 112.293 -171.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -95.76 84.17 0.87 Allowed Glycine 0 N--CA 1.482 1.709 0 CA-C-N 118.846 0.748 . . . . 0.0 111.551 170.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.32 -95.05 0.12 Allowed Glycine 0 CA--C 1.536 1.375 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -176.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.419 0 O-C-N 120.467 -1.607 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.303 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 18.0 t -115.01 -121.09 0.3 Allowed 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 47.4 t -150.83 -77.59 0.13 Allowed 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 117.757 -1.116 . . . . 0.0 109.021 171.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 11' ' ' CYS . . . 114.93 -163.32 12.2 Favored Glycine 0 CA--C 1.558 2.751 0 CA-C-N 119.731 1.151 . . . . 0.0 115.276 -177.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.87 7.01 5.15 Favored 'Trans proline' 0 CA--C 1.569 2.257 0 N-CA-C 119.787 2.956 . . . . 0.0 119.787 -175.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -93.53 -75.55 0.5 Allowed 'General case' 0 CA--C 1.574 1.869 0 CA-C-O 114.377 -2.725 . . . . 0.0 111.224 -164.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -113.46 -52.47 2.76 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.632 1.715 . . . . 0.0 115.632 -155.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.28 -83.28 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -169.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.63 -14.47 60.77 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 117.663 2.468 . . . . 0.0 117.663 171.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 4' ' ' GLY . 1.3 t -75.46 110.39 9.79 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -168.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -135.06 139.93 45.15 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.078 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.6 t -92.7 28.25 2.1 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 170.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.36 -30.89 57.89 Favored Glycine 0 CA--C 1.559 2.825 0 O-C-N 120.745 -1.222 . . . . 0.0 115.22 168.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.8 m -68.7 160.86 29.47 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -84.56 -72.55 0.47 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.295 169.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.45 134.67 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 CA-C-N 113.458 -1.701 . . . . 0.0 109.587 169.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.51 79.36 1.33 Allowed Glycine 0 N--CA 1.482 1.763 0 C-N-CA 123.037 0.351 . . . . 0.0 113.562 177.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.707 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -151.27 155.48 38.85 Favored 'General case' 0 CA--C 1.571 1.768 0 C-N-CA 123.669 0.788 . . . . 0.0 112.455 -174.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -71.08 -31.29 67.64 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 170.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.707 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 18.3 t -84.02 -24.38 30.54 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -89.37 -37.36 14.91 Favored 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 124.58 1.152 . . . . 0.0 111.332 168.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -69.28 164.85 21.87 Favored 'General case' 0 CA--C 1.568 1.648 0 CA-C-N 119.606 1.093 . . . . 0.0 112.771 169.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.3 m -82.5 -66.08 0.93 Allowed 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.69 -171.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -95.25 98.26 2.24 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-N 118.977 0.808 . . . . 0.0 111.989 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 178.96 99.38 0.12 Allowed Glycine 0 CA--C 1.535 1.331 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.464 0 O-C-N 120.458 -1.613 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.471 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.8 t -159.67 104.62 1.59 Allowed 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 100.721 -3.807 . . . . 0.0 100.721 167.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 78.4 m -92.53 80.25 4.86 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -173.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.16 -132.79 0.43 Allowed Glycine 0 CA--C 1.557 2.692 0 N-CA-C 117.792 1.877 . . . . 0.0 117.792 -169.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -34.98 -38.27 0.16 Allowed 'Trans proline' 0 CA--C 1.557 1.634 1 C-N-CA 125.502 4.135 . . . . 0.0 121.468 175.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -115.5 97.59 6.24 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 169.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -172.31 -52.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.889 1.275 . . . . 0.0 109.413 -172.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.5 -47.63 32.01 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.08 65.28 0.82 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 118.784 0.72 . . . . 0.0 111.596 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.5 t -79.43 110.29 14.6 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.111 0.481 . . . . 0.0 109.798 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -144.14 133.3 22.96 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 117.373 -1.299 . . . . 0.0 108.796 -169.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.2 t -89.9 35.08 0.84 Allowed 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 167.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.06 -33.7 6.21 Favored Glycine 0 CA--C 1.566 3.274 0 O-C-N 121.456 -0.778 . . . . 0.0 111.233 168.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 m -45.93 131.92 9.41 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 126.485 1.914 . . . . 0.0 115.027 168.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -93.12 -14.6 27.02 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 169.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 m -145.41 115.03 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.99 84.46 0.72 Allowed Glycine 0 CA--C 1.543 1.783 0 O-C-N 122.186 -0.321 . . . . 0.0 113.48 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 1.01 ' HB3' HD22 ' A' ' 21' ' ' HYP 0.318 1.3 mpt_? -125.65 -170.59 2.21 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -176.739 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' HYP . . . . . 1.01 HD22 ' HB3' ' A' ' 20' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -75.06 -34.32 61.81 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 116.374 1.99 . . . . 0.0 116.374 174.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.7 t -90.24 -20.87 22.48 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -89.55 -35.06 16.13 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.15 0.98 . . . . 0.0 112.44 169.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.969 ' HB3' HD22 ' A' ' 27' ' ' HYP . 99.8 mtt180 -77.53 -160.91 0.2 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 119.683 1.128 . . . . 0.0 112.304 169.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HYP . . . . . 0.969 HD22 ' HB3' ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.3 t -81.93 -65.46 1.01 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -173.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.67 -97.82 0.11 Allowed Glycine 0 N--CA 1.477 1.43 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.04 -99.2 0.12 Allowed Glycine 0 CA--C 1.536 1.398 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.464 0 O-C-N 120.474 -1.603 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.415 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 49.9 t -113.31 -116.77 0.32 Allowed 'General case' 0 CA--C 1.559 1.294 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.5 t -150.64 -90.25 0.06 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.84 178.51 31.95 Favored Glycine 0 CA--C 1.554 2.495 0 N-CA-C 115.928 1.131 . . . . 0.0 115.928 -175.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.07 -14.41 35.06 Favored 'Trans proline' 0 CA--C 1.563 1.95 0 N-CA-C 119.791 2.958 . . . . 0.0 119.791 -173.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -90.99 116.28 28.66 Favored 'General case' 0 CA--C 1.566 1.589 0 CA-C-O 117.288 -1.339 . . . . 0.0 108.443 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -135.64 -104.8 0.22 Allowed 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 169.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.89 -81.07 0.32 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.564 1.075 . . . . 0.0 111.019 172.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.62 -9.73 59.48 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 118.25 2.685 . . . . 0.0 118.25 173.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.5 t -74.03 117.35 15.72 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 119.341 0.973 . . . . 0.0 112.165 -168.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -144.88 151.07 38.15 Favored 'General case' 0 CA--C 1.566 1.589 0 C-N-CA 123.935 0.894 . . . . 0.0 109.835 -173.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.977 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 49.8 t -114.76 64.45 0.67 Allowed 'General case' 0 CA--C 1.552 1.047 0 CA-C-O 121.781 0.8 . . . . 0.0 112.188 165.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.35 -2.54 87.72 Favored Glycine 0 CA--C 1.576 3.856 0 N-CA-C 114.771 0.668 . . . . 0.0 114.771 167.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.9 m -90.11 172.2 8.99 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 126.59 1.956 . . . . 0.0 115.772 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -87.44 -67.69 0.8 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.055 168.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 p -106.57 133.41 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 CA-C-N 113.869 -1.514 . . . . 0.0 108.874 169.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.87 88.05 1.97 Allowed Glycine 0 N--CA 1.484 1.857 0 C-N-CA 123.167 0.413 . . . . 0.0 113.238 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.977 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -160.82 160.48 31.19 Favored 'General case' 0 CA--C 1.562 1.404 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -173.435 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' HYP . . . . . 0.628 ' HA ' HH21 ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -63.54 -33.06 74.76 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.462 ' SG ' ' HG3' ' A' ' 20' ' ' ARG . 30.8 t -78.8 -27.21 44.39 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -174.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -89.37 -32.25 17.39 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 124.046 0.938 . . . . 0.0 112.358 169.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 1.075 ' HB3' ' CD ' ' A' ' 27' ' ' HYP . 0.7 OUTLIER -86.37 -150.2 0.15 Allowed 'General case' 0 CA--C 1.565 1.537 0 CA-C-N 119.541 1.064 . . . . 0.0 110.454 169.499 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HYP . . . . . 1.075 ' CD ' ' HB3' ' A' ' 26' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.2 t -75.99 -63.25 1.35 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -179.96 -96.74 0.1 Allowed Glycine 0 N--CA 1.478 1.476 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.5 -98.3 1.27 Allowed Glycine 0 N--CA 1.481 1.67 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.44 0 O-C-N 120.521 -1.576 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.424 0 CA-C-O 119.968 -0.351 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 45.8 t -115.26 65.8 0.69 Allowed 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 123.624 0.77 . . . . 0.0 109.909 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 99.3 m -91.85 72.72 5.7 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 169.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.86 -128.1 0.42 Allowed Glycine 0 CA--C 1.553 2.423 0 CA-C-O 117.846 -1.53 . . . . 0.0 116.622 -169.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -38.1 -30.75 0.17 Allowed 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 125.144 3.896 . . . . 0.0 121.474 172.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -116.85 89.59 3.15 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 170.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -170.52 -53.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.565 1.146 . . . . 0.0 109.736 -168.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.05 -49.13 60.2 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 172.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.73 64.27 0.77 Allowed 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 118.496 0.589 . . . . 0.0 110.886 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 36.0 t -83.22 106.6 15.13 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.312 0.645 . . . . 0.0 109.61 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -141.58 128.55 20.69 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 116.989 -1.481 . . . . 0.0 108.276 -169.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.537 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -117.67 56.01 0.85 Allowed 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 124.612 1.165 . . . . 0.0 112.451 174.363 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.23 13.32 67.91 Favored Glycine 0 CA--C 1.577 3.945 0 O-C-N 120.454 -1.404 . . . . 0.0 113.563 166.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -91.54 163.79 14.02 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.16 2.184 . . . . 0.0 115.158 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -91.2 -62.67 1.39 Allowed 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 113.042 -1.89 . . . . 0.0 109.206 167.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.23 139.58 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.233 169.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.66 84.41 1.4 Allowed Glycine 0 N--CA 1.486 1.977 0 C-N-CA 123.188 0.423 . . . . 0.0 113.065 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.18 161.27 33.56 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -169.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -72.11 -33.66 68.0 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 173.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.2 m -90.23 -19.41 24.18 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.48 2.029 . . . . 0.0 116.48 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -89.34 -35.53 16.04 Favored 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 124.677 1.191 . . . . 0.0 112.305 169.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -70.95 145.26 50.2 Favored 'General case' 0 CA--C 1.569 1.711 0 CA-C-O 117.253 -1.356 . . . . 0.0 111.201 169.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.9 m -88.0 99.31 12.06 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.563 -171.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.72 -97.29 0.11 Allowed Glycine 0 N--CA 1.479 1.552 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.82 99.29 0.12 Allowed Glycine 0 N--CA 1.477 1.399 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.46 0 O-C-N 120.535 -1.567 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_